BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ackermann M, Verleden SE, Kuehnel M, Haverich A, Welte T, Laenger F, Vanstapel A, Werlein C, Stark H, Tzankov A, Li WW, Li VW, Mentzer SJ, Jonigk D. Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19. N Engl J Med 2020;383:120-8. [PMID: 32437596 DOI: 10.1056/NEJMoa2015432] [Cited by in Crossref: 1993] [Cited by in F6Publishing: 1253] [Article Influence: 996.5] [Reference Citation Analysis]
Number Citing Articles
1 Frydman GH, Streiff MB, Connors JM, Piazza G. The Potential Role of Coagulation Factor Xa in the Pathophysiology of COVID-19: A Role for Anticoagulants as Multimodal Therapeutic Agents. TH Open 2020;4:e288-99. [PMID: 33043235 DOI: 10.1055/s-0040-1718415] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
2 Chernyak BV, Popova EN, Prikhodko AS, Grebenchikov OA, Zinovkina LA, Zinovkin RA. COVID-19 and Oxidative Stress. Biochemistry (Mosc) 2020;85:1543-53. [PMID: 33705292 DOI: 10.1134/S0006297920120068] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 15.0] [Reference Citation Analysis]
3 Blasiak A, Lim JJ, Seah SGK, Kee T, Remus A, Chye H, Wong PS, Hooi L, Truong ATL, Le N, Chan CEZ, Desai R, Ding X, Hanson BJ, Chow EK, Ho D. IDentif.AI: Rapidly optimizing combination therapy design against severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Cov-2) with digital drug development. Bioeng Transl Med 2021;6:e10196. [PMID: 33532594 DOI: 10.1002/btm2.10196] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Ma L, Sahu SK, Cano M, Kuppuswamy V, Bajwa J, McPhatter J, Pine A, Meizlish M, Goshua G, Chang CH, Zhang H, Price C, Bahel P, Rinder H, Lei T, Day A, Reynolds D, Wu X, Schriefer R, Rauseo AM, Goss CW, O'Halloran JA, Presti RM, Kim AH, Gelman AE, Cruz CD, Lee AI, Mudd P, Chun HJ, Atkinson JP, Kulkarni HS. Increased complement activation is a distinctive feature of severe SARS-CoV-2 infection. bioRxiv 2021:2021. [PMID: 33655244 DOI: 10.1101/2021.02.22.432177] [Cited by in Crossref: 7] [Article Influence: 7.0] [Reference Citation Analysis]
5 Deinhardt-Emmer S, Böttcher S, Häring C, Giebeler L, Henke A, Zell R, Jungwirth J, Jordan PM, Werz O, Hornung F, Brandt C, Marquet M, Mosig AS, Pletz MW, Schacke M, Rödel J, Heller R, Nietzsche S, Löffler B, Ehrhardt C. SARS-CoV-2 causes severe epithelial inflammation and barrier dysfunction. J Virol 2021:JVI. [PMID: 33637603 DOI: 10.1128/JVI.00110-21] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 9.0] [Reference Citation Analysis]
6 van Dam LF, Kroft LJM, van der Wal LI, Cannegieter SC, Eikenboom J, de Jonge E, Huisman MV, Klok FA. Clinical and computed tomography characteristics of COVID-19 associated acute pulmonary embolism: A different phenotype of thrombotic disease? Thromb Res 2020;193:86-9. [PMID: 32531548 DOI: 10.1016/j.thromres.2020.06.010] [Cited by in Crossref: 71] [Cited by in F6Publishing: 64] [Article Influence: 35.5] [Reference Citation Analysis]
7 Srivastava SP, Srivastava R, Chand S, Goodwin JE. Coronavirus Disease (COVID)-19 and Diabetic Kidney Disease. Pharmaceuticals (Basel) 2021;14:751. [PMID: 34451848 DOI: 10.3390/ph14080751] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Li Bassi G, Suen JY, Dalton HJ, White N, Shrapnel S, Fanning JP, Liquet B, Hinton S, Vuorinen A, Booth G, Millar JE, Forsyth S, Panigada M, Laffey J, Brodie D, Fan E, Torres A, Chiumello D, Corley A, Elhazmi A, Hodgson C, Ichiba S, Luna C, Murthy S, Nichol A, Ng PY, Ogino M, Pesenti A, Trieu HT, Fraser JF; COVID-19 Critical Care Consortium. An appraisal of respiratory system compliance in mechanically ventilated covid-19 patients. Crit Care 2021;25:199. [PMID: 34108029 DOI: 10.1186/s13054-021-03518-4] [Reference Citation Analysis]
9 Ricke-Hoch M, Stelling E, Lasswitz L, Gunesch AP, Kasten M, Zapatero-Belinchón FJ, Brogden G, Gerold G, Pietschmann T, Montiel V, Balligand JL, Facciotti F, Hirsch E, Gausepohl T, Elbahesh H, Rimmelzwaan GF, Höfer A, Kühnel MP, Jonigk D, Eigendorf J, Tegtbur U, Mink L, Scherr M, Illig T, Schambach A, Pfeffer TJ, Hilfiker A, Haverich A, Hilfiker-Kleiner D. Impaired immune response mediated by prostaglandin E2 promotes severe COVID-19 disease. PLoS One 2021;16:e0255335. [PMID: 34347801 DOI: 10.1371/journal.pone.0255335] [Reference Citation Analysis]
10 Barrett CD, Moore HB, Moore EE, Benjamin Christie D, Orfanos S, Anez‐bustillos L, Jhunjhunwala R, Hussain S, Shaefi S, Wang J, Hajizadeh N, Baedorf‐kassis EN, Al‐shammaa A, Capers K, Banner‐goodspeed V, Wright FL, Bull T, Moore PK, Nemec H, Thomas Buchanan J, Nonnemacher C, Rajcooar N, Ramdeo R, Yacoub M, Guevara A, Espinal A, Hattar L, Moraco A, Mcintyre R, Talmor DS, Sauaia A, Yaffe MB. MUlticenter STudy of tissue plasminogen activator (alteplase) use in COVID‐19 severe respiratory failure (MUST COVID): A retrospective cohort study. Res Pract Thromb Haemost 2022;6. [DOI: 10.1002/rth2.12669] [Reference Citation Analysis]
11 Carlsten C, Gulati M, Hines S, Rose C, Scott K, Tarlo SM, Torén K, Sood A, de la Hoz RE. COVID-19 as an occupational disease. Am J Ind Med 2021;64:227-37. [PMID: 33491195 DOI: 10.1002/ajim.23222] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 10.0] [Reference Citation Analysis]
12 Kintscher U, Slagman A, Domenig O, Röhle R, Konietschke F, Poglitsch M, Möckel M. Plasma Angiotensin Peptide Profiling and ACE (Angiotensin-Converting Enzyme)-2 Activity in COVID-19 Patients Treated With Pharmacological Blockers of the Renin-Angiotensin System. Hypertension 2020;76:e34-6. [PMID: 32851897 DOI: 10.1161/HYPERTENSIONAHA.120.15841] [Cited by in Crossref: 21] [Cited by in F6Publishing: 10] [Article Influence: 10.5] [Reference Citation Analysis]
13 Dwivedi S, Choudhary P, Gupta A, Singh S. The cross-talk between mucormycosis, steroids and diabetes mellitus amidst the global contagion of COVID-19. Crit Rev Microbiol 2022;:1-16. [PMID: 35324372 DOI: 10.1080/1040841X.2022.2052795] [Reference Citation Analysis]
14 Gutierrez Amezcua JM, Jain R, Kleinman G, Muh CR, Guzzetta M, Folkerth R, Snuderl M, Placantonakis DG, Galetta SL, Hochman S, Zagzag D. COVID-19-Induced Neurovascular Injury: a Case Series with Emphasis on Pathophysiological Mechanisms. SN Compr Clin Med 2020;2:2109-25. [PMID: 33106782 DOI: 10.1007/s42399-020-00598-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
15 Perico L, Benigni A, Casiraghi F, Ng LFP, Renia L, Remuzzi G. Immunity, endothelial injury and complement-induced coagulopathy in COVID-19. Nat Rev Nephrol. 2021;17:46-64. [PMID: 33077917 DOI: 10.1038/s41581-020-00357-4] [Cited by in Crossref: 85] [Cited by in F6Publishing: 81] [Article Influence: 42.5] [Reference Citation Analysis]
16 Miró Ò, Llorens P, Jiménez S, Piñera P, Burillo-Putze G, Martín A, Martín-Sánchez FJ, González Del Castillo J; Spanish Investigators on Emergency Situations TeAm (SIESTA) network. Frequency of five cardiovascular/hemostatic entities as primary manifestations of SARS-CoV-2 infection: Results of the UMC-19-S2. Int J Cardiol 2021;330:268-72. [PMID: 33529670 DOI: 10.1016/j.ijcard.2021.01.051] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Allnoch L, Beythien G, Leitzen E, Becker K, Kaup FJ, Stanelle-Bertram S, Schaumburg B, Mounogou Kouassi N, Beck S, Zickler M, Herder V, Gabriel G, Baumgärtner W. Vascular Inflammation Is Associated with Loss of Aquaporin 1 Expression on Endothelial Cells and Increased Fluid Leakage in SARS-CoV-2 Infected Golden Syrian Hamsters. Viruses 2021;13:639. [PMID: 33918079 DOI: 10.3390/v13040639] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
18 Santamarina MG, Beddings I, Lomakin FM, Boisier Riscal D, Gutiérrez Claveria M, Vidal Marambio J, Retamal Báez N, Pavez Novoa C, Reyes Allende C, Ferreira Perey P, Gutiérrez Torres M, Villalobos Mazza C, Vergara Sagredo C, Ahumada Bermejo S, Labarca Mellado E, Barthel Munchmeyer E, Marchant Ramos S, Volpacchio M, Vega J. Sildenafil for treating patients with COVID-19 and perfusion mismatch: a pilot randomized trial. Crit Care 2022;26:1. [PMID: 34980198 DOI: 10.1186/s13054-021-03885-y] [Reference Citation Analysis]
19 Del Turco S, Vianello A, Ragusa R, Caselli C, Basta G. COVID-19 and cardiovascular consequences: Is the endothelial dysfunction the hardest challenge? Thromb Res 2020;196:143-51. [PMID: 32871306 DOI: 10.1016/j.thromres.2020.08.039] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 14.0] [Reference Citation Analysis]
20 Situmeang RFV, Stevano R, Sutanto R. COVID-19 as a trigger of cerebral venous sinus thrombosis in a patient with autoimmune hyperthyroidism: a case report. Egypt J Neurol Psychiatry Neurosurg 2022;58. [DOI: 10.1186/s41983-022-00476-8] [Reference Citation Analysis]
21 Deinhardt-Emmer S, Wittschieber D, Sanft J, Kleemann S, Elschner S, Haupt KF, Vau V, Häring C, Rödel J, Henke A, Ehrhardt C, Bauer M, Philipp M, Gaßler N, Nietzsche S, Löffler B, Mall G. Early postmortem mapping of SARS-CoV-2 RNA in patients with COVID-19 and the correlation with tissue damage. Elife 2021;10:e60361. [PMID: 33781385 DOI: 10.7554/eLife.60361] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
22 Gross A, Albrecht T. One year of COVID-19 pandemic: what we Radiologists have learned about imaging. Rofo 2021. [PMID: 34649291 DOI: 10.1055/a-1522-3155] [Reference Citation Analysis]
23 Zdanyte M, Rath D, Gawaz M, Geisler T. Venous Thrombosis and SARS-CoV-2. Hamostaseologie 2021. [PMID: 34879422 DOI: 10.1055/a-1661-0283] [Reference Citation Analysis]
24 Shibeeb S, Ahmad MN. Thrombotic and Hypercoagulability Complications of COVID-19: An Update. J Blood Med 2021;12:785-93. [PMID: 34512059 DOI: 10.2147/JBM.S316014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
25 Cyprian FS, Suleman M, Abdelhafez I, Doudin A, Masud Danjuma M, Mir FA, Parray A, Yousaf Z, Siddiqui MYA, Abdelmajid A, Mulhim M, Al-Shokri S, Abukhattab M, Shaheen R, Elkord E, Al-Khal AL, Elzouki AN, Girardi G. Complement C5a and Clinical Markers as Predictors of COVID-19 Disease Severity and Mortality in a Multi-Ethnic Population. Front Immunol 2021;12:707159. [PMID: 34966381 DOI: 10.3389/fimmu.2021.707159] [Reference Citation Analysis]
26 Moody WE, Mahmoud-Elsayed HM, Senior J, Gul U, Khan-Kheil AM, Horne S, Banerjee A, Bradlow WM, Huggett R, Hothi SS, Shahid M, Steeds RP. Impact of Right Ventricular Dysfunction on Mortality in Patients Hospitalized With COVID-19, According to Race. CJC Open 2021;3:91-100. [PMID: 32984798 DOI: 10.1016/j.cjco.2020.09.016] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 8.0] [Reference Citation Analysis]
27 Han CY, Tarr AM, Gewirtz AN, Kaunzner UW, Roy-Burman P, Cutler TS, MacGowan DJ. Brachial plexopathy as a complication of COVID-19. BMJ Case Rep 2021;14:e237459. [PMID: 33766961 DOI: 10.1136/bcr-2020-237459] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
28 Tzankov A, Jonigk D. Unlocking the lockdown of science and demystifying COVID-19: how autopsies contribute to our understanding of a deadly pandemic. Virchows Arch 2020;477:331-3. [PMID: 32648040 DOI: 10.1007/s00428-020-02887-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
29 Trinity JD, Craig JC, Fermoyle CC, McKenzie AI, Lewis MT, Park SH, Rondina MT, Richardson RS. Impact of presymptomatic COVID-19 on vascular and skeletal muscle function: a case study. J Appl Physiol (1985) 2021;130:1961-70. [PMID: 34002634 DOI: 10.1152/japplphysiol.00236.2021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Invernizzi A. The impact of COVID-19 on the retina: clinical features and management considerations. Expert Review of Ophthalmology. [DOI: 10.1080/17469899.2022.2021877] [Reference Citation Analysis]
31 Xu S, Liu Y, Ding Y, Luo S, Zheng X, Wu X, Liu Z, Ilyas I, Chen S, Han S, Little PJ, Jain MK, Weng J. The zinc finger transcription factor, KLF2, protects against COVID-19 associated endothelial dysfunction. Signal Transduct Target Ther 2021;6:266. [PMID: 34253708 DOI: 10.1038/s41392-021-00690-5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
32 Zou M, Su X, Wang L, Yi X, Qiu Y, Yin X, Zhou X, Niu X, Wang L, Su M. The Molecular Mechanism of Multiple Organ Dysfunction and Targeted Intervention of COVID-19 Based on Time-Order Transcriptomic Analysis. Front Immunol 2021;12:729776. [PMID: 34504502 DOI: 10.3389/fimmu.2021.729776] [Reference Citation Analysis]
33 Rahimi N. C-type Lectin CD209L/L-SIGN and CD209/DC-SIGN: Cell Adhesion Molecules Turned to Pathogen Recognition Receptors. Biology (Basel) 2020;10:1. [PMID: 33375175 DOI: 10.3390/biology10010001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
34 McCoy MG, Nascimento DW, Veleeparambil M, Murtazina R, Gao D, Tkachenko S, Podrez E, Byzova TV. Endothelial TLR2 promotes proangiogenic immune cell recruitment and tumor angiogenesis. Sci Signal 2021;14:eabc5371. [PMID: 33986920 DOI: 10.1126/scisignal.abc5371] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Grillet F, Busse-Coté A, Calame P, Behr J, Delabrousse E, Aubry S. COVID-19 pneumonia: microvascular disease revealed on pulmonary dual-energy computed tomography angiography. Quant Imaging Med Surg 2020;10:1852-62. [PMID: 32879862 DOI: 10.21037/qims-20-708] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
36 Brandão SCS, Godoi ETAM, Ramos JOX, Melo LMMP, Dompieri LT, Brindeiro Filho DF, Sarinho ESC. The Role of the Endothelium in Severe COVID-19. Arq Bras Cardiol 2020;115:1184-9. [PMID: 33470322 DOI: 10.36660/abc.20200643] [Reference Citation Analysis]
37 An X, Duan L, Zhang YH, Jin, Zhao S, Zhou RR, Duan Y, Lian F, Tong X. The three syndromes and six Chinese patent medicine study during the recovery phase of COVID-19. Chin Med 2021;16:44. [PMID: 34099015 DOI: 10.1186/s13020-021-00454-x] [Reference Citation Analysis]
38 Yang K, Wen G, Wang J, Zhou S, Da W, Meng Y, Xue Y, Tao L. Complication and Sequelae of COVID-19: What Should We Pay Attention to in the Post-Epidemic Era. Front Immunol 2021;12:711741. [PMID: 34539642 DOI: 10.3389/fimmu.2021.711741] [Reference Citation Analysis]
39 Wagner PD, Malhotra A, Prisk GK. Using pulmonary gas exchange to estimate shunt and deadspace in lung disease: Theoretical approach and practical basis. J Appl Physiol (1985) 2022. [PMID: 35323050 DOI: 10.1152/japplphysiol.00621.2021] [Reference Citation Analysis]
40 Natarajan P, Kanchi M, Gunaseelan V, Sigamani A, James H, Kumar B. Coronavirus and Homo Sapiens in Coronavirus Disease 2019 (COVID-19). Journal of Cardiac Critical Care TSS 2020;4:121-31. [DOI: 10.1055/s-0040-1721190] [Reference Citation Analysis]
41 Merdji H, Mayeur S, Schenck M, Oulehri W, Clere-Jehl R, Cunat S, Herbrecht JE, Janssen-Langenstein R, Nicolae A, Helms J, Meziani F, Chenard MP; CRICS TRIGGERSEP Group (Clinical Research in Intensive Care, Sepsis Trial Group for Global Evaluation, Research in Sepsis). Histopathological features in fatal COVID-19 acute respiratory distress syndrome. Med Intensiva (Engl Ed) 2021;45:261-70. [PMID: 34059216 DOI: 10.1016/j.medine.2021.02.005] [Reference Citation Analysis]
42 Piazza G, Campia U, Hurwitz S, Snyder JE, Rizzo SM, Pfeferman MB, Morrison RB, Leiva O, Fanikos J, Nauffal V, Almarzooq Z, Goldhaber SZ. Registry of Arterial and Venous Thromboembolic Complications in Patients With COVID-19. J Am Coll Cardiol 2020;76:2060-72. [PMID: 33121712 DOI: 10.1016/j.jacc.2020.08.070] [Cited by in Crossref: 59] [Cited by in F6Publishing: 52] [Article Influence: 29.5] [Reference Citation Analysis]
43 Simon TP, Stoppe C, Breuer T, Stiehler L, Dreher M, Kersten A, Kluge S, Karakas M, Zechendorf E, Marx G, Martin L. Prognostic Value of Bioactive Adrenomedullin in Critically Ill Patients with COVID-19 in Germany: An Observational Cohort Study. J Clin Med 2021;10:1667. [PMID: 33924637 DOI: 10.3390/jcm10081667] [Reference Citation Analysis]
44 Heissig B, Salama Y, Takahashi S, Osada T, Hattori K. The multifaceted role of plasminogen in inflammation. Cell Signal 2020;75:109761. [PMID: 32861744 DOI: 10.1016/j.cellsig.2020.109761] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 10.0] [Reference Citation Analysis]
45 Nicoletti AS, Visacri MB, da Ronda CRDSC, Vasconcelos PEDNS, Quintanilha JCF, de Souza RN, Ventura DS, Eguti A, Silva LFS, Perroud Junior MW, Catharino RR, Reis LO, Dos Santos LA, Durán N, Fávaro WJ, Lancellotti M, da Costa JL, Moriel P, Pincinato EC. Differentially expressed plasmatic microRNAs in Brazilian patients with Coronavirus disease 2019 (COVID-19): preliminary results. Mol Biol Rep 2022. [PMID: 35301654 DOI: 10.1007/s11033-022-07338-9] [Reference Citation Analysis]
46 Smeda M, Chlopicki S. Endothelial barrier integrity in COVID-19-dependent hyperinflammation: does the protective facet of platelet function matter? Cardiovasc Res 2020;116:e118-21. [PMID: 32707576 DOI: 10.1093/cvr/cvaa190] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
47 Chen R, Gao Y, Chen M, Jian W, Lei C, Zheng J, Li S. Impaired pulmonary function in discharged patients with COVID-19: more work ahead. Eur Respir J 2020;56:2002194. [PMID: 32586883 DOI: 10.1183/13993003.02194-2020] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
48 Casciola-Rosen L, Thiemann DR, Andrade F, Trejo Zambrano MI, Hooper JE, Leonard E, Spangler J, Cox AL, Machamer C, Sauer L, Laeyendecker O, Garibaldi BT, Ray SC, Mecoli C, Christopher-Stine L, Gutierrez-Alamillo L, Yang Q, Hines D, Clarke W, Rothman RE, Pekosz A, Fenstermacher K, Wang Z, Zeger SL, Rosen A. IgM autoantibodies recognizing ACE2 are associated with severe COVID-19. medRxiv 2020:2020. [PMID: 33083808 DOI: 10.1101/2020.10.13.20211664] [Cited by in Crossref: 13] [Cited by in F6Publishing: 2] [Article Influence: 6.5] [Reference Citation Analysis]
49 Lucas K, Fröhlich-Nowoisky J, Oppitz N, Ackermann M. Cinnamon and Hop Extracts as Potential Immunomodulators for Severe COVID-19 Cases. Front Plant Sci 2021;12:589783. [PMID: 33719281 DOI: 10.3389/fpls.2021.589783] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
50 Martyanov AA, Boldova AE, Stepanyan MG, An OI, Gur'ev AS, Kassina DV, Volkov AY, Balatskiy AV, Butylin AA, Karamzin SS, Filimonova EV, Tsarenko SV, Roumiantsev SA, Rumyantsev AG, Panteleev MA, Ataullakhanov FI, Sveshnikova AN. Longitudinal multiparametric characterization of platelet dysfunction in COVID-19: Effects of disease severity, anticoagulation therapy and inflammatory status. Thrombosis Research 2022;211:27-37. [DOI: 10.1016/j.thromres.2022.01.013] [Reference Citation Analysis]
51 Brandão SCS, Godoi ETAM, Ramos JOX, de Melo LMMP, Sarinho ESC. Severe COVID-19: understanding the role of immunity, endothelium, and coagulation in clinical practice. J Vasc Bras 2020;19:e20200131. [PMID: 34211530 DOI: 10.1590/1677-5449.200131] [Reference Citation Analysis]
52 Farhang-sardroodi S, Ghaemi MS, Craig M, Ooi HK, Heffernan JM. . MBE 2022;19:5813-31. [DOI: 10.3934/mbe.2022272] [Reference Citation Analysis]
53 Vogel DJ, Formenti F, Retter AJ, Vasques F, Camporota L. A left shift in the oxyhaemoglobin dissociation curve in patients with severe coronavirus disease 2019 (COVID-19). Br J Haematol 2020;191:390-3. [PMID: 33037620 DOI: 10.1111/bjh.17128] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
54 Lockhart SM, O'Rahilly S. When Two Pandemics Meet: Why Is Obesity Associated with Increased COVID-19 Mortality? Med (N Y) 2020;1:33-42. [PMID: 32838359 DOI: 10.1016/j.medj.2020.06.005] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 9.5] [Reference Citation Analysis]
55 Bhogal P, Makalanda L, Hassan AE, Fiorella D, Andersson T, Ahmad M, Bäzner H, Jaffer O, Henkes H. COVID-19 and Delayed Cerebral Ischemia-More in Common Than First Meets the Eye. J Clin Med 2021;10:2646. [PMID: 34208470 DOI: 10.3390/jcm10122646] [Reference Citation Analysis]
56 Pruthi H, Muthu V, Bhujade H, Sharma A, Baloji A, Ratnakara RG, Bal A, Singh H, Sandhu MS, Negi S, Chakrabarti A, Singhal M. Pulmonary Artery Pseudoaneurysm in COVID-19-Associated Pulmonary Mucormycosis: Case Series and Systematic Review of the Literature. Mycopathologia 2021. [PMID: 34936060 DOI: 10.1007/s11046-021-00610-9] [Reference Citation Analysis]
57 Meini S, Zanichelli A, Sbrojavacca R, Iuri F, Roberts AT, Suffritti C, Tascini C. Understanding the Pathophysiology of COVID-19: Could the Contact System Be the Key? Front Immunol 2020;11:2014. [PMID: 32849666 DOI: 10.3389/fimmu.2020.02014] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 7.5] [Reference Citation Analysis]
58 Henrina J, Santosa Putra IC, Cahyadi I, Lawrensia S, Hadi Gunawan HF, Cahyadi A, Franke J, Suciadi LP. Clinical characteristics and outcomes of venous thromboembolism in patients hospitalized for COVID-19: Systematic review and meta-analysis. Thrombosis Update 2021;2:100037. [DOI: 10.1016/j.tru.2021.100037] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
59 Welte T. SARS-CoV-2-triggered Immune Reaction: For COVID-19, Nothing Is as Old as Yesterday's Knowledge. Am J Respir Crit Care Med 2021;203:156. [PMID: 33270539 DOI: 10.1164/rccm.202011-4194ED] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
60 González-Castro A, Fernandez-Rodríguez A, Cuenca Fito E, Suberviola-Cañas B, Peñasco Y, Rodríguez-Borregán JC. [Comparison of the characteristics of patients with type 2 coronavirus disease and seasonal influenza admitted to an intensive care unit]. Med Intensiva (Engl Ed) 2021. [PMID: 33994615 DOI: 10.1016/j.medin.2021.03.009] [Reference Citation Analysis]
61 Boyd S, Sheng Loh K, Lynch J, Alrashed D, Muzzammil S, Marsh H, Masoud M, Bin Ihsan S, Martin-loeches I. Elevated Rates of Ventilator-Associated Pneumonia and COVID-19 Associated Pulmonary Aspergillosis in Critically Ill Patients with SARS-CoV2 Infection in the Second Wave: A Retrospective Chart Review. Antibiotics 2022;11:632. [DOI: 10.3390/antibiotics11050632] [Reference Citation Analysis]
62 Sweet AN, André NM, Stout AE, Licitra BN, Whittaker GR. Clinical and Molecular Relationships between COVID-19 and Feline Infectious Peritonitis (FIP). Viruses 2022;14:481. [DOI: 10.3390/v14030481] [Reference Citation Analysis]
63 Bugatti A, Filippini F, Bardelli M, Zani A, Chiodelli P, Messali S, Caruso A, Caccuri F. SARS-CoV-2 Infects Human ACE2-Negative Endothelial Cells through an αvβ3 Integrin-Mediated Endocytosis Even in the Presence of Vaccine-Elicited Neutralizing Antibodies. Viruses 2022;14:705. [DOI: 10.3390/v14040705] [Reference Citation Analysis]
64 Tsyganova EV, Glukhoedova NV, Zhilenkova AS, Fedoseeva TI, Iushchuk EN, Smetneva NS. COVID-19 and features of cardiovascular involvement. Terapevticheskii arkhiv 2021;93:1091-9. [DOI: 10.26442/00403660.2021.09.201036] [Reference Citation Analysis]
65 Mondello C, Roccuzzo S, Malfa O, Sapienza D, Gualniera P, Ventura Spagnolo E, Di Nunno N, Salerno M, Pomara C, Asmundo A. Pathological Findings in COVID-19 as a Tool to Define SARS-CoV-2 Pathogenesis. A Systematic Review. Front Pharmacol 2021;12:614586. [PMID: 33867981 DOI: 10.3389/fphar.2021.614586] [Reference Citation Analysis]
66 Agostinis C, Mangogna A, Balduit A, Aghamajidi A, Ricci G, Kishore U, Bulla R. COVID-19, Pre-Eclampsia, and Complement System. Front Immunol 2021;12:775168. [PMID: 34868042 DOI: 10.3389/fimmu.2021.775168] [Reference Citation Analysis]
67 Zhang L, Zetter MA, Guerra EC, Hernández VS, Mahata SK, Eiden LE. ACE2 in the second act of COVID-19 syndrome: Peptide dysregulation and possible correction with oestrogen. J Neuroendocrinol 2021;33:e12935. [PMID: 33462852 DOI: 10.1111/jne.12935] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
68 Yekelchyk M, Madan E, Wilhelm J, Short KR, Palma AM, Liao L, Camacho D, Nkadori E, Winters MT, Rice ES, Rolim I, Cruz-Duarte R, Pelham CJ, Nagane M, Gupta K, Chaudhary S, Braun T, Pillappa R, Parker MS, Menter T, Matter M, Haslbauer JD, Tolnay M, Galior KD, Matkwoskyj KA, McGregor SM, Muller LK, Rakha EA, Lopez-Beltran A, Drapkin R, Ackermann M, Fisher PB, Grossman SR, Godwin AK, Kulasinghe A, Martinez I, Marsh CB, Tang B, Wicha MS, Won KJ, Tzankov A, Moreno E, Gogna R. Flower lose, a cell fitness marker, predicts COVID-19 prognosis. EMBO Mol Med 2021;13:e13714. [PMID: 34661368 DOI: 10.15252/emmm.202013714] [Reference Citation Analysis]
69 Stoddart P, Satchell SC, Ramnath R. Cerebral microvascular endothelial glycocalyx damage, its implications on the blood-brain barrier and a possible contributor to cognitive impairment. Brain Research 2022. [DOI: 10.1016/j.brainres.2022.147804] [Reference Citation Analysis]
70 Habashi NM, Camporota L, Gatto LA, Nieman G. Functional pathophysiology of SARS-CoV-2-induced acute lung injury and clinical implications. J Appl Physiol (1985) 2021;130:877-91. [PMID: 33444117 DOI: 10.1152/japplphysiol.00742.2020] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
71 Middleton EA, Zimmerman GA. COVID-19-Associated Acute Respiratory Distress Syndrome: Lessons from Tissues and Cells. Crit Care Clin 2021;37:777-93. [PMID: 34548133 DOI: 10.1016/j.ccc.2021.05.004] [Reference Citation Analysis]
72 Veenith T, Fisher BA, Slade D, Rowe A, Sharpe R, Thickett DR, Whitehouse T, Rowland M, Scriven J, Parekh D, Bowden SJ, Savage JS, Richards D, Bion J, Kearns P, Gates S; CATALYST Trial Investigators., CATALYST investigators. CATALYST trial protocol: a multicentre, open-label, phase II, multiarm trial for an early and accelerated evaluation of the potential treatments for COVID-19 in hospitalised adults. BMJ Open 2021;11:e050202. [PMID: 34764169 DOI: 10.1136/bmjopen-2021-050202] [Reference Citation Analysis]
73 Carroll T, Fox D, van Doremalen N, Ball E, Morris MK, Sotomayor-Gonzalez A, Servellita V, Rustagi A, Yinda CK, Fritts L, Port JR, Ma ZM, Holbrook M, Schulz J, Blish CA, Hanson C, Chiu CY, Munster V, Stanley S, Miller CJ. The B.1.427/1.429 (epsilon) SARS-CoV-2 variants are more virulent than ancestral B.1 (614G) in Syrian hamsters. bioRxiv 2021:2021. [PMID: 34462750 DOI: 10.1101/2021.08.25.457626] [Reference Citation Analysis]
74 Bian Y, Le Y, Du H, Chen J, Zhang P, He Z, Wang Y, Yu S, Fang Y, Yu G, Ling J, Feng Y, Wei S, Huang J, Xiao L, Zheng Y, Yu Z, Li S. Efficacy and Safety of Anticoagulation Treatment in COVID-19 Patient Subgroups Identified by Clinical-Based Stratification and Unsupervised Machine Learning: A Matched Cohort Study. Front Med (Lausanne) 2021;8:786414. [PMID: 35004751 DOI: 10.3389/fmed.2021.786414] [Reference Citation Analysis]
75 Saha BK, Chong WH, Austin A, Kathuria R, Datar P, Shkolnik B, Beegle S, Chopra A. Pleural abnormalities in COVID-19: a narrative review. J Thorac Dis 2021;13:4484-99. [PMID: 34422375 DOI: 10.21037/jtd-21-542] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
76 Ooi MWX, Rajai A, Patel R, Gerova N, Godhamgaonkar V, Liong SY. Pulmonary thromboembolic disease in COVID-19 patients on CT pulmonary angiography - Prevalence, pattern of disease and relationship to D-dimer. Eur J Radiol 2020;132:109336. [PMID: 33069986 DOI: 10.1016/j.ejrad.2020.109336] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 9.0] [Reference Citation Analysis]
77 Wang J, Hajizadeh N, Shore-Lesserson L. The Value of Thromboelastography (TEG) in COVID-19 Critical Illness as Illustrated by a Case Series. J Cardiothorac Vasc Anesth 2021:S1053-0770(21)00934-4. [PMID: 34802831 DOI: 10.1053/j.jvca.2021.10.015] [Reference Citation Analysis]
78 Faggioli PM, Mumoli N, Mazzone A. Iloprost in COVID-19: The Rationale of Therapeutic Benefit. Front Cardiovasc Med 2021;8:649499. [PMID: 33969013 DOI: 10.3389/fcvm.2021.649499] [Reference Citation Analysis]
79 Zhang J, Huang X, Ding D, Tao Z. Platelet-driven coagulopathy in COVID-19 patients: in comparison to seasonal influenza cases. Exp Hematol Oncol 2021;10:34. [PMID: 34059141 DOI: 10.1186/s40164-021-00228-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
80 Singer M. Outcomes for patients with COVID-19: known knowns, known unknowns, and unknown unknowns. Med J Aust 2021;214:20-1. [PMID: 33296509 DOI: 10.5694/mja2.50890] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
81 Hibbert KA, Goiffon RJ, Fogerty AE. Case 18-2021: An 81-Year-Old Man with Cough, Fever, and Shortness of Breath. N Engl J Med 2021;384:2332-40. [PMID: 34133863 DOI: 10.1056/NEJMcpc2100283] [Reference Citation Analysis]
82 Kwok S, Adam S, Ho JH, Iqbal Z, Turkington P, Razvi S, Le Roux CW, Soran H, Syed AA. Obesity: A critical risk factor in the COVID-19 pandemic. Clin Obes 2020;10:e12403. [PMID: 32857454 DOI: 10.1111/cob.12403] [Cited by in Crossref: 27] [Cited by in F6Publishing: 33] [Article Influence: 13.5] [Reference Citation Analysis]
83 Zhong P, Xu J, Yang D, Shen Y, Wang L, Feng Y, Du C, Song Y, Wu C, Hu X, Sun Y. COVID-19-associated gastrointestinal and liver injury: clinical features and potential mechanisms. Signal Transduct Target Ther 2020;5:256. [PMID: 33139693 DOI: 10.1038/s41392-020-00373-7] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 17.5] [Reference Citation Analysis]
84 Golden JW, Cline CR, Zeng X, Garrison AR, Carey BD, Mucker EM, White LE, Shamblin JD, Brocato RL, Liu J, Babka AM, Rauch HB, Smith JM, Hollidge BS, Fitzpatrick C, Badger CV, Hooper JW. Human angiotensin-converting enzyme 2 transgenic mice infected with SARS-CoV-2 develop severe and fatal respiratory disease. JCI Insight 2020;5:142032. [PMID: 32841215 DOI: 10.1172/jci.insight.142032] [Cited by in Crossref: 67] [Cited by in F6Publishing: 68] [Article Influence: 33.5] [Reference Citation Analysis]
85 van de Veerdonk FL, Netea MG. Blocking IL-1 to prevent respiratory failure in COVID-19. Crit Care 2020;24:445. [PMID: 32682440 DOI: 10.1186/s13054-020-03166-0] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 15.5] [Reference Citation Analysis]
86 Hernández-Píriz A, Tung-Chen Y, Jiménez-Virumbrales D, Ayala-Larrañaga I, Barba-Martín R, Canora-Lebrato J, Zapatero-Gaviria A, Casasola-Sánchez GG. Importance of Lung Ultrasound Follow-Up in Patients Who Had Recovered from Coronavirus Disease 2019: Results from a Prospective Study. J Clin Med 2021;10:3196. [PMID: 34300362 DOI: 10.3390/jcm10143196] [Reference Citation Analysis]
87 Lakshmanan HHS, Pore AA, Kohs TCL, Yazar F, Thompson RM, Jurney PL, Maddala J, Olson SR, Shatzel JJ, Vanapalli SA, McCarty OJT. Design of a Microfluidic Bleeding Chip to Evaluate Antithrombotic Agents for Use in COVID-19 Patients. Cell Mol Bioeng 2020;:1-9. [PMID: 32837586 DOI: 10.1007/s12195-020-00644-x] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
88 Serrano M, Espinosa G, Lalueza A, Bravo-Gallego LY, Diaz-Simón R, Garcinuño S, Gil-Etayo J, Moises J, Naranjo L, Prieto-González S, Ruiz-Ortiz E, Sánchez B, Moreno-Castaño AB, Díaz-Pedroche C, Viñas-Gomis O, Cervera R, Serrano A; APS-COVID 19 Study Group/European Forum on Antiphospholipid Antibodies. Beta-2-Glycoprotein-I Deficiency Could Precipitate an Antiphospholipid Syndrome-like Prothrombotic Situation in Patients With Coronavirus Disease 2019. ACR Open Rheumatol 2021;3:267-76. [PMID: 33738987 DOI: 10.1002/acr2.11245] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
89 Majumdar S, Murphy PM. Chemokine Regulation During Epidemic Coronavirus Infection. Front Pharmacol 2020;11:600369. [PMID: 33613280 DOI: 10.3389/fphar.2020.600369] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
90 Charpentier E, Soulat G, Fayol A, Hernigou A, Livrozet M, Grand T, Reverdito G, Al Haddad J, Dang Tran KD, Charpentier A, Clement O, Hulot JS, Mousseaux E. Visual lung damage CT score at hospital admission of COVID-19 patients and 30-day mortality. Eur Radiol 2021. [PMID: 33914118 DOI: 10.1007/s00330-021-07938-2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
91 Price LC, Garfield B, Bleakley C, Keeling AGM, Mcfadyen C, McCabe C, Ridge CA, Wort SJ, Price S, Arachchillage DJ. Rescue therapy with thrombolysis in patients with severe COVID-19-associated acute respiratory distress syndrome. Pulm Circ 2020;10:2045894020973906. [PMID: 33403100 DOI: 10.1177/2045894020973906] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
92 Clancy CS, Shaia C, Munster V, de Wit E, Hawman D, Okumura A, Feldmann H, Saturday G, Scott D. Histologic pulmonary lesions of SARS-CoV-2 in 4 nonhuman primate species: An institutional comparative review. Vet Pathol 2021;:3009858211067468. [PMID: 34963391 DOI: 10.1177/03009858211067468] [Reference Citation Analysis]
93 Porembskaya O, Toropova Y, Tomson V, Lobastov K, Laberko L, Kravchuk V, Saiganov S, Brill A. Pulmonary Artery Thrombosis: A Diagnosis That Strives for Its Independence. Int J Mol Sci 2020;21:E5086. [PMID: 32708482 DOI: 10.3390/ijms21145086] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
94 Enikeev D, Taratkin M, Efetov S, Shlomina A, Boldyreva M, Galkina I, Spivak L, Gitel E, Kuchieva A, Mikhailov V, Teoh JY, Herrmann TRW, Kikic Ž, Fomin V, Shariat SF, Glybochko P. Acute kidney injury in COVID-19: are kidneys the target or just collateral damage? A comprehensive assessment of viral RNA and AKI rate in patients with COVID-19. Curr Opin Urol 2021;31:363-8. [PMID: 33989230 DOI: 10.1097/MOU.0000000000000901] [Reference Citation Analysis]
95 Hranjec T, Estreicher M, Rogers B, Kohler L, Solomon R, Hennessy S, Cibulas M, Hurst D, Hegazy M, Lee J, Perez D, Doctor N, Kiffin C, Pigneri D, LaGuardia H, Shaw K, Arenas J, Rosenthal A, Katz RS, Sawyer RG, Pepe PE. Integral Use of Thromboelastography With Platelet Mapping to Guide Appropriate Treatment, Avoid Complications, and Improve Survival of Patients With Coronavirus Disease 2019-Related Coagulopathy. Crit Care Explor 2020;2:e0287. [PMID: 33381763 DOI: 10.1097/CCE.0000000000000287] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
96 Diorio C, McNerney KO, Lambert M, Paessler M, Anderson EM, Henrickson SE, Chase J, Liebling EJ, Burudpakdee C, Lee JH, Balamuth FB, Blatz AM, Chiotos K, Fitzgerald JC, Giglia TM, Gollomp K, Odom John AR, Jasen C, Leng T, Petrosa W, Vella LA, Witmer C, Sullivan KE, Laskin BL, Hensley SE, Bassiri H, Behrens EM, Teachey DT. Evidence of thrombotic microangiopathy in children with SARS-CoV-2 across the spectrum of clinical presentations. Blood Adv 2020;4:6051-63. [PMID: 33290544 DOI: 10.1182/bloodadvances.2020003471] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 14.5] [Reference Citation Analysis]
97 Ghosh K, Ghosh K. D-dimer: an analyte with increasing application in Covid-19 infection. Expert Rev Hematol 2022. [PMID: 35262442 DOI: 10.1080/17474086.2022.2052040] [Reference Citation Analysis]
98 Dou Q, Wei X, Zhou K, Yang S, Jia P. Cardiovascular Manifestations and Mechanisms in Patients with COVID-19. Trends Endocrinol Metab 2020;31:893-904. [PMID: 33172748 DOI: 10.1016/j.tem.2020.10.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
99 Klironomos S, Tzortzakakis A, Kits A, Öhberg C, Kollia E, Ahoromazdae A, Almqvist H, Aspelin Å, Martin H, Ouellette R, Al-Saadi J, Hasselberg M, Haghgou M, Pedersen M, Petersson S, Finnsson J, Lundberg J, Falk Delgado A, Granberg T. Nervous System Involvement in Coronavirus Disease 2019: Results from a Retrospective Consecutive Neuroimaging Cohort. Radiology 2020;297:E324-34. [PMID: 32729812 DOI: 10.1148/radiol.2020202791] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 13.5] [Reference Citation Analysis]
100 Moskvin S, Askhadulin E, Kochetkov A. Low-Level Laser Therapy in Prevention of the Development of Endothelial Dysfunction and Clinical Experience of Treatment and Rehabilitation of COVID-19 Patients. Rehabil Res Pract 2021;2021:6626932. [PMID: 33542837 DOI: 10.1155/2021/6626932] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
101 Greenspan H, San José Estépar R, Niessen WJ, Siegel E, Nielsen M. Position paper on COVID-19 imaging and AI: From the clinical needs and technological challenges to initial AI solutions at the lab and national level towards a new era for AI in healthcare. Med Image Anal 2020;66:101800. [PMID: 32890777 DOI: 10.1016/j.media.2020.101800] [Cited by in Crossref: 16] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
102 Cobb NL, Sathe NA, Duan KI, Seitz KP, Thau MR, Sung CC, Morrell ED, Mikacenic C, Kim HN, Liles WC, Luks AM, Town J, Pipavath S, Wurfel MM, Hough CL, West TE, Bhatraju PK. Comparison of Clinical Features and Outcomes in Critically Ill Patients Hospitalized with COVID-19 versus Influenza. Ann Am Thorac Soc 2021;18:632-40. [PMID: 33183067 DOI: 10.1513/AnnalsATS.202007-805OC] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 13.0] [Reference Citation Analysis]
103 Thoreau B, Galland J, Delrue M, Neuwirth M, Stepanian A, Chauvin A, Dellal A, Nallet O, Roriz M, Devaux M, London J, Martin-Lecamp G, Froissart A, Arab N, Ferron B, Groff MH, Queyrel V, Lorut C, Regard L, Berthoux E, Bayer G, Comarmond C, Lioger B, Mekinian A, Szwebel TA, Sené T, Amador-Borrero B, Mangin O, Sellier PO, Siguret V, Mouly S, Kevorkian JP, Lariboisière Covid Group, Vodovar D, Sene D. D-Dimer Level and Neutrophils Count as Predictive and Prognostic Factors of Pulmonary Embolism in Severe Non-ICU COVID-19 Patients. Viruses 2021;13:758. [PMID: 33926038 DOI: 10.3390/v13050758] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
104 Hanchard J, Capó-Vélez CM, Deusch K, Lidington D, Bolz SS. Stabilizing Cellular Barriers: Raising the Shields Against COVID-19. Front Endocrinol (Lausanne) 2020;11:583006. [PMID: 33101215 DOI: 10.3389/fendo.2020.583006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
105 Frara S, Allora A, Castellino L, di Filippo L, Loli P, Giustina A. COVID-19 and the pituitary. Pituitary 2021;24:465-81. [PMID: 33939057 DOI: 10.1007/s11102-021-01148-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
106 Pugliese L, Sbordone FP, Grimaldi F, Ricci F, DI Tosto F, Spiritigliozzi L, DI Donna C, Presicce M, DE Stasio V, Benelli L, D'Errico F, Pasqualetto M, Legramante JM, Materazzo M, Pellicciaro M, Buonomo OC, Vanni G, Rizza S, Bellia A, Floris R, Garaci F, Chiocchi M. Chest Computed Tomography Scoring in Patients With Novel Coronavirus-infected Pneumonia: Correlation With Clinical and Laboratory Features and Disease Outcome. In Vivo 2020;34:3735-46. [PMID: 33144492 DOI: 10.21873/invivo.12223] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
107 Mikhaleva LM, Cherniaev AL, Samsonova MV, Zayratyants OV, Kakturskiy LV, Vasyukova OA, Birukov AE, Kontorshchikov AS, Sorokina AV, Sinelnikov MY. Pathological Features in 100 Deceased Patients With COVID-19 in Correlation With Clinical and Laboratory Data. Pathol Oncol Res 2021;27:1609900. [PMID: 34421396 DOI: 10.3389/pore.2021.1609900] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
108 Colombo C, Garatti L, Ferrante G, Casadei F, Montalto C, Crimi G, Cogliati C, Ammirati E, Savonitto S, Morici N. Cardiovascular injuries and SARS-COV-2 infection: focus on elderly people. J Geriatr Cardiol 2021;18:534-48. [PMID: 34404990 DOI: 10.11909/j.issn.1671-5411.2021.07.001] [Reference Citation Analysis]
109 Hozayen SM, Zychowski D, Benson S, Lutsey PL, Haslbauer J, Tzankov A, Kaltenborn Z, Usher M, Shah S, Tignanelli CJ, Demmer RT. Outpatient and inpatient anticoagulation therapy and the risk for hospital admission and death among COVID-19 patients. EClinicalMedicine 2021;41:101139. [PMID: 34585129 DOI: 10.1016/j.eclinm.2021.101139] [Reference Citation Analysis]
110 Lv N, Zhao Y, Liu X, Ye L, Liang Z, Kang Y, Dong Y, Wang W, Kolliputi N, Shi L. Dysfunctional telomeres through mitostress-induced cGAS/STING activation to aggravate immune senescence and viral pneumonia. Aging Cell 2022;:e13594. [PMID: 35313074 DOI: 10.1111/acel.13594] [Reference Citation Analysis]
111 Yao H, Lu X, Chen Q, Xu K, Chen Y, Cheng M, Chen K, Cheng L, Weng T, Shi D, Liu F, Wu Z, Xie M, Wu H, Jin C, Zheng M, Wu N, Jiang C, Li L. Patient-derived SARS-CoV-2 mutations impact viral replication dynamics and infectivity in vitro and with clinical implications in vivo. Cell Discov. 2020;6:76. [PMID: 33298872 DOI: 10.1038/s41421-020-00226-1] [Cited by in Crossref: 26] [Cited by in F6Publishing: 17] [Article Influence: 13.0] [Reference Citation Analysis]
112 Gattinoni L, Marini JJ, Camporota L. The Respiratory Drive: An Overlooked Tile of COVID-19 Pathophysiology. Am J Respir Crit Care Med 2020;202:1079-80. [PMID: 32881583 DOI: 10.1164/rccm.202008-3142ED] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
113 de Oliveira JCP, Araujo WJB, Belczak SQ, Erzinger FL, de Oliveira LMP, Marques MA, Sarquis LM, Gutfilen B. Limb ischemia in patients with COVID-19. J Vasc Bras 2021;20:e20210004. [PMID: 34211543 DOI: 10.1590/1677-5449.210004] [Reference Citation Analysis]
114 Akella R, Raj R, Kannan L, Jacob A. Coexisting portal vein thrombosis and aortic thrombosis in a patient with COVID-19: A case report and literature review. IDCases 2022;28:e01509. [DOI: 10.1016/j.idcr.2022.e01509] [Reference Citation Analysis]
115 Kollias A, Kyriakoulis KG, Trontzas IP, Rapti V, Kyriakoulis IG, Theochari CA, Dimakakos E, Poulakou G, Syrigos K. High versus Standard Intensity of Thromboprophylaxis in Hospitalized Patients with COVID-19: A Systematic Review and Meta-Analysis. J Clin Med 2021;10:5549. [PMID: 34884258 DOI: 10.3390/jcm10235549] [Reference Citation Analysis]
116 Hottz ED, Bozza PT. Platelet‐leukocyte interactions in COVID‐19: Contributions to hypercoagulability, inflammation, and disease severity. Res Pract Thromb Haemost 2022;6. [DOI: 10.1002/rth2.12709] [Reference Citation Analysis]
117 Kaur S, Tripathi DM, Yadav A. The Enigma of Endothelium in COVID-19. Front Physiol 2020;11:989. [PMID: 32848893 DOI: 10.3389/fphys.2020.00989] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 14.0] [Reference Citation Analysis]
118 Lage SL, Rocco JM, Laidlaw E, Rupert A, Galindo F, Kellogg A, Kumar P, Poon R, Wortmann GW, Lisco A, Manion M, Sereti I. Activation of Complement Components on Circulating Blood Monocytes From COVID-19 Patients. Front Immunol 2022;13:815833. [DOI: 10.3389/fimmu.2022.815833] [Reference Citation Analysis]
119 Kakavas S, Karayiannis D, Mastora Z. The Complex Interplay between Immunonutrition, Mast Cells, and Histamine Signaling in COVID-19. Nutrients 2021;13:3458. [PMID: 34684460 DOI: 10.3390/nu13103458] [Reference Citation Analysis]
120 Murgo S, Lheureux O, Taccone F, Vouche M, Golzarian J. Haemoptysis treated by bronchial artery embolisation in severe acute respiratory syndrome coronavirus 2: case report. CVIR Endovasc 2020;3:61. [PMID: 32889589 DOI: 10.1186/s42155-020-00154-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
121 Hajimohammadebrahim-Ketabforoush M, Shahmohammadi MR, Zali A, Vahdat Shariatpanahi Z. COVID-19-associated stroke risk: Could nutrition and dietary patterns have a contributing role? World J Meta-Anal 2020; 8(6): 435-446 [DOI: 10.13105/wjma.v8.i6.435] [Reference Citation Analysis]
122 Chatterjee V, Yang X, Ma Y, Wu MH, Yuan SY. Extracellular vesicles: new players in regulating vascular barrier function. Am J Physiol Heart Circ Physiol 2020;319:H1181-96. [PMID: 33035434 DOI: 10.1152/ajpheart.00579.2020] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
123 Theoharides TC, Antonopoulou S, Demopoulos CA. Coronavirus 2019, Microthromboses, and Platelet Activating Factor. Clin Ther 2020;42:1850-2. [PMID: 32883529 DOI: 10.1016/j.clinthera.2020.08.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
124 Riou M, Oulehri W, Momas C, Rouyer O, Lebourg F, Meyer A, Enache I, Pistea C, Charloux A, Marcot C, de Blay F, Collange O, Mertes M, Andrès E, Talha S, Geny B. Reduced Flow-Mediated Dilatation Is Not Related to COVID-19 Severity Three Months after Hospitalization for SARS-CoV-2 Infection. J Clin Med 2021;10:1318. [PMID: 33806800 DOI: 10.3390/jcm10061318] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
125 Lang M, Yeung T, Mendoza DP, Flores EJ, Som A, Lang AL, Pianykh OS, Lee SI, Saini S, Little BP, Succi MD. Imaging Volume Trends and Recovery During the COVID-19 Pandemic: A Comparative Analysis Between a Large Urban Academic Hospital and Its Affiliated Imaging Centers. Acad Radiol 2020;27:1353-62. [PMID: 32830030 DOI: 10.1016/j.acra.2020.08.008] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
126 Al-Abani K, Kilhamn N, Maret E, Mårtensson J. Thrombosis and Bleeding After Implementation of an Intermediate-Dose Prophylactic Anticoagulation Protocol in ICU Patients With COVID-19: A Multicenter Screening Study. J Intensive Care Med 2021;:8850666211051960. [PMID: 34821162 DOI: 10.1177/08850666211051960] [Reference Citation Analysis]
127 Vanderbeke L, Van Mol P, Van Herck Y, De Smet F, Humblet-Baron S, Martinod K, Antoranz A, Arijs I, Boeckx B, Bosisio FM, Casaer M, Dauwe D, De Wever W, Dooms C, Dreesen E, Emmaneel A, Filtjens J, Gouwy M, Gunst J, Hermans G, Jansen S, Lagrou K, Liston A, Lorent N, Meersseman P, Mercier T, Neyts J, Odent J, Panovska D, Penttila PA, Pollet E, Proost P, Qian J, Quintelier K, Raes J, Rex S, Saeys Y, Sprooten J, Tejpar S, Testelmans D, Thevissen K, Van Buyten T, Vandenhaute J, Van Gassen S, Velásquez Pereira LC, Vos R, Weynand B, Wilmer A, Yserbyt J, Garg AD, Matthys P, Wouters C, Lambrechts D, Wauters E, Wauters J. Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity. Nat Commun 2021;12:4117. [PMID: 34226537 DOI: 10.1038/s41467-021-24360-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
128 Dhawan RT, Gopalan D, Howard L, Vicente A, Park M, Manalan K, Wallner I, Marsden P, Dave S, Branley H, Russell G, Dharmarajah N, Kon OM. Beyond the clot: perfusion imaging of the pulmonary vasculature after COVID-19. Lancet Respir Med 2021;9:107-16. [PMID: 33217366 DOI: 10.1016/S2213-2600(20)30407-0] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
129 Schiavone M, Gasperetti A, Gherbesi E, Bergamaschi L, Arosio R, Mitacchione G, Viecca M, Forleo GB. Arrhythmogenic Risk and Mechanisms of QT-Prolonging Drugs to Treat COVID-19. Cardiac Electrophysiology Clinics 2021. [DOI: 10.1016/j.ccep.2021.10.009] [Reference Citation Analysis]
130 Qi G, Wang H, Guo Y, Peng C, Zhang C, Chen T, He J, Jin Z. Clinical outcomes of COVID-19 patients with rheumatic diseases: a retrospective cohort study and synthesis analysis in Wuhan, China. Clin Rheumatol 2022. [PMID: 35171364 DOI: 10.1007/s10067-022-06086-2] [Reference Citation Analysis]
131 Trevisan M, Riccetti S, Sinigaglia A, Barzon L. SARS-CoV-2 Infection and Disease Modelling Using Stem Cell Technology and Organoids. Int J Mol Sci 2021;22:2356. [PMID: 33652988 DOI: 10.3390/ijms22052356] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
132 Alfaro-García JP, Granados-Alzate MC, Vicente-Manzanares M, Gallego-Gómez JC. An Integrated View of Virus-Triggered Cellular Plasticity Using Boolean Networks. Cells 2021;10:2863. [PMID: 34831086 DOI: 10.3390/cells10112863] [Reference Citation Analysis]
133 Goel R, Eapen CE. Recognizing dysfunctional innate and adaptive immune responses contributing to liver damage in patients with cirrhosis. J Clin Exp Hepatol 2021. [PMID: 34744379 DOI: 10.1016/j.jceh.2021.10.001] [Reference Citation Analysis]
134 Cryer MJ, Farhan S, Kaufmann CC, Jäger B, Garg A, Krishnan P, Mehran R, Huber K. Prothrombotic Milieu, Thrombotic Events and Prophylactic Anticoagulation in Hospitalized COVID-19 Positive Patients: A Review. Clin Appl Thromb Hemost 2022;28:107602962210743. [DOI: 10.1177/10760296221074353] [Reference Citation Analysis]
135 Dixon L, McNamara C, Gaur P, Mallon D, Coughlan C, Tona F, Jan W, Wilson M, Jones B. Cerebral microhaemorrhage in COVID-19: a critical illness related phenomenon? Stroke Vasc Neurol 2020;5:315-22. [PMID: 33208493 DOI: 10.1136/svn-2020-000652] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
136 Sessa F, Salerno M, Pomara C. Autopsy Tool in Unknown Diseases: The Experience with Coronaviruses (SARS-CoV, MERS-CoV, SARS-CoV-2). Medicina (Kaunas) 2021;57:309. [PMID: 33806100 DOI: 10.3390/medicina57040309] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
137 Goad J, Rudolph J, Rajkovic A. Female reproductive tract has low concentration of SARS-CoV2 receptors. PLoS One 2020;15:e0243959. [PMID: 33315943 DOI: 10.1371/journal.pone.0243959] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
138 Antoniou KM, Vasarmidi E, Russell AM, Andrejak C, Crestani B, Delcroix M, Dinh-Xuan AT, Poletti V, Sverzellati N, Vitacca M, Witzenrath M, Tonia T, Spanevello A. European Respiratory Society Statement on Long COVID-19 Follow-Up. Eur Respir J 2022:2102174. [PMID: 35144991 DOI: 10.1183/13993003.02174-2021] [Reference Citation Analysis]
139 Trifi A, Ouhibi A, Mahdi A, Masseoud L, Seghir E, Meftah A, Sellaouti S, Abdennebi C, Daly F, Touil Y, Abdellatif S, Ben Lakhal S. Shunt in critically ill Covid-19 ARDS patients: Prevalence and impact on outcome (cross-sectional study). J Crit Care 2022;70:154048. [PMID: 35487113 DOI: 10.1016/j.jcrc.2022.154048] [Reference Citation Analysis]
140 Vere G, Alam MR, Farrar S, Kealy R, Kessler BM, O’brien DP, Pinto-fernández A. Targeting the Ubiquitylation and ISGylation Machinery for the Treatment of COVID-19. Biomolecules 2022;12:300. [DOI: 10.3390/biom12020300] [Reference Citation Analysis]
141 Aydin S, Kantarci M, Karavas E, Unver E, Yalcin S, Aydin F. Lung perfusion changes in COVID-19 pneumonia: a dual energy computerized tomography study. Br J Radiol 2021;94:20201380. [PMID: 34415201 DOI: 10.1259/bjr.20201380] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
142 Moin ASM, Sathyapalan T, Atkin SL, Butler AE. The relationship of soluble neuropilin-1 to severe COVID-19 risk factors in polycystic ovary syndrome. Metabol Open 2021;9:100079. [PMID: 33521617 DOI: 10.1016/j.metop.2021.100079] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
143 Mangalmurti NS, Reilly JP, Cines DB, Meyer NJ, Hunter CA, Vaughan AE. COVID-19-associated Acute Respiratory Distress Syndrome Clarified: A Vascular Endotype? Am J Respir Crit Care Med 2020;202:750-3. [PMID: 32631071 DOI: 10.1164/rccm.202006-2598LE] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
144 Willems LH, Nagy M, Ten Cate H, Spronk HMH, Groh LA, Leentjens J, Janssen NAF, Netea MG, Thijssen DHJ, Hannink G, van Petersen AS, Warlé MC. Sustained inflammation, coagulation activation and elevated endothelin-1 levels without macrovascular dysfunction at 3 months after COVID-19. Thromb Res 2022;209:106-14. [PMID: 34922160 DOI: 10.1016/j.thromres.2021.11.027] [Reference Citation Analysis]
145 Vizcaychipi MP, Shovlin CL, McCarthy A, Godfrey A, Patel S, Shah PL, Hayes M, Keays RT, Beveridge I, Davies G; Gary Davies on behalf of the ChelWest COVID19 Consortium. Increase in COVID-19 inpatient survival following detection of Thromboembolic and Cytokine storm risk from the point of admission to hospital by a near real time Traffic-light System (TraCe-Tic). Braz J Infect Dis 2020;24:412-21. [PMID: 32857990 DOI: 10.1016/j.bjid.2020.07.010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
146 Jha AK. Pulmonary Vascular Changes in Acute Respiratory Distress Syndrome due to COVID-19. Am J Respir Crit Care Med 2021;203:259-60. [PMID: 33085907 DOI: 10.1164/rccm.202009-3508LE] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
147 Arastehfar A, Carvalho A, van de Veerdonk FL, Jenks JD, Koehler P, Krause R, Cornely OA, S Perlin D, Lass-Flörl C, Hoenigl M. COVID-19 Associated Pulmonary Aspergillosis (CAPA)-From Immunology to Treatment. J Fungi (Basel) 2020;6:E91. [PMID: 32599813 DOI: 10.3390/jof6020091] [Cited by in Crossref: 83] [Cited by in F6Publishing: 74] [Article Influence: 41.5] [Reference Citation Analysis]
148 Liu W, Guan WJ, Zhong NS. Strategies and Advances in Combating COVID-19 in China. Engineering (Beijing) 2020;6:1076-84. [PMID: 33078078 DOI: 10.1016/j.eng.2020.10.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
149 Batta Y, King C, Johnson J, Haddad N, Boueri M, Haddad G. Sequelae and Comorbidities of COVID-19 Manifestations on the Cardiac and the Vascular Systems. Front Physiol 2022;12:748972. [DOI: 10.3389/fphys.2021.748972] [Reference Citation Analysis]
150 Perier F, Tuffet S, Maraffi T, Alcala G, Victor M, Haudebourg AF, Razazi K, De Prost N, Amato M, Carteaux G, Mekontso Dessap A. Electrical impedance tomography to titrate positive end-expiratory pressure in COVID-19 acute respiratory distress syndrome. Crit Care 2020;24:678. [PMID: 33287864 DOI: 10.1186/s13054-020-03414-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
151 Saeed GA, Gaba W, Shah A, Al Helali AA, Raidullah E, Al Ali AB, Elghazali M, Ahmed DY, Al Kaabi SG, Almazrouei S. Correlation between Chest CT Severity Scores and the Clinical Parameters of Adult Patients with COVID-19 Pneumonia. Radiol Res Pract 2021;2021:6697677. [PMID: 33505722 DOI: 10.1155/2021/6697677] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
152 Gupta YS, Finkelstein M, Manna S, Toussie D, Bernheim A, Little BP, Concepcion J, Maron SZ, Jacobi A, Chung M, Kukar N, Voutsinas N, Cedillo MA, Fernandes A, Eber C, Fayad ZA, Hota P. Coronary artery calcification in COVID-19 patients: an imaging biomarker for adverse clinical outcomes. Clin Imaging 2021;77:1-8. [PMID: 33601125 DOI: 10.1016/j.clinimag.2021.02.016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
153 Namiranian P, Razavi SZE, Karimi M, Ayati MH. Avascular Necrosis in Patients Recovering from COVID-19. Am J Med Sci 2021:S0002-9629(21)00188-9. [PMID: 34033806 DOI: 10.1016/j.amjms.2021.05.018] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
154 Paludan SR, Mogensen TH. Innate immunological pathways in COVID-19 pathogenesis. Sci Immunol 2022;7:eabm5505. [PMID: 34995097 DOI: 10.1126/sciimmunol.abm5505] [Reference Citation Analysis]
155 Chang JC. COVID-19 Sepsis: Pathogenesis and Endothelial Molecular Mechanisms Based on "Two-Path Unifying Theory" of Hemostasis and Endotheliopathy-Associated Vascular Microthrombotic Disease, and Proposed Therapeutic Approach with Antimicrothrombotic Therapy. Vasc Health Risk Manag 2021;17:273-98. [PMID: 34103921 DOI: 10.2147/VHRM.S299357] [Reference Citation Analysis]
156 Zhu W, Zheng Y, Yu M, Wei J, Zhang Y, Topchyan P, Nguyen C, Janecke R, Kreuziger LB, White GC, Hari P, Aster R, Cui W, Jobe S, Graham MB, Wang D, Wen R. SARS-CoV-2 receptor binding domain-specific antibodies activate platelets with features resembling the pathogenic antibodies in heparin-induced thrombocytopenia. Res Sq 2021:rs. [PMID: 34013243 DOI: 10.21203/rs.3.rs-462080/v1] [Reference Citation Analysis]
157 Elbadry MI, Tawfeek A, Abdellatif MG, Salama EH, Abudeif A, Mahmoud H, Ezeldin M, Abdelkareem RM, Rashad UM. Unusual pattern of thrombotic events in young adult non-critically ill patients with COVID-19 may result from an undiagnosed inherited and acquired form of thrombophilia. Br J Haematol 2021. [PMID: 34888860 DOI: 10.1111/bjh.17986] [Reference Citation Analysis]
158 Aly R, Gupta S, Singh B, Kaur P, Kim K, Gupta S. The use of direct acting oral anticoagulants in patients with COVID-19 infection. J Community Hosp Intern Med Perspect 2021;11:184-6. [PMID: 33889317 DOI: 10.1080/20009666.2020.1867295] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
159 Gavriilaki E, Eftychidis I, Papassotiriou I. Update on endothelial dysfunction in COVID-19: severe disease, long COVID-19 and pediatric characteristics. Journal of Laboratory Medicine 2021;45:293-302. [DOI: 10.1515/labmed-2021-0134] [Reference Citation Analysis]
160 Arokiaraj M, Menesson E. Rose Exctracts and In-Vitro Inhibition of SARS-CoV-2 Spike: The Ace-2 Interaction. Acta Medica Bulgarica 2021;48:41-4. [DOI: 10.2478/amb-2021-0022] [Reference Citation Analysis]
161 Schmidbauer ML, Ferse C, Salih F, Klingner C, Musleh R, Kunst S, Wittstock M, Neumann B, Schebesch K, Bösel J, Godau J, Lochner P, Adam EH, Jahnke K, Knier B, Schirotzek I, Müllges W, Notz Q, Dengl M, Güldner A, Onur OA, Garcia Borrega J, Dimitriadis K, Günther A; on behalf of the IGNITE Study Group. COVID-19 and Intracranial Hemorrhage: A Multicenter Case Series, Systematic Review and Pooled Analysis. JCM 2022;11:605. [DOI: 10.3390/jcm11030605] [Reference Citation Analysis]
162 Sheikh D, Tripathi N, Chandler TR, Furmanek S, Bordon J, Ramirez JA, Cavallazzi R. Clinical outcomes in patients with COPD hospitalized with SARS-CoV-2 versus non- SARS-CoV-2 community-acquired pneumonia. Respir Med 2021;191:106714. [PMID: 34915396 DOI: 10.1016/j.rmed.2021.106714] [Reference Citation Analysis]
163 Blot M, de Maistre E, Bourredjem A, Quenot JP, Nguyen M, Bouhemad B, Charles PE, Binquet C, Piroth L. Specific Features of the Coagulopathy Signature in Severe COVID-19 Pneumonia. Front Med (Lausanne) 2021;8:675191. [PMID: 34422854 DOI: 10.3389/fmed.2021.675191] [Reference Citation Analysis]
164 Pang L, Liu Y, Shen M, Ye J, Chen R, Lan Z, Wu Z, Guo Y, Zhang P. Influence of aging on deterioration of patients with COVID-19. Aging (Albany NY) 2020;12:26248-62. [PMID: 33232272 DOI: 10.18632/aging.202136] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
165 Lee S, Yu Y, Trimpert J, Benthani F, Mairhofer M, Richter-Pechanska P, Wyler E, Belenki D, Kaltenbrunner S, Pammer M, Kausche L, Firsching TC, Dietert K, Schotsaert M, Martínez-Romero C, Singh G, Kunz S, Niemeyer D, Ghanem R, Salzer HJF, Paar C, Mülleder M, Uccellini M, Michaelis EG, Khan A, Lau A, Schönlein M, Habringer A, Tomasits J, Adler JM, Kimeswenger S, Gruber AD, Hoetzenecker W, Steinkellner H, Purfürst B, Motz R, Di Pierro F, Lamprecht B, Osterrieder N, Landthaler M, Drosten C, García-Sastre A, Langer R, Ralser M, Eils R, Reimann M, Fan DNY, Schmitt CA. Virus-induced senescence is a driver and therapeutic target in COVID-19. Nature 2021. [PMID: 34517409 DOI: 10.1038/s41586-021-03995-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
166 Bergamaschi G, Borrelli de Andreis F, Aronico N, Lenti MV, Barteselli C, Merli S, Pellegrino I, Coppola L, Cremonte EM, Croce G, Mordà F, Lapia F, Ferrari S, Ballesio A, Parodi A, Calabretta F, Ferrari MG, Fumoso F, Gentile A, Melazzini F, Di Sabatino A; Internal Medicine Covid-19 Collaborators. Anemia in patients with Covid-19: pathogenesis and clinical significance. Clin Exp Med 2021;21:239-46. [PMID: 33417082 DOI: 10.1007/s10238-020-00679-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
167 Muhanna D, Arnipalli SR, Kumar SB, Ziouzenkova O. Osmotic Adaptation by Na+-Dependent Transporters and ACE2: Correlation with Hemostatic Crisis in COVID-19. Biomedicines 2020;8:E460. [PMID: 33142989 DOI: 10.3390/biomedicines8110460] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
168 Limanaqi F, Busceti CL, Biagioni F, Lazzeri G, Forte M, Schiavon S, Sciarretta S, Frati G, Fornai F. Cell Clearing Systems as Targets of Polyphenols in Viral Infections: Potential Implications for COVID-19 Pathogenesis.Antioxidants (Basel). 2020;9:1105. [PMID: 33182802 DOI: 10.3390/antiox9111105] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
169 Mone P, Gambardella J, Wang X, Jankauskas SS, Matarese A, Santulli G. miR-24 targets SARS-CoV-2 co-factor Neuropilin-1 in human brain microvascular endothelial cells: Insights for COVID-19 neurological manifestations. Res Sq 2021:rs. [PMID: 33564755 DOI: 10.21203/rs.3.rs-192099/v1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
170 Aliberti S, Radovanovic D, Billi F, Sotgiu G, Costanzo M, Pilocane T, Saderi L, Gramegna A, Rovellini A, Perotto L, Monzani V, Santus P, Blasi F. Helmet CPAP treatment in patients with COVID-19 pneumonia: a multicentre cohort study. Eur Respir J 2020;56:2001935. [PMID: 32747395 DOI: 10.1183/13993003.01935-2020] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 19.0] [Reference Citation Analysis]
171 Taleb NN, Bar-Yam Y, Cirillo P. On single point forecasts for fat-tailed variables. Int J Forecast 2020. [PMID: 33100449 DOI: 10.1016/j.ijforecast.2020.08.008] [Cited by in Crossref: 12] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
172 Biswas M, Sawajan N, Rungrotmongkol T, Sanachai K, Ershadian M, Sukasem C. Pharmacogenetics and Precision Medicine Approaches for the Improvement of COVID-19 Therapies. Front Pharmacol 2022;13:835136. [DOI: 10.3389/fphar.2022.835136] [Reference Citation Analysis]
173 Scialpi M, Russo P, Piane E, Gallo E, Scalera GB. First case of retroperitoneal hematoma in COVID-19. Turk J Urol. 2020;46:407-409. [PMID: 32915717 DOI: 10.5152/tud.2020.20302] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
174 Rodriguez HC, Gupta M, Cavazos-Escobar E, El-Amin SF 3rd, Gupta A. Umbilical cord: an allogenic tissue for potential treatment of COVID-19. Hum Cell 2021;34:1-13. [PMID: 33033884 DOI: 10.1007/s13577-020-00444-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
175 Shafqat A, Shafqat S, Salameh SA, Kashir J, Alkattan K, Yaqinuddin A. Mechanistic Insights Into the Immune Pathophysiology of COVID-19; An In-Depth Review. Front Immunol 2022;13:835104. [DOI: 10.3389/fimmu.2022.835104] [Reference Citation Analysis]
176 Greco M, Suppressa S, Lazzari RA, Sicuro F, Catanese C, Lobreglio G. sFlt-1 and CA 15.3 are indicators of endothelial damage and pulmonary fibrosis in SARS-CoV-2 infection. Sci Rep 2021;11:19979. [PMID: 34620968 DOI: 10.1038/s41598-021-99470-y] [Reference Citation Analysis]
177 Hightower S, Ellis H, Collen J, Ellis J, Grasso I, Roswarski J, Cap AP, Chung K, Prescher L, Kavanaugh M, Brown T, Nau M, Clark P. Correlation of indirect markers of hypercoagulability with thromboelastography in severe coronavirus 2019. Thromb Res 2020;195:69-71. [PMID: 32659463 DOI: 10.1016/j.thromres.2020.07.013] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
178 Natalello G, De Luca G, Gigante L, Campochiaro C, De Lorenzis E, Verardi L, Paglionico A, Petricca L, Martone AM, Calvisi S, Ripa M, Cavalli G, Della-Torre E, Tresoldi M, Landi F, Bosello SL, Gremese E, Dagna L. Nailfold capillaroscopy findings in patients with coronavirus disease 2019: Broadening the spectrum of COVID-19 microvascular involvement. Microvasc Res 2021;133:104071. [PMID: 32949574 DOI: 10.1016/j.mvr.2020.104071] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
179 Amar J, Touront N, Ciron AM, Pendaries C. Interactions between hypertension and inflammatory tone and the effect on blood pressure and outcomes in patients with COVID-19. J Clin Hypertens (Greenwich) 2021;23:238-44. [PMID: 33491247 DOI: 10.1111/jch.14137] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
180 Zarrilli G, Angerilli V, Businello G, Sbaraglia M, Traverso G, Fortarezza F, Rizzo S, De Gaspari M, Basso C, Calabrese F, Dei Tos AP, Fassan M. The Immunopathological and Histological Landscape of COVID-19-Mediated Lung Injury. Int J Mol Sci 2021;22:974. [PMID: 33478107 DOI: 10.3390/ijms22020974] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
181 Cooper ID, Crofts CAP, DiNicolantonio JJ, Malhotra A, Elliott B, Kyriakidou Y, Brookler KH. Relationships between hyperinsulinaemia, magnesium, vitamin D, thrombosis and COVID-19: rationale for clinical management. Open Heart. 2020;7. [PMID: 32938758 DOI: 10.1136/openhrt-2020-001356] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
182 Kosanovic D, Yaroshetskiy AI, Tsareva NA, Merzhoeva ZM, Trushenko NV, Nekludova GV, Schermuly RT, Avdeev SN. Recombinant tissue plasminogen activator treatment for COVID-19 associated ARDS and acute cor pulmonale. Int J Infect Dis 2021;104:108-10. [PMID: 33352323 DOI: 10.1016/j.ijid.2020.12.043] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
183 Vanella G, Capurso G, Burti C, Fanti L, Ricciardiello L, Souza Lino A, Boskoski I, Bronswijk M, Tyberg A, Krishna Kumar Nair G, Angeletti S, Mauro A, Zingone F, Oppong KW, de la Iglesia-Garcia D, Pouillon L, Papanikolaou IS, Fracasso P, Ciceri F, Rovere-Querini P, Tomba C, Viale E, Eusebi LH, Riccioni ME, van der Merwe S, Shahid H, Sarkar A, Yoo JWG, Dilaghi E, Speight RA, Azzolini F, Buttitta F, Porcari S, Petrone MC, Iglesias-Garcia J, Savarino EV, Di Sabatino A, Di Giulio E, Farrell JJ, Kahaleh M, Roelandt P, Costamagna G, Artifon ELA, Bazzoli F, Testoni PA, Greco S, Arcidiacono PG. Gastrointestinal mucosal damage in patients with COVID-19 undergoing endoscopy: an international multicentre study. BMJ Open Gastroenterol 2021;8:e000578. [PMID: 33627313 DOI: 10.1136/bmjgast-2020-000578] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
184 Chiumello D, Busana M, Coppola S, Romitti F, Formenti P, Bonifazi M, Pozzi T, Palumbo MM, Cressoni M, Herrmann P, Meissner K, Quintel M, Camporota L, Marini JJ, Gattinoni L. Physiological and quantitative CT-scan characterization of COVID-19 and typical ARDS: a matched cohort study. Intensive Care Med 2020;46:2187-96. [PMID: 33089348 DOI: 10.1007/s00134-020-06281-2] [Cited by in Crossref: 52] [Cited by in F6Publishing: 44] [Article Influence: 26.0] [Reference Citation Analysis]
185 Desvaux E, Hamon A, Hubert S, Boudjeniba C, Chassagnol B, Swindle J, Aussy A, Laigle L, Laplume J, Soret P, Jean-François P, Dupin-Roger I, Guedj M, Moingeon P. Network-based repurposing identifies anti-alarmins as drug candidates to control severe lung inflammation in COVID-19. PLoS One 2021;16:e0254374. [PMID: 34293006 DOI: 10.1371/journal.pone.0254374] [Reference Citation Analysis]
186 Zantah M, Dominguez Castillo E, Townsend R, Dikengil F, Criner GJ. Pneumothorax in COVID-19 disease- incidence and clinical characteristics. Respir Res. 2020;21:236. [PMID: 32938445 DOI: 10.1186/s12931-020-01504-y] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 10.5] [Reference Citation Analysis]
187 Borrego-Sanz L, Guermes-Villahoz N, Fernández-Tresguerres F, Santos-Bueso E. Optic neuropathy in a COVID-19 patient. J Fr Ophtalmol 2021:S0181-5512(21)00352-1. [PMID: 34274160 DOI: 10.1016/j.jfo.2021.04.002] [Reference Citation Analysis]
188 Milos RI, Kifjak D, Heidinger BH, Prayer F, Beer L, Röhrich S, Wassipaul C, Gompelmann D, Prosch H. [Morphological and functional sequelae after COVID-19 pneumonia]. Radiologe 2021;61:888-95. [PMID: 34529126 DOI: 10.1007/s00117-021-00905-4] [Reference Citation Analysis]
189 Narasimhan B, Lorente-Ros M, Aguilar-Gallardo JS, Lizardo CP, Narasimhan H, Morton C, Donahue KR, Aronow WS. Anticoagulation in COVID-19: a review of current literature and guidelines. Hosp Pract (1995) 2021;49:307-24. [PMID: 34807786 DOI: 10.1080/21548331.2021.2007648] [Reference Citation Analysis]
190 Mehandru S, Merad M. Pathological sequelae of long-haul COVID. Nat Immunol 2022;23:194-202. [PMID: 35105985 DOI: 10.1038/s41590-021-01104-y] [Reference Citation Analysis]
191 Brogna B, Bignardi E, Brogna C, Volpe M, Lombardi G, Rosa A, Gagliardi G, Capasso PFM, Gravino E, Maio F, Pane F, Picariello V, Buono M, Colucci L, Musto LA. A Pictorial Review of the Role of Imaging in the Detection, Management, Histopathological Correlations, and Complications of COVID-19 Pneumonia. Diagnostics (Basel) 2021;11:437. [PMID: 33806423 DOI: 10.3390/diagnostics11030437] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
192 Dormoy V, Perotin JM, Gosset P, Maskos U, Polette M, Deslée G. Nicotinic receptors as SARS-CoV-2 spike co-receptors? Med Hypotheses 2022;158:110741. [PMID: 34924680 DOI: 10.1016/j.mehy.2021.110741] [Reference Citation Analysis]
193 Smadja DM, Bonnet G, Gendron N, Weizman O, Khider L, Trimaille A, Mirault T, Fauvel C, Diehl JL, Mika D, Philippe A, Pezel T, Goudot G, Sutter W, Planquette B, Waldmann V, Sanchez O, Cohen A, Chocron R. Intermediate- vs. Standard-Dose Prophylactic Anticoagulation in Patients With COVID-19 Admitted in Medical Ward: A Propensity Score-Matched Cohort Study. Front Med (Lausanne) 2021;8:747527. [PMID: 34722585 DOI: 10.3389/fmed.2021.747527] [Reference Citation Analysis]
194 Fikenzer S, Kogel A, Pietsch C, Lavall D, Stöbe S, Rudolph U, Laufs U, Hepp P, Hagendorff A. SARS-CoV2 infection: functional and morphological cardiopulmonary changes in elite handball players. Sci Rep 2021;11:17798. [PMID: 34493765 DOI: 10.1038/s41598-021-97120-x] [Reference Citation Analysis]
195 Fumagalli J, Panigada M, Klompas M, Berra L. Ventilator-associated pneumonia among SARS-CoV-2 acute respiratory distress syndrome patients. Curr Opin Crit Care 2022;28:74-82. [PMID: 34932525 DOI: 10.1097/MCC.0000000000000908] [Reference Citation Analysis]
196 Jud P, Gressenberger P, Muster V, Avian A, Meinitzer A, Strohmaier H, Sourij H, Raggam RB, Stradner MH, Demel U, Kessler HH, Eller K, Brodmann M. Evaluation of Endothelial Dysfunction and Inflammatory Vasculopathy After SARS-CoV-2 Infection-A Cross-Sectional Study. Front Cardiovasc Med 2021;8:750887. [PMID: 34722682 DOI: 10.3389/fcvm.2021.750887] [Reference Citation Analysis]
197 Ferrari M, Santini A, Protti A, Andreis DT, Iapichino G, Castellani G, Rendiniello V, Costantini E, Cecconi M. Inhaled nitric oxide in mechanically ventilated patients with COVID-19. J Crit Care 2020;60:159-60. [PMID: 32814271 DOI: 10.1016/j.jcrc.2020.08.007] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 7.5] [Reference Citation Analysis]
198 Eckstrand CD, Baldwin TJ, Rood KA, Clayton MJ, Lott JK, Wolking RM, Bradway DS, Baszler T. An outbreak of SARS-CoV-2 with high mortality in mink (Neovison vison) on multiple Utah farms. PLoS Pathog 2021;17:e1009952. [PMID: 34767598 DOI: 10.1371/journal.ppat.1009952] [Reference Citation Analysis]
199 Mohamed S, Abo El-Hassan O, Rizk M, Ismail JH, Baioumy A. Death due to Cardiac Arrest in a Young Female With Highly Suspected COVID-19: A Case Report. Cureus. 2020;12:e10127. [PMID: 33005541 DOI: 10.7759/cureus.10127] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
200 Gubbi S, Nazari MA, Taieb D, Klubo-Gwiezdzinska J, Pacak K. Catecholamine physiology and its implications in patients with COVID-19. Lancet Diabetes Endocrinol 2020;8:978-86. [PMID: 33128872 DOI: 10.1016/S2213-8587(20)30342-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 3.5] [Reference Citation Analysis]
201 Ahmadi E, Bagherpour Z, Zarei E, Omidkhoda A. Pathological effects of SARS-CoV-2 on hematological and immunological cells: Alterations in count, morphology, and function. Pathology - Research and Practice 2022;231:153782. [DOI: 10.1016/j.prp.2022.153782] [Reference Citation Analysis]
202 Reynolds AS, Lee AG, Renz J, DeSantis K, Liang J, Powell CA, Ventetuolo CE, Poor HD. Reply to Cherian et al.: Positive Bubble Study in Severe COVID-19 Indicates the Development of Anatomical Intrapulmonary Shunts in Response to Microvascular Occlusion. Am J Respir Crit Care Med 2021;203:265-6. [PMID: 32997507 DOI: 10.1164/rccm.202009-3404LE] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
203 Bianco A, Valente T, Perrotta F, Stellato E, Brunese L, Wood BJ, Carrafiello G, Parrella R; Study Investigators. Remarkable vessel enlargement within lung consolidation in COVID-19 compared to AH1N1 pneumonia: A retrospective study in Italy. Heliyon 2021;7:e07112. [PMID: 34036187 DOI: 10.1016/j.heliyon.2021.e07112] [Reference Citation Analysis]
204 Laney DA, Germain DP, Oliveira JP, Burlina AP, Cabrera GH, Hong GR, Hopkin RJ, Niu DM, Thomas M, Trimarchi H, Wilcox WR, Politei JM, Ortiz A. Fabry disease and COVID-19: international expert recommendations for management based on real-world experience. Clin Kidney J 2020;13:913-25. [PMID: 33391734 DOI: 10.1093/ckj/sfaa227] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
205 Venkatakrishnan AJ, Kayal N, Anand P, Badley AD, Church GM, Soundararajan V. Benchmarking evolutionary tinkering underlying human-viral molecular mimicry shows multiple host pulmonary-arterial peptides mimicked by SARS-CoV-2. Cell Death Discov 2020;6:96. [PMID: 33024578 DOI: 10.1038/s41420-020-00321-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
206 Xu H, Petousi N, Robbins PA. Ventilation-perfusion inequality in COVID-19 pneumonia. J Appl Physiol (1985) 2021;131:868-9. [PMID: 34397292 DOI: 10.1152/japplphysiol.00388.2021] [Reference Citation Analysis]
207 Ciurkiewicz M, Armando F, Schreiner T, de Buhr N, Pilchová V, Krupp-Buzimikic V, Gabriel G, von Köckritz-Blickwede M, Baumgärtner W, Schulz C, Gerhauser I. Ferrets are valuable models for SARS-CoV-2 research. Vet Pathol 2022;:3009858211071012. [PMID: 35001763 DOI: 10.1177/03009858211071012] [Reference Citation Analysis]
208 Schurink B, Roos E, Radonic T, Barbe E, Bouman CSC, de Boer HH, de Bree GJ, Bulle EB, Aronica EM, Florquin S, Fronczek J, Heunks LMA, de Jong MD, Guo L, du Long R, Lutter R, Molenaar PCG, Neefjes-Borst EA, Niessen HWM, van Noesel CJM, Roelofs JJTH, Snijder EJ, Soer EC, Verheij J, Vlaar APJ, Vos W, van der Wel NN, van der Wal AC, van der Valk P, Bugiani M. Viral presence and immunopathology in patients with lethal COVID-19: a prospective autopsy cohort study. Lancet Microbe 2020;1:e290-9. [PMID: 33015653 DOI: 10.1016/S2666-5247(20)30144-0] [Cited by in Crossref: 141] [Cited by in F6Publishing: 99] [Article Influence: 70.5] [Reference Citation Analysis]
209 Galivanche AR, Mercier MR, Schneble CA, Brand J, Pathak N, Varthi AG, Rubin LE, Grauer JN. Clinical Characteristics and Perioperative Complication Profiles of COVID-19-Positive Patients Undergoing Hip Fracture Surgery. J Am Acad Orthop Surg Glob Res Rev 2021;5. [PMID: 34653097 DOI: 10.5435/JAAOSGlobal-D-21-00104] [Reference Citation Analysis]
210 Rea IM, Alexander HD. Triple jeopardy in ageing: COVID-19, co-morbidities and inflamm-ageing. Ageing Res Rev 2021;73:101494. [PMID: 34688926 DOI: 10.1016/j.arr.2021.101494] [Reference Citation Analysis]
211 Geraci TC, Williams D, Chen S, Grossi E, Chang S, Cerfolio RJ, Bizekis C, Zervos M. Incidence, Management, and Outcomes of Patients With COVID-19 and Pneumothorax. Ann Thorac Surg 2021:S0003-4975(21)01545-9. [PMID: 34481799 DOI: 10.1016/j.athoracsur.2021.07.097] [Reference Citation Analysis]
212 Ackermann M, Mentzer SJ, Kolb M, Jonigk D. Inflammation and intussusceptive angiogenesis in COVID-19: everything in and out of flow. Eur Respir J 2020;56:2003147. [PMID: 33008942 DOI: 10.1183/13993003.03147-2020] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 9.0] [Reference Citation Analysis]
213 Fortini F, Vieceli Dalla Sega F, Marracino L, Severi P, Rapezzi C, Rizzo P, Ferrari R. Well-Known and Novel Players in Endothelial Dysfunction: Updates on a Notch(ed) Landscape. Biomedicines 2021;9:997. [PMID: 34440201 DOI: 10.3390/biomedicines9080997] [Reference Citation Analysis]
214 Thwaites RS, Sanchez Sevilla Uruchurtu A, Siggins MK, Liew F, Russell CD, Moore SC, Fairfield C, Carter E, Abrams S, Short CE, Thaventhiran T, Bergstrom E, Gardener Z, Ascough S, Chiu C, Docherty AB, Hunt D, Crow YJ, Solomon T, Taylor GP, Turtle L, Harrison EM, Dunning J, Semple MG, Baillie JK, Openshaw PJ; ISARIC4C investigators. Inflammatory profiles across the spectrum of disease reveal a distinct role for GM-CSF in severe COVID-19. Sci Immunol 2021;6:eabg9873. [PMID: 33692097 DOI: 10.1126/sciimmunol.abg9873] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 29.0] [Reference Citation Analysis]
215 Turcato G, Zaboli A, Kostic I, Melchioretto B, Ciccariello L, Zaccaria E, Olivato A, Maccagnani A, Pfeifer N, Bonora A. Severity of SARS-CoV-2 infection and albumin levels recorded at the first emergency department evaluation: a multicentre retrospective observational study. Emerg Med J 2021:emermed-2020-210081. [PMID: 34548413 DOI: 10.1136/emermed-2020-210081] [Reference Citation Analysis]
216 Barale C, Melchionda E, Morotti A, Russo I. Prothrombotic Phenotype in COVID-19: Focus on Platelets. Int J Mol Sci 2021;22:13638. [PMID: 34948438 DOI: 10.3390/ijms222413638] [Reference Citation Analysis]
217 Matthews L, Baker L, Ferrari M, Sanchez W, Pappachan J, Grocott MP, Dushianthan A; The REACT COVID-19 investigators. Compassionate use of Pulmonary Vasodilators in Acute Severe Hypoxic Respiratory Failure due to COVID-19. J Intensive Care Med. [DOI: 10.1177/08850666221086521] [Reference Citation Analysis]
218 León López R, Fernández SC, Limia Pérez L, Romero Palacios A, Fernández-Roldán MC, Aguilar Alonso E, Pérez Camacho I, Rodriguez-Baño J, Merchante N, Olalla J, Esteban-Moreno MÁ, Santos M, Luque-Pineda A, Torre-Cisneros J. Efficacy and safety of early treatment with sarilumab in hospitalised adults with COVID-19 presenting cytokine release syndrome (SARICOR STUDY): protocol of a phase II, open-label, randomised, multicentre, controlled clinical trial. BMJ Open 2020;10:e039951. [PMID: 33191263 DOI: 10.1136/bmjopen-2020-039951] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
219 Damodaran S, Joshi SS, Kumar V S, Natarajan P, Patangi SO, Kumaran T. COVID Convalescence-A Boon or Bane in Cardiac Surgery?: A "Second Hit" Hypothesis. J Cardiothorac Vasc Anesth 2020:S1053-0770(20)31135-6. [PMID: 33158710 DOI: 10.1053/j.jvca.2020.10.021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
220 Goshua G, Pine AB, Meizlish ML, Chang CH, Zhang H, Bahel P, Baluha A, Bar N, Bona RD, Burns AJ, Dela Cruz CS, Dumont A, Halene S, Hwa J, Koff J, Menninger H, Neparidze N, Price C, Siner JM, Tormey C, Rinder HM, Chun HJ, Lee AI. Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study. Lancet Haematol 2020;7:e575-82. [PMID: 32619411 DOI: 10.1016/S2352-3026(20)30216-7] [Cited by in Crossref: 319] [Cited by in F6Publishing: 214] [Article Influence: 159.5] [Reference Citation Analysis]
221 Moezinia CJ, Ji-Xu A, Azari A, Horlick S, Denton C, Stratton R. Iloprost for COVID-19-related vasculopathy. Lancet Rheumatol 2020;2:e582-3. [PMID: 32838311 DOI: 10.1016/S2665-9913(20)30232-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
222 Meyerholz DK, McCray PB Jr. Illuminating COVID-19 lung disease through autopsy studies. EBioMedicine 2020;57:102865. [PMID: 32629393 DOI: 10.1016/j.ebiom.2020.102865] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
223 Bigalke JA, Greenlund IM, Carter JR. Sex differences in self-report anxiety and sleep quality during COVID-19 stay-at-home orders. Biol Sex Differ 2020;11:56. [PMID: 33050941 DOI: 10.1186/s13293-020-00333-4] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 8.5] [Reference Citation Analysis]
224 Löffler C, Mahrhold J, Fogarassy P, Beyer M, Hellmich B. Two Immunocompromised Patients With Diffuse Alveolar Hemorrhage as a Complication of Severe Coronavirus Disease 2019. Chest 2020;158:e215-9. [PMID: 32622819 DOI: 10.1016/j.chest.2020.06.051] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
225 Nagpal P, Motahari A, Gerard SE, Guo J, Reinhardt JM, Comellas AP, Hoffman EA, Kaczka DW. Case Studies in Physiology: Temporal variations of the lung parenchyma and vasculature in asymptomatic COVID-19 pneumonia: a multispectral CT assessment. J Appl Physiol (1985) 2021;131:454-63. [PMID: 34166081 DOI: 10.1152/japplphysiol.00147.2021] [Reference Citation Analysis]
226 Olson MC, Lubner MG, Menias CO, Mellnick VM, Gettle LM, Kim DH, Elsayes KM, Pickhardt PJ. RadioGraphics Update: Venous Thrombosis and Hypercoagulability in the Abdomen and Pelvis-Findings in COVID-19. Radiographics 2020;40:E24-8. [PMID: 32649264 DOI: 10.1148/rg.2020200119] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
227 Qin Z, Liu F, Blair R, Wang C, Yang H, Mudd J, Currey JM, Iwanaga N, He J, Mi R, Han K, Midkiff CC, Alam MA, Aktas BH, Heide RSV, Veazey R, Piedimonte G, Maness NJ, Ergün S, Mauvais-Jarvis F, Rappaport J, Kolls JK, Qin X. Endothelial cell infection and dysfunction, immune activation in severe COVID-19. Theranostics 2021;11:8076-91. [PMID: 34335981 DOI: 10.7150/thno.61810] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
228 Bhakta S, Pollock BD, Erben YM, Edwards MA, Noe KH, Dowdy SC, Moreno Franco P, Cowart JB. The association of acute COVID‐19 infection with Patient Safety Indicator‐12 events in a multisite healthcare system. Journal of Hospital Medicine. [DOI: 10.1002/jhm.12832] [Reference Citation Analysis]
229 Liang J, Wang Z, Xie J, Liang H, Liang J, Jiang M, Li S. Rigorous Assessment of Guidelines on COVID-19-Related Thrombotic or Thromboembolic Disease: Implications for Clinical Practice of Prevention, Diagnosis, and Treatment. Evid Based Complement Alternat Med 2021;2021:5513744. [PMID: 34589131 DOI: 10.1155/2021/5513744] [Reference Citation Analysis]
230 Kuno T, So M, Iwagami M, Takahashi M, Egorova NN. The association of statins use with survival of patients with COVID-19. J Cardiol 2021:S0914-5087(21)00367-1. [PMID: 34974938 DOI: 10.1016/j.jjcc.2021.12.012] [Reference Citation Analysis]
231 Tissières P, Teboul JL. SARS-CoV-2 post-infective myocarditis: the tip of COVID-19 immune complications? Ann Intensive Care 2020;10:98. [PMID: 32705368 DOI: 10.1186/s13613-020-00717-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
232 Matarese A, Gambardella J, Sardu C, Santulli G. miR-98 Regulates TMPRSS2 Expression in Human Endothelial Cells: Key Implications for COVID-19. Biomedicines 2020;8:E462. [PMID: 33143053 DOI: 10.3390/biomedicines8110462] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 11.5] [Reference Citation Analysis]
233 Haslbauer JD, Tzankov A, Mertz KD, Schwab N, Nienhold R, Twerenbold R, Leibundgut G, Stalder AK, Matter M, Glatz K. Characterisation of cardiac pathology in 23 autopsies of lethal COVID-19. J Pathol Clin Res 2021;7:326-37. [PMID: 33837673 DOI: 10.1002/cjp2.212] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
234 Lim W, Suhail M, Diaz K. Diagnostic Challenges of Pneumocystis Pneumonia during the COVID-19 Pandemic: A Case of a Young Patient with Ground Glass Opacities and Pulmonary Embolism on Chest CT. Case Rep Infect Dis 2021;2021:5669543. [PMID: 34373796 DOI: 10.1155/2021/5669543] [Reference Citation Analysis]
235 Zhang C, Li W, Lei X, Xie Z, Qi L, Wang H, Xiao X, Xiao J, Zheng Y, Dong C, Zheng X, Chen S, Chen J, Sun B, Qin J, Zhai Q, Li J, Wei B, Wang J, Wang H. Targeting lysophospholipid acid receptor 1 and ROCK kinases promotes antiviral innate immunity. Sci Adv 2021;7:eabb5933. [PMID: 34533996 DOI: 10.1126/sciadv.abb5933] [Reference Citation Analysis]
236 Kichloo A, Dettloff K, Aljadah M, Albosta M, Jamal S, Singh J, Wani F, Kumar A, Vallabhaneni S, Khan MZ. COVID-19 and Hypercoagulability: A Review. Clin Appl Thromb Hemost 2020;26:1076029620962853. [PMID: 33074732 DOI: 10.1177/1076029620962853] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
237 Gammone MA, D'Orazio N. Review: Obesity and COVID-19: A Detrimental Intersection. Front Endocrinol (Lausanne) 2021;12:652639. [PMID: 33995281 DOI: 10.3389/fendo.2021.652639] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
238 Caccuri F, Bugatti A, Zani A, De Palma A, Di Silvestre D, Manocha E, Filippini F, Messali S, Chiodelli P, Campisi G, Fiorentini S, Facchetti F, Mauri P, Caruso A. SARS-CoV-2 Infection Remodels the Phenotype and Promotes Angiogenesis of Primary Human Lung Endothelial Cells. Microorganisms 2021;9:1438. [PMID: 34361874 DOI: 10.3390/microorganisms9071438] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
239 Walczak P, Janowski M. The COVID-19 Menace. Glob Chall 2021;:2100004. [PMID: 34178377 DOI: 10.1002/gch2.202100004] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
240 Augustin M, Hallek M, Nitschmann S. [Antibody therapy in patients with COVID-19]. Internist (Berl) 2021;62:572-6. [PMID: 33847768 DOI: 10.1007/s00108-021-01022-z] [Reference Citation Analysis]
241 Levy JH, Iba T, Connors JM. Editorial commentary: Vascular injury in acute infections and COVID-19: everything old is new again. Trends Cardiovasc Med 2021;31:6-7. [PMID: 33129973 DOI: 10.1016/j.tcm.2020.10.011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
242 McConnell MJ, Kawaguchi N, Kondo R, Sonzogni A, Licini L, Valle C, Bonaffini PA, Sironi S, Alessio MG, Previtali G, Seghezzi M, Zhang X, Lee AI, Pine AB, Chun HJ, Zhang X, Fernandez-Hernando C, Qing H, Wang A, Price C, Sun Z, Utsumi T, Hwa J, Strazzabosco M, Iwakiri Y. Liver injury in COVID-19 and IL-6 trans-signaling-induced endotheliopathy. J Hepatol 2021;75:647-58. [PMID: 33991637 DOI: 10.1016/j.jhep.2021.04.050] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
243 Tomidokoro D, Hiroi Y. Cardiovascular implications of the COVID-19 pandemic. J Cardiol 2021:S0914-5087(21)00243-4. [PMID: 34563439 DOI: 10.1016/j.jjcc.2021.09.010] [Reference Citation Analysis]
244 Yang G, Feng F, Li X, Zhang T, Li X, Li B. Changes of lymphocyte subsets in patients with COVID-19 and clinical significance: a case-control observational study. Journal of Bio-X Research 2021;4:36-9. [DOI: 10.1097/jbr.0000000000000089] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
245 Motiejunaite J, Balagny P, Arnoult F, Mangin L, Bancal C, d'Ortho MP, Frija-Masson J. Hyperventilation: A Possible Explanation for Long-Lasting Exercise Intolerance in Mild COVID-19 Survivors? Front Physiol 2020;11:614590. [PMID: 33536937 DOI: 10.3389/fphys.2020.614590] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 9.0] [Reference Citation Analysis]
246 Parra-Medina R, Herrera S, Mejia J. Systematic Review of Microthrombi in COVID-19 Autopsies. Acta Haematol 2021;:1-8. [PMID: 33873184 DOI: 10.1159/000515104] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
247 Xu J, Liang Z, Jian W, Li J, Tang G, Mo X, Zhang D, Zheng J, Qian Y, Liu J, Li S. Changes of quantitative CT-based airway wall dimensions in patients with COVID-19 during early recovery. J Thorac Dis 2021;13:1517-30. [PMID: 33841944 DOI: 10.21037/jtd-20-2790] [Reference Citation Analysis]
248 Bilgin E, Ertenli Aİ. Proposal of a new nomenclature for the underlying pathogenetic mechanism of severe Coronavirus Disease-19: "Inflammatory Thrombosis with Immune Endotheliitis-ITIE". Rheumatol Int 2021;41:679-80. [PMID: 33388970 DOI: 10.1007/s00296-020-04768-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
249 Orfanos S, El Husseini I, Nahass T, Radbel J, Hussain S. Observational study of the use of recombinant tissue-type plasminogen activator in COVID-19 shows a decrease in physiological dead space. ERJ Open Res 2020;6:00455-2020. [PMID: 33043052 DOI: 10.1183/23120541.00455-2020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
250 Vieceli Dalla Sega F, Fortini F, Spadaro S, Ronzoni L, Zucchetti O, Manfrini M, Mikus E, Fogagnolo A, Torsani F, Pavasini R, Marracino L, Verri M, Morandi L, D'Aniello E, Volta CA, Campo G, Ferrari R, Rizzo P, Contoli M. Time course of endothelial dysfunction markers and mortality in COVID-19 patients: A pilot study. Clin Transl Med 2021;11:e283. [PMID: 33784001 DOI: 10.1002/ctm2.283] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
251 Xu Y, Yang X, Bian H, Xia M. Metabolic dysfunction associated fatty liver disease and coronavirus disease 2019: clinical relationship and current management. Lipids Health Dis 2021;20:126. [PMID: 34602072 DOI: 10.1186/s12944-021-01564-z] [Reference Citation Analysis]
252 Kgatle MM, Lawal IO, Mashabela G, Boshomane TMG, Koatale PC, Mahasha PW, Ndlovu H, Vorster M, Rodrigues HG, Zeevaart JR, Gordon S, Moura-Alves P, Sathekge MM. COVID-19 Is a Multi-Organ Aggressor: Epigenetic and Clinical Marks. Front Immunol 2021;12:752380. [PMID: 34691068 DOI: 10.3389/fimmu.2021.752380] [Reference Citation Analysis]
253 Lamers MM, van der Vaart J, Knoops K, Riesebosch S, Breugem TI, Mykytyn AZ, Beumer J, Schipper D, Bezstarosti K, Koopman CD, Groen N, Ravelli RBG, Duimel HQ, Demmers JAA, Verjans GMGM, Koopmans MPG, Muraro MJ, Peters PJ, Clevers H, Haagmans BL. An organoid-derived bronchioalveolar model for SARS-CoV-2 infection of human alveolar type II-like cells. EMBO J 2021;40:e105912. [PMID: 33283287 DOI: 10.15252/embj.2020105912] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 22.0] [Reference Citation Analysis]
254 Kanoore Edul VS, Caminos Eguillor JF, Ferrara G, Estenssoro E, Siles DSP, Cesio CE, Dubin A. Microcirculation alterations in severe COVID-19 pneumonia. J Crit Care 2021;61:73-5. [PMID: 33096349 DOI: 10.1016/j.jcrc.2020.10.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
255 Sridhar S, Nicholls J. Pathophysiology of infection with SARS-CoV-2-What is known and what remains a mystery. Respirology 2021;26:652-65. [PMID: 34041821 DOI: 10.1111/resp.14091] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
256 Stefan G, Mehedinti AM, Andreiana I, Zugravu AD, Cinca S, Busuioc R, Miler I, Stancu S, Petrescu L, Dimitriu I, Moldovanu E, Crasnaru DE, Gugonea G, Georgescu V, Strambu VD, Capusa C. Clinical features and outcome of maintenance hemodialysis patients with COVID-19 from a tertiary nephrology care center in Romania. Ren Fail 2021;43:49-57. [PMID: 33307933 DOI: 10.1080/0886022X.2020.1853571] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
257 Komiya K, Hamanaka R, Shuto H, Yoshikawa H, Yokoyama A, Hiramatsu K, Kadota JI. Re-expansion pulmonary edema following a pneumothorax drainage in a patient with COVID-19. BMC Pulm Med 2021;21:293. [PMID: 34530790 DOI: 10.1186/s12890-021-01661-w] [Reference Citation Analysis]
258 Abou-Arab O, Beyls C, Khalipha A, Guilbart M, Huette P, Malaquin S, Lecat B, Macq PY, Roger PA, Haye G, Bernasinski M, Besserve P, Soriot-Thomas S, Jounieaux V, Dupont H, Mahjoub Y. Microvascular flow alterations in critically ill COVID-19 patients: A prospective study. PLoS One 2021;16:e0246636. [PMID: 33556081 DOI: 10.1371/journal.pone.0246636] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
259 Pine AB, Meizlish ML, Goshua G, Chang CH, Zhang H, Bishai J, Bahel P, Patel A, Gbyli R, Kwan JM, Won CH, Price C, Dela Cruz CS, Halene S, van Dijk D, Hwa J, Lee AI, Chun HJ. Circulating markers of angiogenesis and endotheliopathy in COVID-19. Pulm Circ 2020;10:2045894020966547. [PMID: 33282193 DOI: 10.1177/2045894020966547] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 13.0] [Reference Citation Analysis]
260 Zhan Z, Yang X, Du H, Zhang C, Song Y, Ran X, Zhang A, Yang M. Early Improvement of Acute Respiratory Distress Syndrome in Patients With COVID-19 in the Intensive Care Unit: Retrospective Analysis. JMIR Public Health Surveill 2021;7:e24843. [PMID: 33630743 DOI: 10.2196/24843] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
261 Bellis A, Mauro C, Barbato E, Trimarco B, Morisco C. The Rationale for Angiotensin Receptor Neprilysin Inhibitors in a Multi-Targeted Therapeutic Approach to COVID-19. Int J Mol Sci 2020;21:E8612. [PMID: 33203141 DOI: 10.3390/ijms21228612] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
262 D’ippolito S, Turchiano F, Vitagliano A, Scutiero G, Lanzone A, Scambia G, Greco P. Is There a Role for SARS-CoV-2/COVID-19 on the Female Reproductive System? Front Physiol 2022;13:845156. [DOI: 10.3389/fphys.2022.845156] [Reference Citation Analysis]
263 Hanff TC, Mohareb AM, Giri J, Cohen JB, Chirinos JA. Thrombosis in COVID-19. Am J Hematol 2020;95:1578-89. [PMID: 32857878 DOI: 10.1002/ajh.25982] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 12.5] [Reference Citation Analysis]
264 Zhao Y, Wang D, Mei N, Yin B, Li X, Zheng Y, Xiao A, Yu X, Qiu X, Lu Y, Liu L. Longitudinal Radiological Findings in Patients With COVID-19 With Different Severities: From Onset to Long-Term Follow-Up After Discharge. Front Med (Lausanne) 2021;8:711435. [PMID: 34621760 DOI: 10.3389/fmed.2021.711435] [Reference Citation Analysis]
265 Amenta EM, Spallone A, Rodriguez-Barradas MC, El Sahly HM, Atmar RL, Kulkarni PA. Postacute COVID-19: An Overview and Approach to Classification. Open Forum Infect Dis 2020;7:ofaa509. [PMID: 33403218 DOI: 10.1093/ofid/ofaa509] [Cited by in Crossref: 28] [Cited by in F6Publishing: 18] [Article Influence: 14.0] [Reference Citation Analysis]
266 Siddiqi HK, Libby P, Ridker PM. COVID-19 - A vascular disease. Trends Cardiovasc Med. 2021;31:1-5. [PMID: 33068723 DOI: 10.1016/j.tcm.2020.10.005] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Article Influence: 21.0] [Reference Citation Analysis]
267 Dai M, Guo S, Ke Y, Wang B, Yu F, Xu H, Gu Z, Ge W. The Use of Oral Anticoagulation Is Not Associated With a Reduced Risk of Mortality in Patients With COVID-19: A Systematic Review and Meta-Analysis of Cohort Studies. Front Pharmacol 2022;13:781192. [DOI: 10.3389/fphar.2022.781192] [Reference Citation Analysis]
268 Tung ML, Tan B, Cherian R, Chandra B. Anti-phospholipid syndrome and COVID-19 thrombosis: connecting the dots. Rheumatol Adv Pract 2021;5:rkaa081. [PMID: 33615129 DOI: 10.1093/rap/rkaa081] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
269 Silveira FM, Mello ALR, da Silva Fonseca L, dos Santos Ferreira L, Kirschnick LB, Martins MD, Schuch LF, de Arruda JAA, Soares CD, de Oliveira Sales A, Bologna-molina R, Santos-silva AR, Vasconcelos ACU. Morphological and tissue-based molecular characterization of oral lesions in patients with COVID-19: A living systematic review. Archives of Oral Biology 2022. [DOI: 10.1016/j.archoralbio.2022.105374] [Reference Citation Analysis]
270 Gomes de Farias LP, Caixeta Souza FH, da Silva Teles GB. The Target Sign and Its Variant in COVID-19 Pneumonia. Radiol Cardiothorac Imaging. 2020;2:e200435. [PMID: 33778617 DOI: 10.1148/ryct.2020200435] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
271 Chaturvedi H, Issac R, Sharma SK, Gupta R. Progressive left and right heart dysfunction in coronavirus disease-19: Prospective echocardiographic evaluation. Eur Heart J Cardiovasc Imaging 2021:jeab268. [PMID: 34904153 DOI: 10.1093/ehjci/jeab268] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
272 Dreier E, Malfertheiner MV, Dienemann T, Fisser C, Foltan M, Geismann F, Graf B, Lunz D, Maier LS, Müller T, Offner R, Peterhoff D, Philipp A, Salzberger B, Schmidt B, Sinner B, Lubnow M. ECMO in COVID-19-prolonged therapy needed? A retrospective analysis of outcome and prognostic factors. Perfusion 2021;36:582-91. [PMID: 33612020 DOI: 10.1177/0267659121995997] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
273 Yuan S, Jiang SC, Zhang ZW, Fu YF, Hu J, Li ZL. The Role of Alveolar Edema in COVID-19. Cells 2021;10:1897. [PMID: 34440665 DOI: 10.3390/cells10081897] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
274 Ronit A, Berg RMG, Bay JT, Haugaard AK, Ahlström MG, Burgdorf KS, Ullum H, Rørvig SB, Tjelle K, Foss NB, Benfield T, Marquart HV, Plovsing RR. Compartmental immunophenotyping in COVID-19 ARDS: A case series. J Allergy Clin Immunol 2021;147:81-91. [PMID: 32979342 DOI: 10.1016/j.jaci.2020.09.009] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 9.0] [Reference Citation Analysis]
275 Eddy RL, Sin DD. Computed Tomography Vascular Tree-in-Bud: A Novel Prognostic Imaging Biomarker in COVID-19? Am J Respir Crit Care Med 2020;202:642-4. [PMID: 32687386 DOI: 10.1164/rccm.202007-2833ED] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
276 Golota AS, Kamilova TA, Shneider OV, Vologzhanin DA, Sherbak SG. Pathogenesis of the initial stages of severe COVID-19. Journal of Clinical Practice 2021;12:83-102. [DOI: 10.17816/clinpract71351] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
277 Šikić J, Planinić Z, Matišić V, Friščić T, Molnar V, Jagačić D, Vujičić L, Tudorić N, Postružin Gršić L, Ljubičić Đ, Primorac D. COVID-19: The Impact on Cardiovascular System. Biomedicines 2021;9:1691. [PMID: 34829920 DOI: 10.3390/biomedicines9111691] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
278 Holcomb D, Alexaki A, Hernandez N, Hunt R, Laurie K, Kames J, Hamasaki-Katagiri N, Komar AA, DiCuccio M, Kimchi-Sarfaty C. Gene variants of coagulation related proteins that interact with SARS-CoV-2. PLoS Comput Biol 2021;17:e1008805. [PMID: 33730015 DOI: 10.1371/journal.pcbi.1008805] [Reference Citation Analysis]
279 Cicco S, Vacca A, Cittadini A, Marra AM. Long-Term Follow-Up May be Useful in Coronavirus Disease 2019 Survivors to Prevent Chronic Complications. Infect Chemother 2020;52:407-9. [PMID: 32757498 DOI: 10.3947/ic.2020.52.3.407] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
280 Ameri P, Inciardi RM, Di Pasquale M, Agostoni P, Bellasi A, Camporotondo R, Canale C, Carubelli V, Carugo S, Catagnano F, Danzi G, Dalla Vecchia L, Giovinazzo S, Gnecchi M, Guazzi M, Iorio A, La Rovere MT, Leonardi S, Maccagni G, Mapelli M, Margonato D, Merlo M, Monzo L, Mortara A, Nuzzi V, Piepoli M, Porto I, Pozzi A, Provenzale G, Sarullo F, Sinagra G, Tedino C, Tomasoni D, Volterrani M, Zaccone G, Lombardi CM, Senni M, Metra M. Pulmonary embolism in patients with COVID-19: characteristics and outcomes in the Cardio-COVID Italy multicenter study. Clin Res Cardiol 2021;110:1020-8. [PMID: 33141251 DOI: 10.1007/s00392-020-01766-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
281 Fajnzylber J, Regan J, Coxen K, Corry H, Wong C, Rosenthal A, Worrall D, Giguel F, Piechocka-Trocha A, Atyeo C, Fischinger S, Chan A, Flaherty KT, Hall K, Dougan M, Ryan ET, Gillespie E, Chishti R, Li Y, Jilg N, Hanidziar D, Baron RM, Baden L, Tsibris AM, Armstrong KA, Kuritzkes DR, Alter G, Walker BD, Yu X, Li JZ;  Massachusetts Consortium for Pathogen Readiness. SARS-CoV-2 viral load is associated with increased disease severity and mortality. Nat Commun. 2020;11:5493. [PMID: 33127906 DOI: 10.1038/s41467-020-19057-5] [Cited by in Crossref: 163] [Cited by in F6Publishing: 143] [Article Influence: 81.5] [Reference Citation Analysis]
282 Wang P, Zhu X, Guo W, Ren H, Hu T. Spatiotemporal Differences of COVID-19 Infection Among Healthcare Workers and Patients in China From January to March 2020. IEEE Access 2021;9:28646-57. [PMID: 34812380 DOI: 10.1109/ACCESS.2021.3058155] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
283 Muñoz-Fontela C, Dowling WE, Funnell SGP, Gsell PS, Riveros-Balta AX, Albrecht RA, Andersen H, Baric RS, Carroll MW, Cavaleri M, Qin C, Crozier I, Dallmeier K, de Waal L, de Wit E, Delang L, Dohm E, Duprex WP, Falzarano D, Finch CL, Frieman MB, Graham BS, Gralinski LE, Guilfoyle K, Haagmans BL, Hamilton GA, Hartman AL, Herfst S, Kaptein SJF, Klimstra WB, Knezevic I, Krause PR, Kuhn JH, Le Grand R, Lewis MG, Liu WC, Maisonnasse P, McElroy AK, Munster V, Oreshkova N, Rasmussen AL, Rocha-Pereira J, Rockx B, Rodríguez E, Rogers TF, Salguero FJ, Schotsaert M, Stittelaar KJ, Thibaut HJ, Tseng CT, Vergara-Alert J, Beer M, Brasel T, Chan JFW, García-Sastre A, Neyts J, Perlman S, Reed DS, Richt JA, Roy CJ, Segalés J, Vasan SS, Henao-Restrepo AM, Barouch DH. Animal models for COVID-19. Nature 2020;586:509-15. [PMID: 32967005 DOI: 10.1038/s41586-020-2787-6] [Cited by in Crossref: 206] [Cited by in F6Publishing: 190] [Article Influence: 103.0] [Reference Citation Analysis]
284 Bikdeli B. Anticoagulation in COVID-19: Randomized trials should set the balance between excitement and evidence. Thromb Res 2020;196:638-40. [PMID: 33066998 DOI: 10.1016/j.thromres.2020.09.033] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
285 Torres Acosta MA, Singer BD. Pathogenesis of COVID-19-induced ARDS: implications for an ageing population. Eur Respir J 2020;56:2002049. [PMID: 32747391 DOI: 10.1183/13993003.02049-2020] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 20.5] [Reference Citation Analysis]
286 Medzikovic L, Cunningham CM, Li M, Amjedi M, Hong J, Ruffenach G, Eghbali M. Sex differences underlying preexisting cardiovascular disease and cardiovascular injury in COVID-19. J Mol Cell Cardiol 2020;148:25-33. [PMID: 32835666 DOI: 10.1016/j.yjmcc.2020.08.007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
287 Terrier O, Si-Tahar M, Ducatez M, Chevalier C, Pizzorno A, Le Goffic R, Crépin T, Simon G, Naffakh N. Influenza viruses and coronaviruses: Knowns, unknowns, and common research challenges. PLoS Pathog 2021;17:e1010106. [PMID: 34969061 DOI: 10.1371/journal.ppat.1010106] [Reference Citation Analysis]
288 Tleyjeh IM, Kashour Z, AlDosary O, Riaz M, Tlayjeh H, Garbati MA, Tleyjeh R, Al-Mallah MH, Sohail MR, Gerberi D, Bin Abdulhak AA, Giudicessi JR, Ackerman MJ, Kashour T. Cardiac Toxicity of Chloroquine or Hydroxychloroquine in Patients With COVID-19: A Systematic Review and Meta-regression Analysis. Mayo Clin Proc Innov Qual Outcomes 2021;5:137-50. [PMID: 33163895 DOI: 10.1016/j.mayocpiqo.2020.10.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
289 Sahebnasagh A, Nabavi SM, Kashani HRK, Abdollahian S, Habtemariam S, Rezabakhsh A. Anti-VEGF agents: As appealing targets in the setting of COVID-19 treatment in critically ill patients. Int Immunopharmacol 2021;101:108257. [PMID: 34673299 DOI: 10.1016/j.intimp.2021.108257] [Reference Citation Analysis]
290 Mazzoni A, Salvati L, Maggi L, Annunziato F, Cosmi L. Hallmarks of immune response in COVID-19: Exploring dysregulation and exhaustion. Semin Immunol 2021;:101508. [PMID: 34728121 DOI: 10.1016/j.smim.2021.101508] [Reference Citation Analysis]
291 Jain A, Tolba R, Salti A, Lamperti M. Alternate mechanisms of SARS-CoV-2-induced analgesia and additional pathological significance of SARS-CoV-2 spike protein interaction with vascular endothelial growth factor-A/neuropilin-1 receptor signaling. Pain 2021;162:2956-7. [PMID: 34793407 DOI: 10.1097/j.pain.0000000000002447] [Reference Citation Analysis]
292 Calabretta F, Preti P, Russo M, Klersy C, Di Sabatino A. The role of heparin in reducing in-hospital complications and three-month mortality rates in hospitalized COVID-19 patients. European Journal of Internal Medicine 2022. [DOI: 10.1016/j.ejim.2022.03.015] [Reference Citation Analysis]
293 Mackman N, Antoniak S, Wolberg AS, Kasthuri R, Key NS. Coagulation Abnormalities and Thrombosis in Patients Infected With SARS-CoV-2 and Other Pandemic Viruses. Arterioscler Thromb Vasc Biol 2020;40:2033-44. [PMID: 32657623 DOI: 10.1161/ATVBAHA.120.314514] [Cited by in Crossref: 47] [Cited by in F6Publishing: 34] [Article Influence: 23.5] [Reference Citation Analysis]
294 Si-Mohamed S, Chebib N, Sigovan M, Zumbihl L, Turquier S, Boccalini S, Boussel L, Mornex JF, Cottin V, Douek P. In vivo demonstration of pulmonary microvascular involvement in COVID-19 using dual-energy computed tomography. Eur Respir J 2020;56:2002608. [PMID: 32943402 DOI: 10.1183/13993003.02608-2020] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
295 Grassin-Delyle S, Roquencourt C, Moine P, Saffroy G, Carn S, Heming N, Fleuriet J, Salvator H, Naline E, Couderc LJ, Devillier P, Thévenot EA, Annane D; Garches COVID-19 Collaborative Group RECORDS Collaborators and Exhalomics® Collaborators. Metabolomics of exhaled breath in critically ill COVID-19 patients: A pilot study. EBioMedicine 2021;63:103154. [PMID: 33279860 DOI: 10.1016/j.ebiom.2020.103154] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 10.0] [Reference Citation Analysis]
296 Albóniga OE, Jiménez D, Sánchez-Conde M, Vizcarra P, Ron R, Herrera S, Martínez-Sanz J, Moreno E, Moreno S, Barbas C, Serrano-Villar S. Metabolic Snapshot of Plasma Samples Reveals New Pathways Implicated in SARS-CoV-2 Pathogenesis. J Proteome Res 2022. [PMID: 35133846 DOI: 10.1021/acs.jproteome.1c00786] [Reference Citation Analysis]
297 Birnhuber A, Fliesser E, Gorkiewicz G, Zacharias M, Seeliger B, David S, Welte T, Schmidt J, Olschewski H, Wygrecka M, Kwapiszewska G. Between inflammation and thrombosis - endothelial cells in COVID-19. Eur Respir J 2021:2100377. [PMID: 33958433 DOI: 10.1183/13993003.00377-2021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
298 Mansour E, Palma AC, Ulaf RG, Ribeiro LC, Bernardes AF, Nunes TA, Agrela MV, Bombassaro B, Monfort-Pires M, Camargo RL, Araujo EP, Brunetti NS, Farias AS, Falcão ALE, Santos TM, Trabasso P, Dertkigil RP, Dertkigil SS, Moretti ML, Velloso LA. Safety and Outcomes Associated with the Pharmacological Inhibition of the Kinin-Kallikrein System in Severe COVID-19. Viruses 2021;13:309. [PMID: 33669276 DOI: 10.3390/v13020309] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
299 Xiao D, Tang F, Chen L, Gao H, Li X. Cumulative Evidence for the Association of Thrombosis and the Prognosis of COVID-19: Systematic Review and Meta-Analysis. Front Cardiovasc Med 2022;8:819318. [DOI: 10.3389/fcvm.2021.819318] [Reference Citation Analysis]
300 Gaisinskaya P, Vanhelmond TA, Reano K. Acute Limb Ischemia Following a Mild Case of COVID-19. Cureus. [DOI: 10.7759/cureus.25234] [Reference Citation Analysis]
301 Seiler C, Klingberg C, Hårdstedt M. Lung Ultrasound for Identification of Patients Requiring Invasive Mechanical Ventilation in COVID-19. J Ultrasound Med 2021. [PMID: 33496362 DOI: 10.1002/jum.15617] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
302 Billoir P, Alexandre K, Duflot T, Roger M, Miranda S, Goria O, Joly LM, Demeyere M, Feugray G, Brunel V, Etienne M, Le Cam Duchez V. Investigation of Coagulation Biomarkers to Assess Clinical Deterioration in SARS-CoV-2 Infection. Front Med (Lausanne) 2021;8:670694. [PMID: 34150806 DOI: 10.3389/fmed.2021.670694] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
303 Christensen RH, Berg RMG. Vascular Inflammation as a Therapeutic Target in COVID-19 "Long Haulers": HIITing the Spot? Front Cardiovasc Med 2021;8:643626. [PMID: 33869305 DOI: 10.3389/fcvm.2021.643626] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
304 Adivitiya, Kaushik MS, Chakraborty S, Veleri S, Kateriya S. Mucociliary Respiratory Epithelium Integrity in Molecular Defense and Susceptibility to Pulmonary Viral Infections. Biology (Basel) 2021;10:95. [PMID: 33572760 DOI: 10.3390/biology10020095] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
305 Bakouny Z, Hawley JE, Choueiri TK, Peters S, Rini BI, Warner JL, Painter CA. COVID-19 and Cancer: Current Challenges and Perspectives. Cancer Cell 2020;38:629-46. [PMID: 33049215 DOI: 10.1016/j.ccell.2020.09.018] [Cited by in Crossref: 45] [Cited by in F6Publishing: 44] [Article Influence: 22.5] [Reference Citation Analysis]
306 Jenner WJ, Kanji R, Mirsadraee S, Gue YX, Price S, Prasad S, Gorog DA. Thrombotic complications in 2928 patients with COVID-19 treated in intensive care: a systematic review. J Thromb Thrombolysis 2021;51:595-607. [PMID: 33586113 DOI: 10.1007/s11239-021-02394-7] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 15.0] [Reference Citation Analysis]
307 Ray JG, Vermeulen MJ, Schull MJ, Park AL. ABO Blood Group, SARS-CoV-2 Infection, and Risk of Venous Thromboembolism: Population-Based Cohort Study. Clin Appl Thromb Hemost 2021;27:10760296211008986. [PMID: 33827287 DOI: 10.1177/10760296211008986] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
308 Bascuñana A, Mijaylova A, Vega A, Macías N, Verde E, Rodríguez-Ferrero ML, Delgado A, Carbayo J, Goicoechea M. Thrombotic Microangiopathy in a Kidney Transplant Patient With COVID-19. Kidney Med 2021;3:124-7. [PMID: 33319192 DOI: 10.1016/j.xkme.2020.09.014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
309 Awasthi S, Wagner T, Venkatakrishnan AJ, Puranik A, Hurchik M, Agarwal V, Conrad I, Kirkup C, Arunachalam R, O'Horo J, Kremers W, Kashyap R, Morice W 2nd, Halamka J, Williams AW, Faubion WA Jr, Badley AD, Gores GJ, Soundararajan V. Plasma IL-6 levels following corticosteroid therapy as an indicator of ICU length of stay in critically ill COVID-19 patients. Cell Death Discov 2021;7:55. [PMID: 33723251 DOI: 10.1038/s41420-021-00429-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
310 Tangphokhanon W, Pradidarcheep W, Lametschwandtner A. α-mangostin preserves hepatic microvascular architecture in fibrotic rats as shown by scanning electron microscopy of vascular corrosion casts. Biomed Rep 2021;14:48. [PMID: 33859819 DOI: 10.3892/br.2021.1424] [Reference Citation Analysis]
311 Kiener M, Roldan N, Machahua C, Sengupta A, Geiser T, Guenat OT, Funke-Chambour M, Hobi N, Kruithof-de Julio M. Human-Based Advanced in vitro Approaches to Investigate Lung Fibrosis and Pulmonary Effects of COVID-19. Front Med (Lausanne) 2021;8:644678. [PMID: 34026781 DOI: 10.3389/fmed.2021.644678] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
312 Önal H, Arslan B, Üçüncü Ergun N, Topuz Ş, Yilmaz Semerci S, Kurnaz ME, Molu YM, Bozkurt MA, Süner N, Kocataş A. Treatment of COVID-19 patients with quercetin: a prospective, single center, randomized, controlled trial. Turk J Biol 2021;45:518-29. [PMID: 34803451 DOI: 10.3906/biy-2104-16] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
313 Bo W, Xi Y, Tian Z. The role of exercise in rehabilitation of discharged COVID-19 patients. Sports Med Health Sci 2021. [PMID: 34541561 DOI: 10.1016/j.smhs.2021.09.001] [Reference Citation Analysis]
314 Gelzo M, Cacciapuoti S, Pinchera B, De Rosa A, Cernera G, Scialò F, Comegna M, Mormile M, Gallicchio A, Fabbrocini G, Parrella R, Corso G, Gentile I, Castaldo G. A Transient Increase in the Serum ANCAs in Patients with SARS-CoV-2 Infection: A Signal of Subclinical Vasculitis or an Epiphenomenon with No Clinical Manifestations? A Pilot Study. Viruses 2021;13:1718. [PMID: 34578298 DOI: 10.3390/v13091718] [Reference Citation Analysis]
315 Grasselli G, Tonetti T, Protti A, Langer T, Girardis M, Bellani G, Laffey J, Carrafiello G, Carsana L, Rizzuto C, Zanella A, Scaravilli V, Pizzilli G, Grieco DL, Di Meglio L, de Pascale G, Lanza E, Monteduro F, Zompatori M, Filippini C, Locatelli F, Cecconi M, Fumagalli R, Nava S, Vincent JL, Antonelli M, Slutsky AS, Pesenti A, Ranieri VM;  collaborators. Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study. Lancet Respir Med. 2020;8:1201-1208. [PMID: 32861276 DOI: 10.1016/s2213-2600(20)30370-2] [Cited by in Crossref: 175] [Cited by in F6Publishing: 118] [Article Influence: 87.5] [Reference Citation Analysis]
316 Hou J, Gao T. Explainable DCNN based chest X-ray image analysis and classification for COVID-19 pneumonia detection. Sci Rep 2021;11:16071. [PMID: 34373554 DOI: 10.1038/s41598-021-95680-6] [Reference Citation Analysis]
317 Kapoor S, Chand S, Dieiev V, Fazzari M, Tanner T, Lewandowski DC, Nalla A, Abdulfattah O, Aboodi MS, Shiloh AL, Gong MN. Thromboembolic Events and Role of Point of Care Ultrasound in Hospitalized Covid-19 Patients Needing Intensive Care Unit Admission. J Intensive Care Med 2020;:885066620964392. [PMID: 33021131 DOI: 10.1177/0885066620964392] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
318 Menezes RG, Rizwan T, Saad Ali S, Hassan W, Khetpal A, Aqil M, Madadin M, Jamal Siddiqi T, Shariq Usman M. Postmortem findings in COVID-19 fatalities: A systematic review of current evidence. Legal Medicine 2022;54:102001. [DOI: 10.1016/j.legalmed.2021.102001] [Reference Citation Analysis]
319 Zhou M, Xu J, Liao T, Yin Z, Yang F, Wang K, Wang Z, Yang D, Wang S, Peng Y, Peng S, Wu F, Chen L, Jin Y. Comparison of Residual Pulmonary Abnormalities 3 Months After Discharge in Patients Who Recovered From COVID-19 of Different Severity. Front Med (Lausanne) 2021;8:682087. [PMID: 34249973 DOI: 10.3389/fmed.2021.682087] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
320 Schultz IC, Bertoni APS, Wink MR. Mesenchymal Stem Cell-Derived Extracellular Vesicles Carrying miRNA as a Potential Multi Target Therapy to COVID-19: an In Silico Analysis. Stem Cell Rev Rep 2021;17:341-56. [PMID: 33511519 DOI: 10.1007/s12015-021-10122-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
321 Sherren PB, Ostermann M, Agarwal S, Meadows CIS, Ioannou N, Camporota L. COVID-19-related organ dysfunction and management strategies on the intensive care unit: a narrative review. Br J Anaesth 2020;125:912-25. [PMID: 32988604 DOI: 10.1016/j.bja.2020.08.050] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
322 Calabrese EJ, Kozumbo WJ, Kapoor R, Dhawan G, Lara PC, Giordano J. Nrf2 activation putatively mediates clinical benefits of low-dose radiotherapy in COVID-19 pneumonia and acute respiratory distress syndrome (ARDS): Novel mechanistic considerations. Radiother Oncol 2021;160:125-31. [PMID: 33932453 DOI: 10.1016/j.radonc.2021.04.015] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
323 Sashindranath M, Nandurkar HH. Endothelial Dysfunction in the Brain: Setting the Stage for Stroke and Other Cerebrovascular Complications of COVID-19. Stroke 2021;52:1895-904. [PMID: 33794655 DOI: 10.1161/STROKEAHA.120.032711] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
324 Kooranifar S, Sadeghipour A, Riahi T, Goodarzi A, Tabrizi S, Davoody N. Histopathologic survey on lung necropsy specimens of 15 patients who died from COVID-19: A large study from Iran with a high rate of anthracosis. Med J Islam Repub Iran 2021;35:63. [PMID: 34277500 DOI: 10.47176/mjiri.35.63] [Reference Citation Analysis]
325 Rosovsky RP, Grodzin C, Channick R, Davis GA, Giri JS, Horowitz J, Kabrhel C, Lookstein R, Merli G, Morris TA, Rivera-Lebron B, Tapson V, Todoran TM, Weinberg AS, Rosenfield K; PERT Consortium. Diagnosis and Treatment of Pulmonary Embolism During the Coronavirus Disease 2019 Pandemic: A Position Paper From the National PERT Consortium. Chest 2020;158:2590-601. [PMID: 32861692 DOI: 10.1016/j.chest.2020.08.2064] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 7.5] [Reference Citation Analysis]
326 Haslbauer JD, Matter MS, Stalder AK, Tzankov A. Histomorphological patterns of regional lymph nodes in COVID-19 lungs. Pathologe 2021. [PMID: 33950285 DOI: 10.1007/s00292-021-00945-6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
327 Gemcioglu E, Davutoglu M, Catalbas R, Karabuga B, Kaptan E, Aypak A, Kalem AK, Özdemir M, Yeşilova NY, Kalkan EA, Civak M, Kücüksahin O, Erden A, Ates I. Predictive values of biochemical markers as early indicators for severe COVID-19 cases in admission. Future Virology 2021;16:353-67. [DOI: 10.2217/fvl-2020-0319] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
328 Burger AL, Kaufmann CC, Jäger B, Pogran E, Ahmed A, Wojta J, Farhan S, Huber K. Direct cardiovascular complications and indirect collateral damage during the COVID-19 pandemic : A review. Wien Klin Wochenschr 2021;133:1289-97. [PMID: 34671829 DOI: 10.1007/s00508-021-01956-2] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
329 Safai Zadeh E, Dietrich CF, Kmoth L, Trenker C, Alhyari A, Ludwig M, Görg C. Peripheral Pulmonary Lesions in Confirmed Pulmonary Arterial Embolism: Follow-up Study of B-Mode Ultrasound and of Perfusion Patterns Using Contrast-Enhanced Ultrasound (CEUS). J Ultrasound Med 2021. [PMID: 34694040 DOI: 10.1002/jum.15852] [Reference Citation Analysis]
330 Desnos C, Boussouar S, Hekimian G, Redheuil A, Combes A. Spontaneous hemothorax in 4 COVID-19 ARDS patients on VV-ECMO revealing pulmonary artery aneurysms. Crit Care 2020;24:638. [PMID: 33158462 DOI: 10.1186/s13054-020-03359-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
331 Farouk AF, Shafqat A, Shafqat S, Kashir J, Alkattan K, Yaqinuddin A; College of Medicine, Alfaisal University, Riyadh, Saudi Arabia, Medical College, Aga Khan University, Karachi, Pakistan, Department of Comparative Medicine, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia. . AIMSMOLES 2021;8:275-90. [DOI: 10.3934/molsci.2021021] [Reference Citation Analysis]
332 Pan P, Su LX, Liu DW, Wang XT; Chinese Critical Ultrasound Study Group (CCUSG). Acute respiratory distress syndrome: focusing on secondary injury. Chin Med J (Engl) 2021;134:2017-24. [PMID: 34432651 DOI: 10.1097/CM9.0000000000001694] [Reference Citation Analysis]
333 Ribeiro Dos Santos Miggiolaro AF, da Silva Motta Junior J, Busatta Vaz de Paula C, Nagashima S, Alessandra Scaranello Malaquias M, Baena Carstens L, N Moreno-Amaral A, Pellegrino Baena C, de Noronha L. Covid-19 cytokine storm in pulmonary tissue: Anatomopathological and immunohistochemical findings. Respir Med Case Rep 2020;31:101292. [PMID: 33200067 DOI: 10.1016/j.rmcr.2020.101292] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
334 Pérez-Mies B, Gómez-Rojo M, Carretero-Barrio I, Bardi T, Benito A, García-Cosío M, Caballero Á, de Pablo R, Galán JC, Pestaña D, Palacios J. Pulmonary vascular proliferation in patients with severe COVID-19: an autopsy study. Thorax 2021:thoraxjnl-2020-216714. [PMID: 33758071 DOI: 10.1136/thoraxjnl-2020-216714] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
335 Sánchez-Marteles M, Rubio-Gracia J, Peña-Fresneda N, Garcés-Horna V, Gracia-Tello B, Martínez-Lostao L, Crespo-Aznárez S, Pérez-Calvo JI, Giménez-López I. Early Measurement of Blood sST2 Is a Good Predictor of Death and Poor Outcomes in Patients Admitted for COVID-19 Infection. J Clin Med 2021;10:3534. [PMID: 34441830 DOI: 10.3390/jcm10163534] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
336 Zhang Q, Meng Y, Wang K, Zhang X, Chen W, Sheng J, Qiu Y, Diao H, Li L. Inflammation and Antiviral Immune Response Associated With Severe Progression of COVID-19. Front Immunol 2021;12:631226. [PMID: 33679778 DOI: 10.3389/fimmu.2021.631226] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
337 Gao Y, Chen R, Geng Q, Mo X, Zhan C, Jian W, Li S, Zheng J. Cardiopulmonary exercise testing might be helpful for interpretation of impaired pulmonary function in recovered COVID-19 patients. Eur Respir J 2021;57:2004265. [PMID: 33361097 DOI: 10.1183/13993003.04265-2020] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
338 Schifino G, Vega ML, Pisani L, Prediletto I, Catalanotti V, Comellini V, Bassi I, Zompatori M, Ranieri MV, Nava S. Effects of Non-Invasive Respiratory Supports on inspiratory effort in moderate-severe COVID-19 patients. A randomized physiological study. European Journal of Internal Medicine 2022. [DOI: 10.1016/j.ejim.2022.04.012] [Reference Citation Analysis]
339 Jounieaux V, Mahjoub Y, El-Esper I, Rodenstein DO. The importance of lung hyperperfusion patterns in COVID-19-related AVDS. Eur J Nucl Med Mol Imaging 2021. [PMID: 34247272 DOI: 10.1007/s00259-021-05451-8] [Reference Citation Analysis]
340 Arévalos V, Ortega-Paz L, Rodríguez-Arias JJ, Calvo López M, Castrillo-Golvano L, Salazar-Rodríguez A, Sabaté-Tormos M, Spione F, Sabaté M, Brugaletta S. Acute and Chronic Effects of COVID-19 on the Cardiovascular System. J Cardiovasc Dev Dis 2021;8:128. [PMID: 34677197 DOI: 10.3390/jcdd8100128] [Reference Citation Analysis]
341 Pfister F, Vonbrunn E, Ries T, Jäck HM, Überla K, Lochnit G, Sheriff A, Herrmann M, Büttner-Herold M, Amann K, Daniel C. Complement Activation in Kidneys of Patients With COVID-19. Front Immunol 2020;11:594849. [PMID: 33584662 DOI: 10.3389/fimmu.2020.594849] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 10.0] [Reference Citation Analysis]
342 Divisi D, Zaccagna G, Angeletti C, Cicerone E, De Vico A, Moretti R, Imbriglio G, Carbuglia N, Quaglione GR, Chiatamone Ranieri S, Crisci R. Pleural empyema associated with alveolar-pleural fistulas in severe acute respiratory syndrome coronavirus 2. Clin Case Rep 2021;9:e04262. [PMID: 34188928 DOI: 10.1002/ccr3.4262] [Reference Citation Analysis]
343 de Almeida RMC, Thomas GL, Glazier JA. Transcriptogram analysis reveals relationship between viral titer and gene sets responses during Corona-virus infection. NAR Genomics and Bioinformatics 2022;4:lqac020. [DOI: 10.1093/nargab/lqac020] [Reference Citation Analysis]
344 Pérez-calatayud AA, Enriquez-garcía R, Fareli-gonzález C, Barrett CD, Saldivar-rodea CA, Perulles-marin J, Reyes-caldelas MA, Rosenberg-contreras CI, Gómez-moreno JB, Guerrero-avendaño G, Serrano-loyola R, Carrillo-esper R, Moore EE. In Situ Pulmonary Thrombolysis and Perfusion Lung Angiography in Severe COVID-19 Respiratory Failure. Critical Care Explorations 2022;4:e0670. [DOI: 10.1097/cce.0000000000000670] [Reference Citation Analysis]
345 Mastellos DC, Pires da Silva BGP, Fonseca BAL, Fonseca NP, Auxiliadora-Martins M, Mastaglio S, Ruggeri A, Sironi M, Radermacher P, Chrysanthopoulou A, Skendros P, Ritis K, Manfra I, Iacobelli S, Huber-Lang M, Nilsson B, Yancopoulou D, Connolly ES, Garlanda C, Ciceri F, Risitano AM, Calado RT, Lambris JD. Complement C3 vs C5 inhibition in severe COVID-19: Early clinical findings reveal differential biological efficacy. Clin Immunol 2020;220:108598. [PMID: 32961333 DOI: 10.1016/j.clim.2020.108598] [Cited by in Crossref: 68] [Cited by in F6Publishing: 66] [Article Influence: 34.0] [Reference Citation Analysis]
346 Gheware A, Dholakia D, Kannan S, Panda L, Rani R, Pattnaik BR, Jain V, Parekh Y, Enayathullah MG, Bokara KK, Subramanian V, Mukerji M, Agrawal A, Prasher B. Adhatoda Vasica attenuates inflammatory and hypoxic responses in preclinical mouse models: potential for repurposing in COVID-19-like conditions. Respir Res 2021;22:99. [PMID: 33823870 DOI: 10.1186/s12931-021-01698-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
347 Xiong C, Li J, Li L, Chen L, Zhang R, Mi X, Liu Y. Label-free electrical monitoring of nucleic acid amplification with integrated hydrogel ionic diodes. Materials Today Bio 2022. [DOI: 10.1016/j.mtbio.2022.100281] [Reference Citation Analysis]
348 Mukerji SS, Das S, Alabsi H, Brenner LN, Jain A, Magdamo C, Collens SI, Ye E, Keller K, Boutros CL, Leone MJ, Newhouse A, Foy B, Li MD, Lang M, Anahtar MN, Shao YP, Ge W, Sun H, Triant VA, Kalpathy-Cramer J, Higgins J, Rosand J, Robbins GK, Westover MB. Prolonged Intubation in Patients With Prior Cerebrovascular Disease and COVID-19. Front Neurol 2021;12:642912. [PMID: 33897598 DOI: 10.3389/fneur.2021.642912] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
349 Geramizadeh B, Marzban M. Histopathologic Findings of Coronavirus in Lung: A Mini-Review. Clin Pathol 2020;13:2632010X20951823. [PMID: 33111059 DOI: 10.1177/2632010X20951823] [Reference Citation Analysis]
350 Fakhoury HMA, Kvietys PR, Shakir I, Shams H, Grant WB, Alkattan K. Lung-Centric Inflammation of COVID-19: Potential Modulation by Vitamin D. Nutrients 2021;13:2216. [PMID: 34203190 DOI: 10.3390/nu13072216] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
351 Berzuini A, Bianco C, Migliorini AC, Maggioni M, Valenti L, Prati D. Red blood cell morphology in patients with COVID-19-related anaemia. Blood Transfus 2021;19:34-6. [PMID: 32955421 DOI: 10.2450/2020.0242-20] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
352 Estenssoro E, Loudet CI, Dubin A, Kanoore Edul VS, Plotnikow G, Andrian M, Romero I, Sagardía J, Bezzi M, Mandich V, Groer C, Torres S, Orlandi C, Rubatto Birri PN, Valenti MF, Cunto E, Sáenz MG, Tiribelli N, Aphalo V, Bettini L, Ríos FG, Reina R. Clinical characteristics, respiratory management, and determinants of oxygenation in COVID-19 ARDS: A prospective cohort study. Journal of Critical Care 2022;71:154021. [DOI: 10.1016/j.jcrc.2022.154021] [Reference Citation Analysis]
353 Méndez R, González-Jiménez P, Latorre A, Piqueras M, Bouzas L, Yépez K, Ferrando A, Zaldívar-Olmeda E, Moscardó A, Alonso R, Reyes S, Menéndez R. Acute and sustained increase in endothelial biomarkers in COVID-19. Thorax 2021:thoraxjnl-2020-216797. [PMID: 34607904 DOI: 10.1136/thoraxjnl-2020-216797] [Reference Citation Analysis]
354 Gencer S, Lacy M, Atzler D, van der Vorst EPC, Döring Y, Weber C. Immunoinflammatory, Thrombohaemostatic, and Cardiovascular Mechanisms in COVID-19. Thromb Haemost 2020;120:1629-41. [PMID: 33124029 DOI: 10.1055/s-0040-1718735] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 9.0] [Reference Citation Analysis]
355 Aydın E, Kant A, Yilmaz G. Evaluation of the cardio-ankle vascular index in COVID-19 patients. Rev Assoc Med Bras (1992) 2021:S0104-42302021005012202. [PMID: 34909966 DOI: 10.1590/1806-9282.20210781] [Reference Citation Analysis]
356 Haslbauer JD, Matter MS, Stalder AK, Tzankov A. [Histomorphological patterns of regional lymph nodes in COVID-19 lungs]. Pathologe 2021;42:188-96. [PMID: 33575887 DOI: 10.1007/s00292-021-00914-z] [Reference Citation Analysis]
357 Nurek M, Rayner C, Freyer A, Taylor S, Järte L, MacDermott N, Delaney BC; Delphi panellists. Recommendations for the recognition, diagnosis, and management of long COVID: a Delphi study. Br J Gen Pract 2021;71:e815-25. [PMID: 34607799 DOI: 10.3399/BJGP.2021.0265] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
358 Pretorius E, Vlok M, Venter C, Bezuidenhout JA, Laubscher GJ, Steenkamp J, Kell DB. Persistent clotting protein pathology in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin. Cardiovasc Diabetol 2021;20:172. [PMID: 34425843 DOI: 10.1186/s12933-021-01359-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
359 Haryalchi K, Heidarzadeh A, Abedinzade M, Olangian-Tehrani S, Ghazanfar Tehran S. The Importance of Happy Hypoxemia in COVID-19. Anesth Pain Med 2021;11:e111872. [PMID: 34221943 DOI: 10.5812/aapm.111872] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
360 Odilov AA, Tsimbalist NS, Volkov AV, Babichenko II. [Organ changes found by postmortem examination in COVID-19 patients]. Arkh Patol 2020;82:63-9. [PMID: 33274630 DOI: 10.17116/patol20208206163] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
361 van der Vaart J, Lamers MM, Haagmans BL, Clevers H. Advancing lung organoids for COVID-19 research. Dis Model Mech 2021;14:dmm049060. [PMID: 34219165 DOI: 10.1242/dmm.049060] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
362 Takano AM. Pulmonary pathology of infection by SARS-CoV-2, what we have learnt through post-mortem studies and pathophysiological considerations. Proceedings of Singapore Healthcare 2021;30:152-8. [DOI: 10.1177/2010105820960495] [Reference Citation Analysis]
363 Calabrese F, Pezzuto F, Fortarezza F, Hofman P, Kern I, Panizo A, von der Thüsen J, Timofeev S, Gorkiewicz G, Lunardi F. Pulmonary pathology and COVID-19: lessons from autopsy. The experience of European Pulmonary Pathologists. Virchows Arch 2020;477:359-72. [PMID: 32642842 DOI: 10.1007/s00428-020-02886-6] [Cited by in Crossref: 73] [Cited by in F6Publishing: 83] [Article Influence: 36.5] [Reference Citation Analysis]
364 Lu YF, Pan LY, Zhang WW, Cheng F, Hu SS, Zhang X, Jiang HY. A meta-analysis of the incidence of venous thromboembolic events and impact of anticoagulation on mortality in patients with COVID-19. Int J Infect Dis 2020;100:34-41. [PMID: 32798659 DOI: 10.1016/j.ijid.2020.08.023] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 9.5] [Reference Citation Analysis]
365 Trahtemberg U, Slutsky AS, Villar J. What have we learned ventilating COVID-19 patients? Intensive Care Med 2020;46:2458-60. [PMID: 33044572 DOI: 10.1007/s00134-020-06275-0] [Reference Citation Analysis]
366 Shirvaliloo M. The unfavorable clinical outcome of COVID-19 in smokers is mediated by H3K4me3, H3K9me3 and H3K27me3 histone marks. Epigenomics 2022. [PMID: 35021853 DOI: 10.2217/epi-2021-0476] [Reference Citation Analysis]
367 Kenny G, Mallon PW. COVID19- clinical presentation and therapeutic considerations. Biochem Biophys Res Commun 2021;538:125-31. [PMID: 33218685 DOI: 10.1016/j.bbrc.2020.11.021] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
368 von der Thüsen JH, van Bommel J, Kros JM, Verdijk RM, Lopuhaä B, Lam KH, Dik WA, Miedema JR. Case report: a fatal combination of hemophagocytic lymphohistiocytosis with extensive pulmonary microvascular damage in COVID-19 pneumonia. J Hematop 2020;:1-5. [PMID: 33110452 DOI: 10.1007/s12308-020-00423-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
369 Gil-Etayo FJ, Garcinuño S, Lalueza A, Díaz-Simón R, García-Reyne A, Pleguezuelo DE, Cabrera-Marante O, Rodriguez-Frias EA, Perez-Rivilla A, Serrano M, Serrano A. Anti-Phospholipid Antibodies and COVID-19 Thrombosis: A Co-Star, Not a Supporting Actor. Biomedicines 2021;9:899. [PMID: 34440103 DOI: 10.3390/biomedicines9080899] [Reference Citation Analysis]
370 Kang JY, Xu MM, Sun Y, Ding ZX, Wei YY, Zhang DW, Wang YG, Shen JL, Wu HM, Fei GH. Melatonin attenuates LPS-induced pyroptosis in acute lung injury by inhibiting NLRP3-GSDMD pathway via activating Nrf2/HO-1 signaling axis. Int Immunopharmacol 2022;109:108782. [PMID: 35468366 DOI: 10.1016/j.intimp.2022.108782] [Reference Citation Analysis]
371 Thomas M, Abtin F, Roth A, Yim C, Pahwa A, Paige J, Ukpo O. Postmortem CT in decedents with SARS-CoV-2 infection. A single institution experience. Forensic Sciences Research. [DOI: 10.1080/20961790.2021.1977479] [Reference Citation Analysis]
372 Brosnahan SB, Jonkman AH, Kugler MC, Munger JS, Kaufman DA. COVID-19 and Respiratory System Disorders: Current Knowledge, Future Clinical and Translational Research Questions. Arterioscler Thromb Vasc Biol 2020;40:2586-97. [PMID: 32960072 DOI: 10.1161/ATVBAHA.120.314515] [Cited by in Crossref: 18] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
373 Pfeifer M, Hamer OW. [COVID-19 pneumonia]. Internist (Berl) 2020;61:793-803. [PMID: 32728817 DOI: 10.1007/s00108-020-00854-5] [Cited by in Crossref: 5] [Article Influence: 2.5] [Reference Citation Analysis]
374 Battaglini D, Robba C, Ball L, Silva PL, Cruz FF, Pelosi P, Rocco PRM. Noninvasive respiratory support and patient self-inflicted lung injury in COVID-19: a narrative review. Br J Anaesth 2021:S0007-0912(21)00340-8. [PMID: 34217468 DOI: 10.1016/j.bja.2021.05.024] [Reference Citation Analysis]
375 Ren AL, Digby RJ, Needham EJ. Neurological update: COVID-19. J Neurol 2021. [PMID: 33929617 DOI: 10.1007/s00415-021-10581-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
376 Berger JS, Connors JM. Anticoagulation in COVID-19: reaction to the ACTION trial. Lancet 2021;397:2226-8. [PMID: 34119049 DOI: 10.1016/S0140-6736(21)01291-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
377 Bordallo B, Bellas M, Cortez AF, Vieira M, Pinheiro M. Severe COVID-19: what have we learned with the immunopathogenesis? Adv Rheumatol 2020;60:50. [PMID: 32962761 DOI: 10.1186/s42358-020-00151-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
378 Li A, Kuderer NM, Hsu CY, Shyr Y, Warner JL, Shah DP, Kumar V, Shah S, Kulkarni AA, Fu J, Gulati S, Zon RL, Li M, Desai A, Egan PC, Bakouny Z, Kc D, Hwang C, Akpan IJ, McKay RR, Girard J, Schmidt AL, Halmos B, Thompson MA, Patel JM, Pennell NA, Peters S, Elshoury A, de Lima Lopes G, Stover DG, Grivas P, Rini BI, Painter CA, Mishra S, Connors JM, Lyman GH, Rosovsky RP; CCC19 consortium. The CoVID-TE risk assessment model for venous thromboembolism in hospitalized patients with cancer and COVID-19. J Thromb Haemost 2021. [PMID: 34260813 DOI: 10.1111/jth.15463] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
379 Ma Z, Yang KY, Huang Y, Lui KO. Endothelial contribution to COVID-19: an update on mechanisms and therapeutic implications. J Mol Cell Cardiol 2021;164:69-82. [PMID: 34838588 DOI: 10.1016/j.yjmcc.2021.11.010] [Reference Citation Analysis]
380 McGonagle D, Bridgewood C, Ramanan AV, Meaney JFM, Watad A. COVID-19 vasculitis and novel vasculitis mimics. Lancet Rheumatol 2021;3:e224-33. [PMID: 33521655 DOI: 10.1016/S2665-9913(20)30420-3] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 22.0] [Reference Citation Analysis]
381 Swenson KE, Swenson ER. Pathophysiology of Acute Respiratory Distress Syndrome and COVID-19 Lung Injury. Crit Care Clin 2021;37:749-76. [PMID: 34548132 DOI: 10.1016/j.ccc.2021.05.003] [Reference Citation Analysis]
382 Wu L, Zhang C, Zhao X. The Impact of COVID-19 Pandemic on Lung Cancer Community. World J Oncol 2021;12:1-6. [PMID: 33738000 DOI: 10.14740/wjon1367] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
383 Arena AW, Hussein A, Kurkowski EJ, Kulkarni ML. Can't Dissolve Me Now: A COVID-19 Provoked Venous Thromboembolism Breaks Through Apixaban: Case Report. Clin Pract Cases Emerg Med 2021;5:202-5. [PMID: 34437005 DOI: 10.5811/cpcem.2021.3.50505] [Reference Citation Analysis]
384 Eltobgy MM, Zani A, Kenney AD, Estfanous S, Kim E, Badr A, Carafice C, Daily K, Whitham O, Pietrzak M, Webb A, Kawahara J, Eddy AC, Denz P, Lu M, Kc M, Peeples ME, Li J, Zhu J, Que J, Robinson R, Rosas Mejia O, Rayner RE, Hall-Stoodley L, Seveau S, Gavrilin MA, Zhang X, Thomas J, Kohlmeier JE, Suthar MS, Oltz E, Tedeschi A, Robledo-Avila FH, Partida-Sanchez S, Hemann EA, Abdelrazik E, Forero A, Nimjee SM, Boyaka PN, Cormet-Boyaka E, Yount JS, Amer AO. Caspase-4/11 exacerbates disease severity in SARS-CoV-2 infection by promoting inflammation and immunothrombosis. Proc Natl Acad Sci U S A 2022;119:e2202012119. [PMID: 35588457 DOI: 10.1073/pnas.2202012119] [Reference Citation Analysis]
385 Cao T, Zhang G, Xie H, Pellegrini E, Li J, Chen X, Pan H. Case Report: The Coronavirus Disease 2019 (COVID-19) Pneumonia With Multiple Thromboembolism. Front Neurol. 2020;11:625272. [PMID: 33551979 DOI: 10.3389/fneur.2020.625272] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
386 Zhan X, Dowell S, Shen Y, Lee DL. Chloroquine to fight COVID-19: A consideration of mechanisms and adverse effects? Heliyon 2020;6:e04900. [PMID: 32935064 DOI: 10.1016/j.heliyon.2020.e04900] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
387 Adams HJA, Kwee TC, Kwee RM. Response. Chest 2021;159:2108. [PMID: 33965135 DOI: 10.1016/j.chest.2021.01.002] [Reference Citation Analysis]
388 Chen L, Tang R, Chen H, Huang Y, Yi S, Bai Q, Zhu Y, Hong C, Liu C, Zhang N, Wang T. Pulmonary Vasculature: A Target for COVID-19. Am J Respir Crit Care Med 2021;203:260-1. [PMID: 33085902 DOI: 10.1164/rccm.202009-3564LE] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
389 Vannucchi AM, Sordi B, Morettini A, Nozzoli C, Poggesi L, Pieralli F, Bartoloni A, Atanasio A, Miselli F, Paoli C, Loscocco GG, Fanelli A, Para O, Berni A, Tassinari I, Zammarchi L, Maggi L, Mazzoni A, Scotti V, Falchetti G, Malandrino D, Luise F, Millotti G, Bencini S, Capone M, Piccinni MP, Annunziato F, Guglielmelli P; RUXO-COVID Study Group. Compassionate use of JAK1/2 inhibitor ruxolitinib for severe COVID-19: a prospective observational study. Leukemia 2021;35:1121-33. [PMID: 32814839 DOI: 10.1038/s41375-020-01018-y] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 11.0] [Reference Citation Analysis]
390 Becker RC. Anticipating the long-term cardiovascular effects of COVID-19. J Thromb Thrombolysis 2020;50:512-24. [PMID: 32880795 DOI: 10.1007/s11239-020-02266-6] [Cited by in Crossref: 31] [Cited by in F6Publishing: 20] [Article Influence: 15.5] [Reference Citation Analysis]
391 Tsolaki V, Zakynthinos GE, Mantzarlis K. Right ventricular dilation: The additive effect of mechanical ventilation on pulmonary embolism in Covid-19 patients. Thromb Res 2020;196:25-6. [PMID: 32823172 DOI: 10.1016/j.thromres.2020.07.057] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
392 Corse T, Dayan L, Kersten S, Battaglia F, Terlecky SR, Han Z. Clinical Outcomes of COVID-19 Patients with Pre-existing, Compromised Immune Systems: A Review of Case Reports. Int J Med Sci 2020;17:2974-86. [PMID: 33173418 DOI: 10.7150/ijms.50537] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
393 Sies H, Parnham MJ. Potential therapeutic use of ebselen for COVID-19 and other respiratory viral infections. Free Radic Biol Med 2020;156:107-12. [PMID: 32598985 DOI: 10.1016/j.freeradbiomed.2020.06.032] [Cited by in Crossref: 52] [Cited by in F6Publishing: 43] [Article Influence: 26.0] [Reference Citation Analysis]
394 Liu Y, Garron TM, Chang Q, Su Z, Zhou C, Qiu Y, Gong EC, Zheng J, Yin YW, Ksiazek T, Brasel T, Jin Y, Boor P, Comer JE, Gong B. Cell-Type Apoptosis in Lung during SARS-CoV-2 Infection. Pathogens 2021;10:509. [PMID: 33922476 DOI: 10.3390/pathogens10050509] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
395 Sender V, Hentrich K, Henriques-Normark B. Virus-Induced Changes of the Respiratory Tract Environment Promote Secondary Infections With Streptococcus pneumoniae. Front Cell Infect Microbiol 2021;11:643326. [PMID: 33828999 DOI: 10.3389/fcimb.2021.643326] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
396 Wu ML, Liu FL, Sun J, Li X, He XY, Zheng HY, Zhou YH, Yan Q, Chen L, Yu GY, Chang J, Jin X, Zhao J, Chen XW, Zheng YT, Wang JH. SARS-CoV-2-triggered mast cell rapid degranulation induces alveolar epithelial inflammation and lung injury. Signal Transduct Target Ther 2021;6:428. [PMID: 34921131 DOI: 10.1038/s41392-021-00849-0] [Reference Citation Analysis]
397 Basra R, Whyte M, Karalliedde J, Vas P. What is the impact of microvascular complications of diabetes on severe COVID-19? Microvasc Res 2021;140:104310. [PMID: 34979154 DOI: 10.1016/j.mvr.2021.104310] [Reference Citation Analysis]
398 Sekhawat V, Green A, Mahadeva U. COVID-19 autopsies: conclusions from international studies. Diagn Histopathol (Oxf). 2021;27:103-107. [PMID: 33312230 DOI: 10.1016/j.mpdhp.2020.11.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
399 Steadman E, Fandaros M, Yin W. SARS-CoV-2 and Plasma Hypercoagulability. Cell Mol Bioeng 2021;:1-10. [PMID: 34221178 DOI: 10.1007/s12195-021-00685-w] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
400 Kwaan HC, Lindholm PF. The Central Role of Fibrinolytic Response in COVID-19-A Hematologist's Perspective. Int J Mol Sci 2021;22:1283. [PMID: 33525440 DOI: 10.3390/ijms22031283] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
401 McVaney KE, Pepe PE, Maloney LM, Bronsky ES, Crowe RP, Augustine JJ, Gilliam SO, Asaeda GH, Eckstein M, Mattu A, Fumagalli R, Aufderheide TP, Osterholm MT; Writing group on behalf of the Metropolitan EMS Medical Directors Global Alliance. The relationship of large city out-of-hospital cardiac arrests and the prevalence of COVID-19. EClinicalMedicine 2021;34:100815. [PMID: 33997730 DOI: 10.1016/j.eclinm.2021.100815] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
402 Passarelli VC, Perosa AH, de Souza Luna LK, Conte DD, Nascimento OA, Ota-Arakaki J, Bellei N. Detected SARS-CoV-2 in Ascitic Fluid Followed by Cryptococcemia: a Case Report. SN Compr Clin Med 2020;:1-5. [PMID: 33047097 DOI: 10.1007/s42399-020-00574-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
403 Thachil J, Lisman T. Pulmonary Megakaryocytes in Coronavirus Disease 2019 (COVID-19): Roles in Thrombi and Fibrosis. Semin Thromb Hemost 2020;46:831-4. [PMID: 32882717 DOI: 10.1055/s-0040-1714274] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
404 Guler SA, Ebner L, Aubry-Beigelman C, Bridevaux PO, Brutsche M, Clarenbach C, Garzoni C, Geiser TK, Lenoir A, Mancinetti M, Naccini B, Ott SR, Piquilloud L, Prella M, Que YA, Soccal PM, von Garnier C, Funke-Chambour M. Pulmonary function and radiological features 4 months after COVID-19: first results from the national prospective observational Swiss COVID-19 lung study. Eur Respir J 2021;57:2003690. [PMID: 33419891 DOI: 10.1183/13993003.03690-2020] [Cited by in Crossref: 48] [Cited by in F6Publishing: 52] [Article Influence: 48.0] [Reference Citation Analysis]
405 Kalafatis D, Löfdahl A, Näsman P, Dellgren G, Wheelock ÅM, Elowsson Rendin L, Sköld M, Westergren-Thorsson G. Distal Lung Microenvironment Triggers Release of Mediators Recognized as Potential Systemic Biomarkers for Idiopathic Pulmonary Fibrosis. Int J Mol Sci 2021;22:13421. [PMID: 34948231 DOI: 10.3390/ijms222413421] [Reference Citation Analysis]
406 Anderson MR, Geleris J, Anderson DR, Zucker J, Nobel YR, Freedberg D, Small-Saunders J, Rajagopalan KN, Greendyk R, Chae SR, Natarajan K, Roh D, Edwin E, Gallagher D, Podolanczuk A, Barr RG, Ferrante AW, Baldwin MR. Body Mass Index and Risk for Intubation or Death in SARS-CoV-2 Infection : A Retrospective Cohort Study. Ann Intern Med 2020;173:782-90. [PMID: 32726151 DOI: 10.7326/M20-3214] [Cited by in Crossref: 61] [Cited by in F6Publishing: 42] [Article Influence: 30.5] [Reference Citation Analysis]
407 Rastogi A, Dogra H, Jude EB. COVID-19 and peripheral arterial complications in people with diabetes and hypertension: A systematic review. Diabetes Metab Syndr 2021;15:102204. [PMID: 34303918 DOI: 10.1016/j.dsx.2021.102204] [Reference Citation Analysis]
408 Malone RW, Tisdall P, Fremont-Smith P, Liu Y, Huang XP, White KM, Miorin L, Moreno E, Alon A, Delaforge E, Hennecker CD, Wang G, Pottel J, Blair RV, Roy CJ, Smith N, Hall JM, Tomera KM, Shapiro G, Mittermaier A, Kruse AC, García-Sastre A, Roth BL, Glasspool-Malone J, Ricke DO. COVID-19: Famotidine, Histamine, Mast Cells, and Mechanisms. Front Pharmacol 2021;12:633680. [PMID: 33833683 DOI: 10.3389/fphar.2021.633680] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 8.0] [Reference Citation Analysis]
409 Mak SM, Mak D, Hodson D, Preston R, Retter A, Camporota L, Benedetti G. Pulmonary ischaemia without pulmonary arterial thrombus in COVID-19 patients receiving extracorporeal membrane oxygenation: a cohort study. Clin Radiol 2020;75:795.e1-5. [PMID: 32778329 DOI: 10.1016/j.crad.2020.07.006] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
410 Halawa S, Pullamsetti SS, Bangham CRM, Stenmark KR, Dorfmüller P, Frid MG, Butrous G, Morrell NW, de Jesus Perez VA, Stuart DI, O'Gallagher K, Shah AM, Aguib Y, Yacoub MH. Potential long-term effects of SARS-CoV-2 infection on the pulmonary vasculature: a global perspective. Nat Rev Cardiol 2021. [PMID: 34873286 DOI: 10.1038/s41569-021-00640-2] [Reference Citation Analysis]
411 Sriram K, Insel PA. Proteinase-activated receptor 1: A target for repurposing in the treatment of COVID-19? Br J Pharmacol 2020;177:4971-4. [PMID: 32639031 DOI: 10.1111/bph.15194] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
412 Bradley P, Frost F, Tharmaratnam K, Wootton DG; NW Collaborative Organisation for Respiratory Research. Utility of established prognostic scores in COVID-19 hospital admissions: multicentre prospective evaluation of CURB-65, NEWS2 and qSOFA. BMJ Open Respir Res 2020;7:e000729. [PMID: 33293361 DOI: 10.1136/bmjresp-2020-000729] [Cited by in Crossref: 13] [Cited by in F6Publishing: 19] [Article Influence: 6.5] [Reference Citation Analysis]
413 Pastorek M, Dúbrava M, Celec P. On the Origin of Neutrophil Extracellular Traps in COVID-19. Front Immunol 2022;13:821007. [DOI: 10.3389/fimmu.2022.821007] [Reference Citation Analysis]
414 Jia H, Harikumar P, Atkinson E, Rigsby P, Wadhwa M. The First WHO International Standard for Harmonizing the Biological Activity of Bevacizumab. Biomolecules 2021;11:1610. [PMID: 34827607 DOI: 10.3390/biom11111610] [Reference Citation Analysis]
415 Mone P, Gambardella J, Wang X, Jankauskas SS, Matarese A, Santulli G. miR-24 Targets the Transmembrane Glycoprotein Neuropilin-1 in Human Brain Microvascular Endothelial Cells. Noncoding RNA 2021;7:9. [PMID: 33540664 DOI: 10.3390/ncrna7010009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
416 Kalinskaya A, Dukhin O, Molodtsov I, Maltseva A, Sokorev D, Elizarova A, Sapozhnikova O, Glebova K, Stonogina D, Shakhidzhanov S, Nikonov E, Mazus A, Spiridonov I, Ataullakhanov F, Margolis L, Shpektor A, Vasilieva E. Dynamics of coagulopathy in patients with different COVID-19 severity. medRxiv 2020:2020. [PMID: 32637973 DOI: 10.1101/2020.07.02.20145284] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
417 Busana M, Schiavone M, Lanfranchi A, Battista Forleo G, Ceriani E, Beatrice Cogliati C, Gasperetti A. Non-invasive hemodynamic profile of early COVID-19 infection. Physiol Rep 2020;8:e14628. [PMID: 33113285 DOI: 10.14814/phy2.14628] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
418 Preissner KT, Fischer S, Deindl E. Extracellular RNA as a Versatile DAMP and Alarm Signal That Influences Leukocyte Recruitment in Inflammation and Infection. Front Cell Dev Biol 2020;8:619221. [PMID: 33392206 DOI: 10.3389/fcell.2020.619221] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
419 Kruip MJHA, Cannegieter SC, Ten Cate H, van Gorp ECM, Juffermans NP, Klok FA, Maas C, Vonk-Noordegraaf A; Dutch COVID Thrombosis Coalition study group. Caging the dragon: Research approach to COVID-19-related thrombosis. Res Pract Thromb Haemost 2021;5:278-90. [PMID: 33733026 DOI: 10.1002/rth2.12470] [Reference Citation Analysis]
420 Woo MS, Malsy J, Pöttgen J, Seddiq Zai S, Ufer F, Hadjilaou A, Schmiedel S, Addo MM, Gerloff C, Heesen C, Schulze Zur Wiesch J, Friese MA. Frequent neurocognitive deficits after recovery from mild COVID-19. Brain Commun 2020;2:fcaa205. [PMID: 33376990 DOI: 10.1093/braincomms/fcaa205] [Cited by in Crossref: 37] [Cited by in F6Publishing: 24] [Article Influence: 18.5] [Reference Citation Analysis]
421 Chen W, Pan JY. Anatomical and Pathological Observation and Analysis of SARS and COVID-19: Microthrombosis Is the Main Cause of Death. Biol Proced Online 2021;23:4. [PMID: 33472576 DOI: 10.1186/s12575-021-00142-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 13.0] [Reference Citation Analysis]
422 Brito-Dellan N, Tsoukalas N, Font C. Thrombosis, cancer, and COVID-19. Support Care Cancer 2022. [PMID: 35567609 DOI: 10.1007/s00520-022-07098-z] [Reference Citation Analysis]
423 Daisley H Jr, Rampersad A, Daisley M, Ramdin A, Acco O. Coronavirus 229E with Rhinovirus co-infection causing severe acute respiratory distress syndrome with thrombotic microangiopathy and death during Covid-19 pandemic: lessons to be learnt. Autops Case Rep 2020;10:e2020194. [PMID: 33344304 DOI: 10.4322/acr.2020.194] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
424 Sweeney JM, Barouqa M, Krause GJ, Gonzalez-Lugo JD, Rahman S, Gil MR. Low ADAMTS13 Activity Correlates with Increased Mortality in COVID-19 Patients. TH Open 2021;5:e89-e103. [PMID: 33709050 DOI: 10.1055/s-0041-1723784] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
425 Shukla AK, Misra S. An overview of post COVID sequelae. J Basic Clin Physiol Pharmacol 2022. [PMID: 35428040 DOI: 10.1515/jbcpp-2022-0057] [Reference Citation Analysis]
426 Smirnov AV, Ermilov VV, Dorofeev NA, Tolokolnikov VA, Chernetsky OA, Poplavsky AE, Botasheva VS, Samusev RP, Alexandrova LI, Belik TA, Makarova MM, Gurov DY. [Features of pathological anatomy of COVID-19 according to autopsy results in the Volgograd Region]. Arkh Patol 2021;83:5-13. [PMID: 34859980 DOI: 10.17116/patol2021830615] [Reference Citation Analysis]
427 Nardo AD, Schneeweiss-Gleixner M, Bakail M, Dixon ED, Lax SF, Trauner M. Pathophysiological mechanisms of liver injury in COVID-19. Liver Int 2021;41:20-32. [PMID: 33190346 DOI: 10.1111/liv.14730] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
428 Zheng S, Chen Q, Jiang H, Guo C, Luo J, Li S, Wang H, Li H, Zheng X, Weng Z. No significant benefit of moderate-dose vitamin C on severe COVID-19 cases. Open Med (Wars) 2021;16:1403-14. [PMID: 34616916 DOI: 10.1515/med-2021-0361] [Reference Citation Analysis]
429 Anft M, Paniskaki K, Blazquez-Navarro A, Doevelaar A, Seibert FS, Hölzer B, Skrzypczyk S, Kohut E, Kurek J, Zapka J, Wehler P, Kaliszczyk S, Bajda S, Thieme CJ, Roch T, Konik MJ, Berger MM, Brenner T, Kölsch U, Meister TL, Pfaender S, Steinmann E, Tempfer C, Watzl C, Dolff S, Dittmer U, Abou-El-Enein M, Westhoff TH, Witzke O, Stervbo U, Babel N. COVID-19-Induced ARDS Is Associated with Decreased Frequency of Activated Memory/Effector T Cells Expressing CD11a+. Mol Ther 2020;28:2691-702. [PMID: 33186542 DOI: 10.1016/j.ymthe.2020.10.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
430 Bagate F, Tuffet S, Masi P, Perier F, Razazi K, de Prost N, Carteaux G, Payen D, Mekontso Dessap A. Rescue therapy with inhaled nitric oxide and almitrine in COVID-19 patients with severe acute respiratory distress syndrome. Ann Intensive Care 2020;10:151. [PMID: 33150525 DOI: 10.1186/s13613-020-00769-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
431 Angelini DE, Kaatz S, Rosovsky R, Zon RL, Pillai S, Robertson WE, Elavalakanar P, Patell R, Khorana A. COVID‐19 and venous thromboembolism: A narrative review. Res Pract Thromb Haemost 2022;6. [DOI: 10.1002/rth2.12666] [Reference Citation Analysis]
432 Braga CL, Silva-Aguiar RP, Battaglini D, Peruchetti DB, Robba C, Pelosi P, Rocco PRM, Caruso-Neves C, Silva PL. The renin-angiotensin-aldosterone system: Role in pathogenesis and potential therapeutic target in COVID-19. Pharmacol Res Perspect 2020;8:e00623. [PMID: 32658389 DOI: 10.1002/prp2.623] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
433 Yang LV, Oppelt KA, Thomassen MJ, Marie MA, Nik Akhtar S, McCallen JD. Can GPR4 Be a Potential Therapeutic Target for COVID-19? Front Med (Lausanne) 2020;7:626796. [PMID: 33553219 DOI: 10.3389/fmed.2020.626796] [Reference Citation Analysis]
434 Deigendesch N, Sironi L, Kutza M, Wischnewski S, Fuchs V, Hench J, Frank A, Nienhold R, Mertz KD, Cathomas G, Matter MS, Siegemund M, Tolnay M, Schirmer L, Pröbstel AK, Tzankov A, Frank S. Correlates of critical illness-related encephalopathy predominate postmortem COVID-19 neuropathology. Acta Neuropathol 2020;140:583-6. [PMID: 32851506 DOI: 10.1007/s00401-020-02213-y] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 20.5] [Reference Citation Analysis]
435 Sanwal R, Joshi K, Ditmans M, Tsai SSH, Lee WL. Ultrasound and Microbubbles for Targeted Drug Delivery to the Lung Endothelium in ARDS: Cellular Mechanisms and Therapeutic Opportunities. Biomedicines 2021;9:803. [PMID: 34356867 DOI: 10.3390/biomedicines9070803] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
436 Alschuler L, Chiasson AM, Horwitz R, Sternberg E, Crocker R, Weil A, Maizes V. Integrative medicine considerations for convalescence from mild-to-moderate COVID-19 disease. Explore (NY) 2020:S1550-8307(20)30417-1. [PMID: 33358750 DOI: 10.1016/j.explore.2020.12.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
437 Karmouty-Quintana H, Thandavarayan RA, Keller SP, Sahay S, Pandit LM, Akkanti B. Emerging Mechanisms of Pulmonary Vasoconstriction in SARS-CoV-2-Induced Acute Respiratory Distress Syndrome (ARDS) and Potential Therapeutic Targets. Int J Mol Sci 2020;21:E8081. [PMID: 33138181 DOI: 10.3390/ijms21218081] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
438 Papageorghiou AT, Deruelle P, Gunier RB, Rauch S, García-May PK, Mhatre M, Usman MA, Abd-Elsalam S, Etuk S, Simmons LE, Napolitano R, Deantoni S, Liu B, Prefumo F, Savasi V, do Vale MS, Baafi E, Zainab G, Nieto R, Maiz N, Aminu MB, Cardona-Perez JA, Craik R, Winsey A, Tavchioska G, Bako B, Oros D, Rego A, Benski AC, Hassan-Hanga F, Savorani M, Giuliani F, Sentilhes L, Risso M, Takahashi K, Vecchiarelli C, Ikenoue S, Thiruvengadam R, Soto Conti CP, Ferrazzi E, Cetin I, Nachinab VB, Ernawati E, Duro EA, Kholin A, Firlit ML, Easter SR, Sichitiu J, Bowale A, Casale R, Cerbo RM, Cavoretto PI, Eskenazi B, Thornton JG, Bhutta ZA, Kennedy SH, Villar J. Preeclampsia and COVID-19: results from the INTERCOVID prospective longitudinal study. Am J Obstet Gynecol 2021:S0002-9378(21)00561-5. [PMID: 34187688 DOI: 10.1016/j.ajog.2021.05.014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
439 Invernizzi A, Torre A, Parrulli S, Zicarelli F, Schiuma M, Colombo V, Giacomelli A, Cigada M, Milazzo L, Ridolfo A, Faggion I, Cordier L, Oldani M, Marini S, Villa P, Rizzardini G, Galli M, Antinori S, Staurenghi G, Meroni L. Retinal findings in patients with COVID-19: Results from the SERPICO-19 study. EClinicalMedicine 2020;27:100550. [PMID: 32984785 DOI: 10.1016/j.eclinm.2020.100550] [Cited by in Crossref: 44] [Cited by in F6Publishing: 44] [Article Influence: 22.0] [Reference Citation Analysis]
440 Buenen AG, Sinkeldam M, Maas ML, Verdonschot M, Wever PC. Prior use of anticoagulation is associated with a better survival in COVID-19. J Thromb Thrombolysis 2021. [PMID: 34061283 DOI: 10.1007/s11239-021-02486-4] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
441 Sim R, Cheung G, Ting D, Wong E, Wong TY, Yeo I, Wong CW. Retinal microvascular signs in COVID-19. Br J Ophthalmol 2021:bjophthalmol-2020-318236. [PMID: 33741583 DOI: 10.1136/bjophthalmol-2020-318236] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
442 Adhikary AB, R U, Patel NB, S VP, Boruah P, Chandrakar S. Spectrum of pneumothorax/pneumomediastinum in patients with coronavirus disease 2019. Qatar Med J 2021;2021:41. [PMID: 34604018 DOI: 10.5339/qmj.2021.41] [Reference Citation Analysis]
443 Kreidieh F, Temraz S. Anticoagulation for COVID-19 Patients: A Bird's-Eye View. Clin Appl Thromb Hemost 2021;27:10760296211039288. [PMID: 34595937 DOI: 10.1177/10760296211039288] [Reference Citation Analysis]
444 Li Z, Paulin D, Lacolley P, Coletti D, Agbulut O. Vimentin as a target for the treatment of COVID-19. BMJ Open Respir Res 2020;7:e000623. [PMID: 32913008 DOI: 10.1136/bmjresp-2020-000623] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
445 Sisinni A, Rossi L, Battista A, Poletti E, Battista F, Battista RA, Malagoli A, Biagi A, Zanni A, Sticozzi C, Comastri G, Marrocco-Trischitta MM, Monello A, Margonato A, Bandera F, Vergara P, Guazzi M, Godino C. Pre-admission acetylsalicylic acid therapy and impact on in-hospital outcome in COVID-19 patients: The ASA-CARE study. Int J Cardiol 2021;344:240-5. [PMID: 34619262 DOI: 10.1016/j.ijcard.2021.09.058] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
446 Obermayer A, Jakob LM, Haslbauer JD, Matter MS, Tzankov A, Stoiber W. Neutrophil Extracellular Traps in Fatal COVID-19-Associated Lung Injury. Dis Markers 2021;2021:5566826. [PMID: 34367376 DOI: 10.1155/2021/5566826] [Reference Citation Analysis]
447 Apicella M, Campopiano MC, Mantuano M, Mazoni L, Coppelli A, Del Prato S. COVID-19 in people with diabetes: understanding the reasons for worse outcomes. Lancet Diabetes Endocrinol. 2020;8:782-792. [PMID: 32687793 DOI: 10.1016/s2213-8587(20)30238-2] [Cited by in Crossref: 263] [Cited by in F6Publishing: 170] [Article Influence: 131.5] [Reference Citation Analysis]
448 Franciosi MLM, Lima MDM, Schetinger MRC, Cardoso AM. Possible role of purinergic signaling in COVID-19. Mol Cell Biochem 2021;476:2891-8. [PMID: 33740184 DOI: 10.1007/s11010-021-04130-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
449 Hekman RM, Hume AJ, Goel RK, Abo KM, Huang J, Blum BC, Werder RB, Suder EL, Paul I, Phanse S, Youssef A, Alysandratos KD, Padhorny D, Ojha S, Mora-Martin A, Kretov D, Ash PEA, Verma M, Zhao J, Patten JJ, Villacorta-Martin C, Bolzan D, Perea-Resa C, Bullitt E, Hinds A, Tilston-Lunel A, Varelas X, Farhangmehr S, Braunschweig U, Kwan JH, McComb M, Basu A, Saeed M, Perissi V, Burks EJ, Layne MD, Connor JH, Davey R, Cheng JX, Wolozin BL, Blencowe BJ, Wuchty S, Lyons SM, Kozakov D, Cifuentes D, Blower M, Kotton DN, Wilson AA, Mühlberger E, Emili A. Actionable Cytopathogenic Host Responses of Human Alveolar Type 2 Cells to SARS-CoV-2. Mol Cell 2020;80:1104-1122.e9. [PMID: 33259812 DOI: 10.1016/j.molcel.2020.11.028] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 10.0] [Reference Citation Analysis]
450 Bordallo B, Bellas M, Cortez AF, Vieira M, Pinheiro M. Severe COVID-19: what have we learned with the immunopathogenesis? Adv Rheumatol 2020;60:50. [PMID: 32962761 DOI: 10.1186/s42358-020-00151-7] [Cited by in Crossref: 23] [Cited by in F6Publishing: 1] [Article Influence: 11.5] [Reference Citation Analysis]
451 Nishibori M, Stonestreet BS. Understanding of COVID-19 Pathology: Much More Attention to Plasma Proteins. Front Immunol 2021;12:656099. [PMID: 33841442 DOI: 10.3389/fimmu.2021.656099] [Reference Citation Analysis]
452 Kamel MH, Yin W, Zavaro C, Francis JM, Chitalia VC. Hyperthrombotic Milieu in COVID-19 Patients. Cells 2020;9:E2392. [PMID: 33142844 DOI: 10.3390/cells9112392] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
453 Dupuis C, de Montmollin E, Buetti N, Goldgran-Toledano D, Reignier J, Schwebel C, Domitile J, Neuville M, Ursino M, Siami S, Ruckly S, Alberti C, Mourvillier B, Bailly S, Laurent V, Gainnier M, Souweine B, Timsit JF; OutcomeReaTM research network. Impact of early corticosteroids on 60-day mortality in critically ill patients with COVID-19: A multicenter cohort study of the OUTCOMEREA network. PLoS One 2021;16:e0255644. [PMID: 34347836 DOI: 10.1371/journal.pone.0255644] [Reference Citation Analysis]
454 Cen G, Liu L, Wang J, Wang X, Chen S, Song Y, Liang Z. Weighted Gene Co-Expression Network Analysis to Identify Potential Biological Processes and Key Genes in COVID-19-Related Stroke. Oxid Med Cell Longev 2022;2022:4526022. [PMID: 35557984 DOI: 10.1155/2022/4526022] [Reference Citation Analysis]
455 Zamboni P, Bortolotti D, Occhionorelli S, Traina L, Neri LM, Rizzo R, Gafà R, Passaro A. Bowel ischemia as onset of COVID-19 in otherwise asymptomatic patients with persistently negative swab. J Intern Med 2021. [PMID: 34437741 DOI: 10.1111/joim.13385] [Reference Citation Analysis]
456 Salamanna F, Maglio M, Sartori M, Landini MP, Fini M. Vitamin D and Platelets: A Menacing Duo in COVID-19 and Potential Relation to Bone Remodeling. Int J Mol Sci 2021;22:10010. [PMID: 34576172 DOI: 10.3390/ijms221810010] [Reference Citation Analysis]
457 Goerlich E, Metkus TS, Gilotra NA, Wu KC, Cingolani OH, Hays AG. Prevalence and Clinical Correlates of Echo-Estimated Right and Left Heart Filling Pressures in Hospitalized Patients With Coronavirus Disease 2019. Crit Care Explor 2020;2:e0227. [PMID: 33063031 DOI: 10.1097/CCE.0000000000000227] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
458 Kommoss FKF, Schwab C, Tavernar L, Schreck J, Wagner WL, Merle U, Jonigk D, Schirmacher P, Longerich T. The Pathology of Severe COVID-19-Related Lung Damage. Dtsch Arztebl Int 2020;117:500-6. [PMID: 32865490 DOI: 10.3238/arztebl.2020.0500] [Cited by in Crossref: 6] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
459 Ambrosino P, Calcaterra IL, Mosella M, Formisano R, D’anna SE, Bachetti T, Marcuccio G, Galloway B, Mancini FP, Papa A, Motta A, Di Minno MND, Maniscalco M. Endothelial Dysfunction in COVID-19: A Unifying Mechanism and a Potential Therapeutic Target. Biomedicines 2022;10:812. [DOI: 10.3390/biomedicines10040812] [Reference Citation Analysis]
460 Muhl L, He L, Sun Y, Andaloussi Mäe M, Pietilä R, Liu J, Genové G, Zhang L, Xie Y, Leptidis S, Mocci G, Stritt S, Osman A, Anisimov A, Hemanthakumar KA, Räsänen M, Hansson EM, Björkegren J, Vanlandewijck M, Blomgren K, Mäkinen T, Peng XR, Hu Y, Ernfors P, Arnold TD, Alitalo K, Lendahl U, Betsholtz C. The SARS-CoV-2 receptor ACE2 is expressed in mouse pericytes but not endothelial cells: Implications for COVID-19 vascular research. Stem Cell Reports 2022:S2213-6711(22)00149-7. [PMID: 35452595 DOI: 10.1016/j.stemcr.2022.03.016] [Reference Citation Analysis]
461 Triposkiadis F, Starling RC, Xanthopoulos A, Butler J, Boudoulas H. The Counter Regulatory Axis of the Lung Renin-Angiotensin System in Severe COVID-19: Pathophysiology and Clinical Implications. Heart Lung Circ 2021;30:786-94. [PMID: 33454213 DOI: 10.1016/j.hlc.2020.11.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
462 Semeraro N, Colucci M. The Prothrombotic State Associated with SARS-CoV-2 Infection: Pathophysiological Aspects. Mediterr J Hematol Infect Dis 2021;13:e2021045. [PMID: 34276914 DOI: 10.4084/MJHID.2021.045] [Reference Citation Analysis]
463 Wu C, Hou D, Du C, Cai Y, Zheng J, Xu J, Chen X, Chen C, Hu X, Zhang Y, Song J, Wang L, Chao YC, Feng Y, Xiong W, Chen D, Zhong M, Hu J, Jiang J, Bai C, Zhou X, Song Y, Gong F. Corticosteroid therapy for coronavirus disease 2019-related acute respiratory distress syndrome: a cohort study with propensity score analysis.Crit Care. 2020;24:643. [PMID: 33172477 DOI: 10.1186/s13054-020-03340-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
464 Ville S, Le Bot S, Chapelet-Debout A, Blancho G, Fremeaux-Bacchi V, Deltombe C, Fakhouri F. Atypical HUS relapse triggered by COVID-19. Kidney Int 2021;99:267-8. [PMID: 33188793 DOI: 10.1016/j.kint.2020.10.030] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
465 Mitchell WB. Thromboinflammation in COVID-19 acute lung injury. Paediatr Respir Rev 2020;35:20-4. [PMID: 32653469 DOI: 10.1016/j.prrv.2020.06.004] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
466 Al-Kuraishy HM, Al-Gareeb AI, Alkazmi L, Habotta OA, Batiha GE. High-mobility group box 1 (HMGB1) in COVID-19: extrapolation of dangerous liaisons. Inflammopharmacology 2022. [PMID: 35471628 DOI: 10.1007/s10787-022-00988-y] [Reference Citation Analysis]
467 Rentsch CT, Beckman JA, Tomlinson L, Gellad WF, Alcorn C, Kidwai-Khan F, Skanderson M, Brittain E, King JT Jr, Ho YL, Eden S, Kundu S, Lann MF, Greevy RA Jr, Ho PM, Heidenreich PA, Jacobson DA, Douglas IJ, Tate JP, Evans SJW, Atkins D, Justice AC, Freiberg MS. Early initiation of prophylactic anticoagulation for prevention of coronavirus disease 2019 mortality in patients admitted to hospital in the United States: cohort study. BMJ 2021;372:n311. [PMID: 33574135 DOI: 10.1136/bmj.n311] [Cited by in Crossref: 38] [Cited by in F6Publishing: 25] [Article Influence: 38.0] [Reference Citation Analysis]
468 Stassi C, Mondello C, Baldino G, Cardia L, Asmundo A, Ventura Spagnolo E. An Insight into the Role of Postmortem Immunohistochemistry in the Comprehension of the Inflammatory Pathophysiology of COVID-19 Disease and Vaccine-Related Thrombotic Adverse Events: A Narrative Review. Int J Mol Sci 2021;22:12024. [PMID: 34769454 DOI: 10.3390/ijms222112024] [Reference Citation Analysis]
469 Yatim N, Boussier J, Chocron R, Hadjadj J, Philippe A, Gendron N, Barnabei L, Charbit B, Szwebel TA, Carlier N, Pène F, Azoulay C, Khider L, Mirault T, Diehl JL, Guerin CL, Rieux-Laucat F, Duffy D, Kernéis S, Smadja DM, Terrier B. Platelet activation in critically ill COVID-19 patients. Ann Intensive Care 2021;11:113. [PMID: 34273008 DOI: 10.1186/s13613-021-00899-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
470 Otifi HM, Adiga BK. Endothelial Dysfunction in Covid-19. The American Journal of the Medical Sciences 2022. [DOI: 10.1016/j.amjms.2021.12.010] [Reference Citation Analysis]
471 Caro-Codón J, Rey JR, Buño A, Iniesta AM, Rosillo SO, Castrejon-Castrejon S, Merino C, Marco I, Martinez LA, Garcia-Veas JM, Martin-Polo L, Rodriguez-Sotelo L, Martinez-Cossiani M, Gonzalez-Valle L, Herrero A, López-de-Sá E, Merino JL; CARD-COVID Investigators. Characterization of myocardial injury in a cohort of patients with SARS-CoV-2 infection. Med Clin (Engl Ed) 2021;157:274-80. [PMID: 34568576 DOI: 10.1016/j.medcle.2021.02.008] [Reference Citation Analysis]
472 Diehl JL, Peron N, Chocron R, Debuc B, Guerot E, Hauw-Berlemont C, Hermann B, Augy JL, Younan R, Novara A, Langlais J, Khider L, Gendron N, Goudot G, Fagon JF, Mirault T, Smadja DM. Respiratory mechanics and gas exchanges in the early course of COVID-19 ARDS: a hypothesis-generating study. Ann Intensive Care 2020;10:95. [PMID: 32676824 DOI: 10.1186/s13613-020-00716-1] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 13.5] [Reference Citation Analysis]
473 Hariri LP, North CM, Shih AR, Israel RA, Maley JH, Villalba JA, Vinarsky V, Rubin J, Okin DA, Sclafani A, Alladina JW, Griffith JW, Gillette MA, Raz Y, Richards CJ, Wong AK, Ly A, Hung YP, Chivukula RR, Petri CR, Calhoun TF, Brenner LN, Hibbert KA, Medoff BD, Hardin CC, Stone JR, Mino-Kenudson M. Lung Histopathology in Coronavirus Disease 2019 as Compared With Severe Acute Respiratory Sydrome and H1N1 Influenza: A Systematic Review. Chest. 2021;159:73-84. [PMID: 33038391 DOI: 10.1016/j.chest.2020.09.259] [Cited by in Crossref: 34] [Cited by in F6Publishing: 37] [Article Influence: 17.0] [Reference Citation Analysis]
474 Natarajan P, Kanchi M, Gunaseelan V, Sigamani A, Harmon J, Belani K. Coronavirus and Homo Sapiens. Journal of Cardiac Critical Care TSS. [DOI: 10.1055/s-0040-1716634] [Reference Citation Analysis]
475 Leppkes M, Knopf J, Naschberger E, Lindemann A, Singh J, Herrmann I, Stürzl M, Staats L, Mahajan A, Schauer C, Kremer AN, Völkl S, Amann K, Evert K, Falkeis C, Wehrfritz A, Rieker RJ, Hartmann A, Kremer AE, Neurath MF, Muñoz LE, Schett G, Herrmann M. Vascular occlusion by neutrophil extracellular traps in COVID-19. EBioMedicine 2020;58:102925. [PMID: 32745993 DOI: 10.1016/j.ebiom.2020.102925] [Cited by in Crossref: 116] [Cited by in F6Publishing: 116] [Article Influence: 58.0] [Reference Citation Analysis]
476 Bharat A, Querrey M, Markov NS, Kim S, Kurihara C, Garza-Castillon R, Manerikar A, Shilatifard A, Tomic R, Politanska Y, Abdala-Valencia H, Yeldandi AV, Lomasney JW, Misharin AV, Budinger GRS. Lung transplantation for patients with severe COVID-19. Sci Transl Med 2020;12:eabe4282. [PMID: 33257409 DOI: 10.1126/scitranslmed.abe4282] [Cited by in Crossref: 43] [Cited by in F6Publishing: 35] [Article Influence: 21.5] [Reference Citation Analysis]
477 Maiti S, Banerjee A, Kanwar M. Effects of theaflavin-gallate in-silico binding with different proteins of SARS-CoV-2 and host inflammation and vasoregulations referring an experimental rat-lung injury. Phytomedicine Plus 2022;2:100237. [DOI: 10.1016/j.phyplu.2022.100237] [Reference Citation Analysis]
478 Barisione E, Grillo F, Ball L, Bianchi R, Grosso M, Morbini P, Pelosi P, Patroniti NA, De Lucia A, Orengo G, Gratarola A, Verda M, Cittadini G, Mastracci L, Fiocca R. Fibrotic progression and radiologic correlation in matched lung samples from COVID-19 post-mortems. Virchows Arch 2021;478:471-85. [PMID: 32989525 DOI: 10.1007/s00428-020-02934-1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 8.5] [Reference Citation Analysis]
479 Jalkanen J, Hollmén M, Jalkanen S. Interferon beta-1a for COVID-19: critical importance of the administration route. Crit Care 2020;24:335. [PMID: 32532353 DOI: 10.1186/s13054-020-03048-5] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 8.5] [Reference Citation Analysis]
480 Sharma S, Mishra A, Ashraf Z. COVID-19 Induced Coagulopathy (CIC): Thrombotic Manifestations of Viral Infection. TH Open 2022;6:e70-9. [PMID: 35280973 DOI: 10.1055/s-0042-1744185] [Reference Citation Analysis]
481 Coban MA, Morrison J, Maharjan S, Hernandez Medina DH, Li W, Zhang YS, Freeman WD, Radisky ES, Le Roch KG, Weisend CM, Ebihara H, Caulfield TR. Attacking COVID-19 Progression Using Multi-Drug Therapy for Synergetic Target Engagement. Biomolecules 2021;11:787. [PMID: 34071060 DOI: 10.3390/biom11060787] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
482 Miró Ò, Jiménez S, Mebazaa A, Freund Y, Burillo-Putze G, Martín A, Martín-Sánchez FJ, García-Lamberechts EJ, Alquézar-Arbé A, Jacob J, Llorens P, Piñera P, Gil V, Guardiola J, Cardozo C, Mòdol Deltell JM, Tost J, Aguirre Tejedo A, Palau-Vendrell A, LLauger García L, Adroher Muñoz M, Del Arco Galán C, Agudo Villa T, López-Laguna N, López Díez MP, Beddar Chaib F, Quero Motto E, González Tejera M, Ponce MC, González Del Castillo J. Pulmonary embolism in patients with COVID-19: incidence, risk factors, clinical characteristics, and outcome. Eur Heart J 2021:ehab314. [PMID: 34164664 DOI: 10.1093/eurheartj/ehab314] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
483 Liu T, Dai J, Yang Z, Yu X, Xu Y, Shi X, Wei D, Tang Z, Xu G, Xu W, Liu Y, Shi C, Ni Q, Yang C, Zhang X, Wang X, Chen E, Qu J. Inactivated SARS-CoV-2 vaccine does not influence the profile of prothrombotic antibody nor increase the risk of thrombosis in a prospective Chinese cohort. Sci Bull (Beijing) 2021. [PMID: 34336365 DOI: 10.1016/j.scib.2021.07.033] [Reference Citation Analysis]
484 Lee Y, Jehangir Q, Li P, Gudimella D, Mahale P, Lin CH, Apala DR, Krishnamoorthy G, Halabi AR, Patel K, Poisson L, Balijepally V, Sule AA, Nair GB. Venous thromboembolism in COVID-19 patients and prediction model: a multicenter cohort study. BMC Infect Dis 2022;22:462. [PMID: 35562677 DOI: 10.1186/s12879-022-07421-3] [Reference Citation Analysis]
485 Onesti CE, Tagliamento M, Curigliano G, Harbeck N, Bartsch R, Wildiers H, Tjan-Heijnen V, Martin M, Rottey S, Generali D, Campone M, Cristofanilli M, Pusztai L, Peeters M, Berchem G, Cortes J, Ruhstaller T, Ciruelos E, Rugo HS, Jerusalem G. Expected Medium- and Long-Term Impact of the COVID-19 Outbreak in Oncology. JCO Glob Oncol 2021;7:162-72. [PMID: 33529077 DOI: 10.1200/GO.20.00589] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
486 Garg RK, Singh GP, Garg R, Kumar N, Parihar A. Severe COVID-19: A distinct entity. J Family Med Prim Care 2021;10:84-92. [PMID: 34017708 DOI: 10.4103/jfmpc.jfmpc_1600_20] [Reference Citation Analysis]
487 Iliadi V, Konstantinidou I, Aftzoglou K, Iliadis S, Konstantinidis TG, Tsigalou C. The Emerging Role of Neutrophils in the Pathogenesis of Thrombosis in COVID-19. Int J Mol Sci 2021;22:5368. [PMID: 34065210 DOI: 10.3390/ijms22105368] [Reference Citation Analysis]
488 Mangalmurti N, Hunter CA. Cytokine Storms: Understanding COVID-19. Immunity. 2020;53:19-25. [PMID: 32610079 DOI: 10.1016/j.immuni.2020.06.017] [Cited by in Crossref: 191] [Cited by in F6Publishing: 183] [Article Influence: 95.5] [Reference Citation Analysis]
489 Cardillo A, Refaai M. Platelet Recruitment in COVID-19. Am J Clin Pathol 2021:aqab102. [PMID: 34463341 DOI: 10.1093/ajcp/aqab102] [Reference Citation Analysis]
490 Castro-Verdes M, Gkouma A, Wort J, Ridge C, Mirsadraee S, Padley S, Sheikh A, Singh S. Corona Virus Disease 2019 in situ arterial and venous thrombosis in critically ill patients: a case series. Eur Heart J Case Rep 2020;4:1-7. [PMID: 33442596 DOI: 10.1093/ehjcr/ytaa470] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
491 Jarius S, Pache F, Körtvelyessy P, Jelčić I, Stettner M, Franciotta D, Keller E, Neumann B, Ringelstein M, Senel M, Regeniter A, Kalantzis R, Willms JF, Berthele A, Busch M, Capobianco M, Eisele A, Reichen I, Dersch R, Rauer S, Sandner K, Ayzenberg I, Gross CC, Hegen H, Khalil M, Kleiter I, Lenhard T, Haas J, Aktas O, Angstwurm K, Kleinschnitz C, Lewerenz J, Tumani H, Paul F, Stangel M, Ruprecht K, Wildemann B; ; in cooperation with the German Society for Cerebrospinal Fluid Diagnostics and Clinical Neurochemistry. Cerebrospinal fluid findings in COVID-19: a multicenter study of 150 lumbar punctures in 127 patients. J Neuroinflammation 2022;19. [DOI: 10.1186/s12974-021-02339-0] [Reference Citation Analysis]
492 Rodriguez-Gonzalez M, Castellano-Martinez A, Cascales-Poyatos HM, Perez-Reviriego AA. Cardiovascular impact of COVID-19 with a focus on children: A systematic review. World J Clin Cases 2020; 8(21): 5250-5283 [PMID: 33269260 DOI: 10.12998/wjcc.v8.i21.5250] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
493 Zhang W, Sang L, Shi J, Zhong M, Jiang L, Song B, Kang L, Zhang Y, Zhang D, Yu Y, Zheng X. Association of D-dimer elevation with inflammation and organ dysfunction in ICU patients with COVID-19 in Wuhan, China: a retrospective observational study. Aging (Albany NY) 2021;13:4794-810. [PMID: 33591951 DOI: 10.18632/aging.202496] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
494 Gattinoni L, Gattarello S, Steinberg I, Busana M, Palermo P, Lazzari S, Romitti F, Quintel M, Meissner K, Marini JJ, Chiumello D, Camporota L. COVID-19 pneumonia: pathophysiology and management. Eur Respir Rev 2021;30:210138. [PMID: 34670808 DOI: 10.1183/16000617.0138-2021] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
495 Cohen KR, Anderson D, Ren S, Cook DJ. Contribution of the elevated thrombosis risk of males to the excess male mortality observed in COVID-19: an observational study. BMJ Open 2022;12:e051624. [PMID: 35217534 DOI: 10.1136/bmjopen-2021-051624] [Reference Citation Analysis]
496 Stals MAM, Kaptein FHJ, Bemelmans RHH, van Bemmel T, Boukema IC, Braeken DCW, Braken SJE, Bresser C, Cate HT, Deenstra DD, Dooren YPAV, Faber LM, Grootenboers MJJH, Haan LR, Haazer C, Sol AID, Kelliher S, Koster T, Kroft LJM, Meijer RI, Pals F, van Thiel ERE, Westerweel PE, Wolde MT, Klok FA, Huisman MV; Dutch COVID & Thrombosis Coalition (DCTC) . Ruling out Pulmonary Embolism in Patients with (Suspected) COVID-19-A Prospective Cohort Study. TH Open 2021;5:e387-99. [PMID: 34541450 DOI: 10.1055/s-0041-1735155] [Reference Citation Analysis]
497 To KK, Sridhar S, Chiu KH, Hung DL, Li X, Hung IF, Tam AR, Chung TW, Chan JF, Zhang AJ, Cheng VC, Yuen KY. Lessons learned 1 year after SARS-CoV-2 emergence leading to COVID-19 pandemic. Emerg Microbes Infect 2021;10:507-35. [PMID: 33666147 DOI: 10.1080/22221751.2021.1898291] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 17.0] [Reference Citation Analysis]
498 Ondracek AS, Lang IM. Neutrophil Extracellular Traps as Prognostic Markers in COVID-19: A Welcome Piece to the Puzzle. Arterioscler Thromb Vasc Biol 2021;41:995-8. [PMID: 33955780 DOI: 10.1161/ATVBAHA.120.315633] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
499 Chen K, Lei Y, He Y, Xiao F, Yu Y, Lai X, Liu Y, Wang J, Dai H. Clinical outcomes of hospitalized COVID-19 patients with renal injury: a multi-hospital observational study from Wuhan. Sci Rep 2021;11:15205. [PMID: 34312430 DOI: 10.1038/s41598-021-94570-1] [Reference Citation Analysis]
500 Noy-Porat T, Mechaly A, Levy Y, Makdasi E, Alcalay R, Gur D, Aftalion M, Falach R, Leviatan Ben-Arye S, Lazar S, Zauberman A, Epstein E, Chitlaru T, Weiss S, Achdout H, Edgeworth JD, Kikkeri R, Yu H, Chen X, Yitzhaki S, Shapira SC, Padler-Karavani V, Mazor O, Rosenfeld R. Therapeutic antibodies, targeting the SARS-CoV-2 spike N-terminal domain, protect lethally infected K18-hACE2 mice. iScience 2021;24:102479. [PMID: 33937725 DOI: 10.1016/j.isci.2021.102479] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
501 González-García JG, Pascual-Guardia S, Aguilar Colindres RJ, Ausín Herrero P, Alvarado Miranda M, Arita Guevara M, Badenes Bonet D, Bellido Calduch S, Caguana Vélez OA, Cumpli Gargallo C, Dominguez-Alvarez M, Gea J, Grau N, Khilzi K, Martínez-Llorens J, Sánchez Ortiz M, Sánchez-Font A, Sancho-Muñoz A, Parrilla-Gómez FJ, Marín Corral J, Pérez Terán P, Rodríguez-Sevilla JJ, Chalela R, Rodríguez-Chiaradia D. Incidence of pulmonary embolism in patients with non-invasive respiratory support during COVID-19 outbreak. Respir Med 2021;178:106325. [PMID: 33581510 DOI: 10.1016/j.rmed.2021.106325] [Reference Citation Analysis]
502 Connors JM, Ridker PM. Thromboinflammation and Antithrombotics in COVID-19: Accumulating Evidence and Current Status. JAMA 2022. [PMID: 35315488 DOI: 10.1001/jama.2022.2361] [Reference Citation Analysis]
503 Tan WYT, Young BE, Lye DC, Chew DEK, Dalan R. Statin use is associated with lower disease severity in COVID-19 infection. Sci Rep 2020;10:17458. [PMID: 33060704 DOI: 10.1038/s41598-020-74492-0] [Cited by in Crossref: 39] [Cited by in F6Publishing: 31] [Article Influence: 19.5] [Reference Citation Analysis]
504 Goyal R, Bala R, Sindhu RK, Zehravi M, Madaan R, Ramproshad S, Mondal B, Dey A, Rahman MH, Cavalu S. Bioactive Based Nanocarriers for the Treatment of Viral Infections and SARS-CoV-2. Nanomaterials 2022;12:1530. [DOI: 10.3390/nano12091530] [Reference Citation Analysis]
505 Lebeau G, Vagner D, Frumence É, Ah-Pine F, Guillot X, Nobécourt E, Raffray L, Gasque P. Deciphering SARS-CoV-2 Virologic and Immunologic Features. Int J Mol Sci 2020;21:E5932. [PMID: 32824753 DOI: 10.3390/ijms21165932] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
506 Fayol A, Livrozet M, Boutouyrie P, Khettab H, Betton M, Tea V, Blanchard A, Bruno RM, Hulot JS; French COVID cohort study group. Cardiac performance in patients hospitalized with COVID-19: a 6 month follow-up study. ESC Heart Fail 2021;8:2232-9. [PMID: 33773099 DOI: 10.1002/ehf2.13315] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
507 Dominguez LJ, Veronese N, Guerrero-Romero F, Barbagallo M. Magnesium in Infectious Diseases in Older People. Nutrients 2021;13:E180. [PMID: 33435521 DOI: 10.3390/nu13010180] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
508 Diamond MS, Kanneganti TD. Innate immunity: the first line of defense against SARS-CoV-2. Nat Immunol 2022;23:165-76. [PMID: 35105981 DOI: 10.1038/s41590-021-01091-0] [Reference Citation Analysis]
509 Schwab N, Nienhold R, Henkel M, Baschong A, Graber A, Frank A, Mensah N, Koike J, Hernach C, Sachs M, Daun T, Zsikla V, Willi N, Junt T, Mertz KD. COVID-19 Autopsies Reveal Underreporting of SARS-CoV-2 Infection and Scarcity of Co-infections. Front Med 2022;9:868954. [DOI: 10.3389/fmed.2022.868954] [Reference Citation Analysis]
510 Tufano A, Rendina D, Abate V, Casoria A, Marra A, Buonanno P, Galletti F, Di Minno G, Servillo G, Vargas M. Venous Thromboembolism in COVID-19 Compared to Non-COVID-19 Cohorts: A Systematic Review with Meta-Analysis. J Clin Med 2021;10:4925. [PMID: 34768445 DOI: 10.3390/jcm10214925] [Reference Citation Analysis]
511 Lin CR, Bahmed K, Simborio H, Hayek H, Bolla S, Marchetti N, Criner GJ, Kosmider B. Expression of SARS-CoV-2 Entry Factors in Human Alveolar Type II Cells in Aging and Emphysema. Biomedicines 2021;9:779. [PMID: 34356843 DOI: 10.3390/biomedicines9070779] [Reference Citation Analysis]
512 Villa E, Critelli R, Lasagni S, Melegari A, Curatolo A, Celsa C, Romagnoli D, Melegari G, Pivetti A, Di Marco L, Casari F, Arioli D, Turrini F, Zuccaro V, Cassaniti I, Riefolo M, de Santis E, Bernabucci V, Bianchini M, Lei B, De Maria N, Carulli L, Schepis F, Gozzi C, Malaguti S, Del Buono M, Brugioni L, Torricelli P, Trenti T, Pinelli G, Bertellini E, Bruno R, Cammà C, d'Errico A. Dynamic angiopoietin-2 assessment predicts survival and chronic course in hospitalized patients with COVID-19. Blood Adv 2021;5:662-73. [PMID: 33560382 DOI: 10.1182/bloodadvances.2020003736] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
513 Gutiérrez-Zarate D, Rosas-Sánchez K, Flores-Carrillo JC, Medrano-Ahumada S, Martínez-Franco M. Early management of critically ill patients with COVID-19. J Am Coll Emerg Physicians Open 2020;1:1418-26. [PMID: 33392546 DOI: 10.1002/emp2.12294] [Reference Citation Analysis]
514 Verhoef PA, Kannan S, Sturgill JL, Tucker EW, Morris PE, Miller AC, Sexton TR, Koyner JL, Hejal R, Brakenridge SC, Moldawer LL, Hotchkiss RS, Blood TM, Mazer MB, Bolesta S, Alexander SA, Armaignac DL, Shein SL, Jones C, Hoemann CD, Doctor A, Friess SH, Parker RI, Rotta AT, Remy KE. Severe Acute Respiratory Syndrome-Associated Coronavirus 2 Infection and Organ Dysfunction in the ICU: Opportunities for Translational Research. Crit Care Explor 2021;3:e0374. [PMID: 33786450 DOI: 10.1097/CCE.0000000000000374] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
515 Fernández-Sarmiento J, Flórez S, Alarcón-Forero LC, Salazar-Peláez LM, Garcia-Casallas J, Mulett H, Acevedo L, Salamanca C. Case Report: Endothelial Glycocalyx Damage in Critically ill Patients With SARS-CoV-2-Related Multisystem Inflammatory Syndrome (MIS-C). Front Pediatr 2021;9:726949. [PMID: 34552899 DOI: 10.3389/fped.2021.726949] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
516 Rosa BA, Ahmed M, Singh DK, Choreño-Parra JA, Cole J, Jiménez-Álvarez LA, Rodríguez-Reyna TS, Singh B, Gonzalez O, Carrion R Jr, Schlesinger LS, Martin J, Zúñiga J, Mitreva M, Kaushal D, Khader SA. IFN signaling and neutrophil degranulation transcriptional signatures are induced during SARS-CoV-2 infection. Commun Biol 2021;4:290. [PMID: 33674719 DOI: 10.1038/s42003-021-01829-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
517 Rakislova N, Marimon L, Ismail MR, Carrilho C, Fernandes F, Ferrando M, Castillo P, Rodrigo-Calvo MT, Guerrero J, Ortiz E, Muñoz-Beatove A, Martinez MJ, Hurtado JC, Navarro M, Bassat Q, Maixenchs M, Delgado V, Wallong E, Aceituno A, Kim J, Paganelli C, Goco NJ, Aldecoa I, Martinez-Pozo A, Martinez D, Ramírez-Ruz J, Cathomas G, Haab M, Menéndez C, Ordi J. Minimally Invasive Autopsy Practice in COVID-19 Cases: Biosafety and Findings. Pathogens 2021;10:412. [PMID: 33915771 DOI: 10.3390/pathogens10040412] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
518 Díaz LA, Idalsoaga F, Cannistra M, Candia R, Cabrera D, Barrera F, Soza A, Graham R, Riquelme A, Arrese M, Leise MD, Arab JP. High prevalence of hepatic steatosis and vascular thrombosis in COVID-19: A systematic review and meta-analysis of autopsy data. World J Gastroenterol 2020; 26(48): 7693-7706 [PMID: 33505145 DOI: 10.3748/wjg.v26.i48.7693] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
519 Huertas A, Montani D, Savale L, Pichon J, Tu L, Parent F, Guignabert C, Humbert M. Endothelial cell dysfunction: a major player in SARS-CoV-2 infection (COVID-19)? Eur Respir J 2020;56:2001634. [PMID: 32554538 DOI: 10.1183/13993003.01634-2020] [Cited by in Crossref: 108] [Cited by in F6Publishing: 110] [Article Influence: 54.0] [Reference Citation Analysis]
520 Chan C, Foster ST, Chan KG, Cacace MJ, Ladd SL, Sandum CT, Wright PT, Volmert B, Yang W, Aguirre A, Li W, Wright NT. Repositioned Drugs for COVID-19-the Impact on Multiple Organs. SN Compr Clin Med 2021;:1-18. [PMID: 33898925 DOI: 10.1007/s42399-021-00874-8] [Reference Citation Analysis]
521 Busana M, Giosa L, Cressoni M, Gasperetti A, Di Girolamo L, Martinelli A, Sonzogni A, Lorini L, Palumbo MM, Romitti F, Gattarello S, Steinberg I, Herrmann P, Meissner K, Quintel M, Gattinoni L. The impact of ventilation-perfusion inequality in COVID-19: a computational model. J Appl Physiol (1985) 2021;130:865-76. [PMID: 33439790 DOI: 10.1152/japplphysiol.00871.2020] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
522 Alsinglawi B, Mubin O, Alnajjar F, Kheirallah K, Elkhodr M, Al Zobbi M, Novoa M, Arsalan M, Poly TN, Gochoo M, Khan G, Dev K. A simulated measurement for COVID-19 pandemic using the effective reproductive number on an empirical portion of population: epidemiological models. Neural Comput Appl 2021;:1-9. [PMID: 34658535 DOI: 10.1007/s00521-021-06579-2] [Reference Citation Analysis]
523 Heidinger BH, Kifjak D, Prayer F, Beer L, Milos RI, Röhrich S, Arndt H, Prosch H. [Radiological manifestations of pulmonary diseases in COVID-19]. Radiologe 2020;60:908-15. [PMID: 32897438 DOI: 10.1007/s00117-020-00749-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
524 Khattab K, Kempa AT, Atas R, Asani H, Ehab A. Peripheral ischemic limb necrosis (Acro-ischemia) associated with severe COVID-19 patients (COVID-19 limbs): A report of three cases. Lung India 2021;38:S58-60. [PMID: 33686981 DOI: 10.4103/lungindia.lungindia_470_20] [Reference Citation Analysis]
525 El Karoui K, De Vriese AS. COVID-19 in dialysis: clinical impact, immune response, prevention and treatment. Kidney International 2022. [DOI: 10.1016/j.kint.2022.01.022] [Reference Citation Analysis]
526 Wu M, Chen Y, Xia H, Wang C, Tan CY, Cai X, Liu Y, Ji F, Xiong P, Liu R, Guan Y, Duan Y, Kuang D, Xu S, Cai H, Xia Q, Yang D, Wang MW, Chiu IM, Cheng C, Ahern PP, Liu L, Wang G, Surana NK, Xia T, Kasper DL. Transcriptional and proteomic insights into the host response in fatal COVID-19 cases. Proc Natl Acad Sci U S A 2020;117:28336-43. [PMID: 33082228 DOI: 10.1073/pnas.2018030117] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 19.0] [Reference Citation Analysis]
527 Giordo R, Paliogiannis P, Mangoni AA, Pintus G. SARS-CoV-2 and endothelial cell interaction in COVID-19: molecular perspectives. Vasc Biol 2021;3:R15-23. [PMID: 33659858 DOI: 10.1530/VB-20-0017] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
528 Kovacs-Kasa A, Zaied AA, Leanhart S, Koseoglu M, Sridhar S, Lucas R, Fulton DJ, Vazquez JA, Annex BH. Elevated Cytokine Levels in Plasma of Patients with SARS-CoV-2 Do Not Contribute to Pulmonary Microvascular Endothelial Permeability. Microbiol Spectr 2022;:e0167121. [PMID: 35171047 DOI: 10.1128/spectrum.01671-21] [Reference Citation Analysis]
529 Kakarla V, Kaneko N, Nour M, Khatibi K, Elahi F, Liebeskind DS, Hinman JD. Pathophysiologic mechanisms of cerebral endotheliopathy and stroke due to Sars-CoV-2. J Cereb Blood Flow Metab 2021;41:1179-92. [PMID: 33530831 DOI: 10.1177/0271678X20985666] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
530 Marik PE, Iglesias J, Varon J, Kory P. A scoping review of the pathophysiology of COVID-19. Int J Immunopathol Pharmacol 2021;35:20587384211048026. [PMID: 34569339 DOI: 10.1177/20587384211048026] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
531 Stark K, Massberg S. Interplay between inflammation and thrombosis in cardiovascular pathology. Nat Rev Cardiol 2021;18:666-82. [PMID: 33958774 DOI: 10.1038/s41569-021-00552-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
532 Hamali HA, Saboor M, Dobie G, Madkhali AM, Akhter MS, Hakamy A, Al-mekhlafi HM, Jackson DE, Matari YH, Mobarki AA. Procoagulant Microvesicles in COVID-19 Patients: Possible Modulators of Inflammation and Prothrombotic Tendency. IDR 2022;Volume 15:2359-68. [DOI: 10.2147/idr.s355395] [Reference Citation Analysis]
533 Raimondi F, Novelli L, Marchesi G, Fabretti F, Grazioli L, Riva I, Allegri C, Biza R, Galimberti C, Lorini FL, Di Marco F. Worsening of gas exchange parameters at high FiO2 in COVID-19: misleading or informative? Multidiscip Respir Med 2021;16:759. [PMID: 34123380 DOI: 10.4081/mrm.2021.759] [Reference Citation Analysis]
534 Seibel A, Heinz W, Greim CA, Weber S. [Lung ultrasound in COVID-19]. Anaesthesist 2021;70:146-54. [PMID: 33185697 DOI: 10.1007/s00101-020-00883-7] [Reference Citation Analysis]
535 Tabassum A, Iqbal MS, Sultan S, Alhuthali RA, Alshubaili DI, Sayyam RS, Abyad LM, Qasem AH, Arbaeen AF, Cervellati C. Dysregulated Bradykinin: Mystery in the Pathogenesis of COVID-19. Mediators of Inflammation 2022;2022:1-8. [DOI: 10.1155/2022/7423537] [Reference Citation Analysis]
536 Tilliridou V, Kirkbride R, Dickinson R, Tiernan J, Yong GL, van Beek EJ, Murchison JT, Williams MC. Pulmonary embolism severity before and during the COVID-19 pandemic. Br J Radiol 2021;94:20210264. [PMID: 34106780 DOI: 10.1259/bjr.20210264] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
537 Nava-Santana C, Rodríguez-Armida M, Jiménez JV, Vargas-Parra N, León DEA, Campos-Murguia A, Macías-Rodriguez R, Arteaga-Garrido A, Hernández-Villegas AC, Dominguez-Cherit G, Rivero-Sigarroa E, Gamboa-Dominguez A, Gullias-Herrero A, Sifuentes-Osornio J, Uribe-Uribe NO, Morales-Buenrostro LE. Clinicopathologic characteristics of severe COVID-19 patients in Mexico City: A post-mortem analysis using a minimally invasive autopsy approach. PLoS One 2022;17:e0262783. [PMID: 35239660 DOI: 10.1371/journal.pone.0262783] [Reference Citation Analysis]
538 Shin J, Ro SK. Newly Diagnosed Right Coronary Artery Aneurysm in an Adult with Recent Coronavirus Disease 2019 Infection. Diagnostics 2022;12:815. [DOI: 10.3390/diagnostics12040815] [Reference Citation Analysis]
539 Gündoğan M, Vural E, Bayram N, Altunel O, Gündoğan F, Göktaş S. Change in retinal vessel diameter and choroidal thickness in patients with severe COVID-19: Change In Retinal Parameters In Patients With Severe COVID-19. Photodiagnosis Photodyn Ther 2021;37:102674. [PMID: 34879296 DOI: 10.1016/j.pdpdt.2021.102674] [Reference Citation Analysis]
540 Ito GNW, Rodrigues VAC, Hümmelgen J, Meschino GSPG, Abou-Rejaile GM, Brenny ID, de Castro Júnior CR, Artigas RC, Munhoz JPS, Cardoso GC, Picheth GF. COVID-19 pathophysiology and ultrasound imaging: A multiorgan review. J Clin Ultrasound 2022. [PMID: 35218034 DOI: 10.1002/jcu.23160] [Reference Citation Analysis]
541 Rahi MS, Jindal V, Reyes SP, Gunasekaran K, Gupta R, Jaiyesimi I. Hematologic disorders associated with COVID-19: a review. Ann Hematol 2021;100:309-20. [PMID: 33415422 DOI: 10.1007/s00277-020-04366-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
542 Dumoulin DW, Gietema HA, Paats MS, Hendriks LEL, Cornelissen R. Differentiation of COVID-19 Pneumonitis and ICI Induced Pneumonitis. Front Oncol. 2020;10:577696. [PMID: 33194697 DOI: 10.3389/fonc.2020.577696] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
543 Schultz IC, Bertoni APS, Wink MR. Purinergic signaling elements are correlated with coagulation players in peripheral blood and leukocyte samples from COVID-19 patients. J Mol Med. [DOI: 10.1007/s00109-021-02175-y] [Reference Citation Analysis]
544 Bullock HA, Goldsmith CS, Zaki SR, Martines RB, Miller SE. Difficulties in Differentiating Coronaviruses from Subcellular Structures in Human Tissues by Electron Microscopy. Emerg Infect Dis 2021;27:1023-31. [PMID: 33600302 DOI: 10.3201/eid2704.204337] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 13.0] [Reference Citation Analysis]
545 Robinson PC, Liew DFL, Tanner HL, Grainger JR, Dwek RA, Reisler RB, Steinman L, Feldmann M, Ho LP, Hussell T, Moss P, Richards D, Zitzmann N. COVID-19 therapeutics: Challenges and directions for the future. Proc Natl Acad Sci U S A 2022;119:e2119893119. [PMID: 35385354 DOI: 10.1073/pnas.2119893119] [Reference Citation Analysis]
546 Bonnemain J, Ltaief Z, Liaudet L. The Right Ventricle in COVID-19. J Clin Med 2021;10:2535. [PMID: 34200990 DOI: 10.3390/jcm10122535] [Reference Citation Analysis]
547 Pluskota-Karwatka D, Hoffmann M, Barciszewski J. Reducing SARS-CoV-2 Pathological Protein Activity with Small Molecules. J Pharm Anal 2021. [PMID: 33842018 DOI: 10.1016/j.jpha.2021.03.012] [Reference Citation Analysis]
548 Boyle EC, Haverich A. Microvasculature dysfunction as the common thread between atherosclerosis, Kawasaki disease, and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-associated multi-system inflammatory syndrome in children. Eur J Cardiothorac Surg 2020;58:1109-10. [PMID: 33247736 DOI: 10.1093/ejcts/ezaa367] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
549 Lupacchini L, Maggi F, Tomino C, De Dominicis C, Mollinari C, Fini M, Bonassi S, Merlo D, Russo P. Nicotine Changes Airway Epithelial Phenotype and May Increase the SARS-COV-2 Infection Severity. Molecules 2020;26:E101. [PMID: 33379366 DOI: 10.3390/molecules26010101] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
550 Dorward DA, Russell CD, Um IH, Elshani M, Armstrong SD, Penrice-Randal R, Millar T, Lerpiniere CEB, Tagliavini G, Hartley CS, Randle NP, Gachanja NN, Potey PMD, Dong X, Anderson AM, Campbell VL, Duguid AJ, Al Qsous W, BouHaidar R, Baillie JK, Dhaliwal K, Wallace WA, Bellamy COC, Prost S, Smith C, Hiscox JA, Harrison DJ, Lucas CD. Tissue-Specific Immunopathology in Fatal COVID-19. Am J Respir Crit Care Med. 2021;203:192-201. [PMID: 33217246 DOI: 10.1164/rccm.202008-3265oc] [Cited by in Crossref: 53] [Cited by in F6Publishing: 39] [Article Influence: 53.0] [Reference Citation Analysis]
551 González Pessolani T, Muñóz Fernández de Legaria M, Elices Apellániz M, Salinas Moreno S, Lorido Cortés MDM, García Sánchez S. Multi-organ pathological findings associated with COVID-19 in postmortem needle core biopsies in four patients and a review of the current literature. Rev Esp Patol. 2021;54:275-280. [PMID: 34544557 DOI: 10.1016/j.patol.2020.09.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
552 Salabei JK, Fishman TJ, Asnake ZT, Ali A, Iyer UG. COVID-19 Coagulopathy: Current knowledge and guidelines on anticoagulation. Heart Lung 2021;50:357-60. [PMID: 33524866 DOI: 10.1016/j.hrtlng.2021.01.011] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 12.0] [Reference Citation Analysis]
553 Bhandari S, Solanki R, Jindal A, Rankawat G, Pathak D, Bagarhatta M, Singh A. Demystifying COVID-19 lung pathology: A clinicopathological study of postmortem core needle biopsy. Lung India 2021;38:343-9. [PMID: 34259173 DOI: 10.4103/lungindia.lungindia_919_20] [Reference Citation Analysis]
554 El-Shimy IA, Mohamed MMA, Hasan SS, Hadi MA. Targeting host cell proteases as a potential treatment strategy to limit the spread of SARS-CoV-2 in the respiratory tract. Pharmacol Res Perspect 2021;9:e00698. [PMID: 33369210 DOI: 10.1002/prp2.698] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
555 Hosoki K, Kimata JT, Chakraborty A, Sur S. Reply. J Allergy Clin Immunol 2020;146:1455-6. [PMID: 33077246 DOI: 10.1016/j.jaci.2020.09.008] [Reference Citation Analysis]
556 Hsieh IN, White M, Hoeksema M, Deluna X, Hartshorn K. Histone H4 potentiates neutrophil inflammatory responses to influenza A virus: Down-modulation by H4 binding to C-reactive protein and Surfactant protein D. PLoS One 2021;16:e0247605. [PMID: 33635872 DOI: 10.1371/journal.pone.0247605] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
557 Yu JS, Pan NN, Chen RD, Zeng LC, Yang HK, Li H. Cardiac Biomarker Levels and Their Prognostic Values in COVID-19 Patients With or Without Concomitant Cardiac Disease. Front Cardiovasc Med 2020;7:599096. [PMID: 33553255 DOI: 10.3389/fcvm.2020.599096] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
558 Overmyer KA, Shishkova E, Miller IJ, Balnis J, Bernstein MN, Peters-Clarke TM, Meyer JG, Quan Q, Muehlbauer LK, Trujillo EA, He Y, Chopra A, Chieng HC, Tiwari A, Judson MA, Paulson B, Brademan DR, Zhu Y, Serrano LR, Linke V, Drake LA, Adam AP, Schwartz BS, Singer HA, Swanson S, Mosher DF, Stewart R, Coon JJ, Jaitovich A. Large-scale Multi-omic Analysis of COVID-19 Severity. medRxiv 2020:2020. [PMID: 32743614 DOI: 10.1101/2020.07.17.20156513] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 5.5] [Reference Citation Analysis]
559 Combet M, Pavot A, Savale L, Humbert M, Monnet X. Rapid onset honeycombing fibrosis in spontaneously breathing patient with COVID-19. Eur Respir J 2020;56:2001808. [PMID: 32631838 DOI: 10.1183/13993003.01808-2020] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
560 Ganjali S, Bianconi V, Penson PE, Pirro M, Banach M, Watts GF, Sahebkar A. Commentary: Statins, COVID-19, and coronary artery disease: killing two birds with one stone. Metabolism 2020;113:154375. [PMID: 32976855 DOI: 10.1016/j.metabol.2020.154375] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
561 Hendry BM, Stafford N, Arnold AD, Sangwaiya A, Manglam V, Rosen SD, Arnold J. Hypothesis: Pentoxifylline is a potential cytokine modulator therapeutic in COVID-19 patients. Pharmacol Res Perspect 2020;8:e00631. [PMID: 32715661 DOI: 10.1002/prp2.631] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
562 Rasras H, Boudihi A, Hbali A, Ismaili N, Ouafi NE. Multiple cardiovascular complications of COVID-19 infection in a young patient: a case report. Pan Afr Med J 2021;38:192. [PMID: 33995798 DOI: 10.11604/pamj.2021.38.192.27471] [Reference Citation Analysis]
563 Afrazi A, Garcia-Rodriguez S, Maloney JD, Morgan CT. Cavitary lung lesions and pneumothorax in a healthy patient with active coronavirus-19 (COVID-19) viral pneumonia. Interact Cardiovasc Thorac Surg 2021;32:150-2. [PMID: 33332525 DOI: 10.1093/icvts/ivaa238] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
564 Gragueb-Chatti I, Lopez A, Hamidi D, Guervilly C, Loundou A, Daviet F, Cassir N, Papazian L, Forel JM, Leone M, Dellamonica J, Hraiech S. Impact of dexamethasone on the incidence of ventilator-associated pneumonia and blood stream infections in COVID-19 patients requiring invasive mechanical ventilation: a multicenter retrospective study. Ann Intensive Care 2021;11:87. [PMID: 34057642 DOI: 10.1186/s13613-021-00876-8] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
565 RECOVERY Collaborative Group. Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet 2021:S0140-6736(21)01825-0. [PMID: 34800427 DOI: 10.1016/S0140-6736(21)01825-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
566 John TM, Jacob CN, Kontoyiannis DP. When Uncontrolled Diabetes Mellitus and Severe COVID-19 Converge: The Perfect Storm for Mucormycosis. J Fungi (Basel) 2021;7:298. [PMID: 33920755 DOI: 10.3390/jof7040298] [Cited by in Crossref: 43] [Cited by in F6Publishing: 26] [Article Influence: 43.0] [Reference Citation Analysis]
567 Bavishi AA, Mylvaganam RJ, Agarwal R, Avery RJ, Cuttica MJ. Timing of Intubation in Coronavirus Disease 2019: A Study of Ventilator Mechanics, Imaging, Findings, and Outcomes. Crit Care Explor 2021;3:e0415. [PMID: 34079946 DOI: 10.1097/CCE.0000000000000415] [Reference Citation Analysis]
568 Kulasinghe A, Tan CW, Dos Santos Miggiolaro AFR, Monkman J, SadeghiRad H, Bhuva DD, da Silva Motta Junior J, Vaz de Paula CB, Nagashima S, Baena CP, Souza-Fonseca-Guimaraes P, de Noronha L, McCulloch T, Rodrigues Rossi G, Cooper C, Tang B, Short KR, Davis MJ, Souza-Fonseca-Guimaraes F, Belz GT, O'Byrne K. Profiling of lung SARS-CoV-2 and influenza virus infection dissects virus-specific host responses and gene signatures. Eur Respir J 2021:2101881. [PMID: 34675048 DOI: 10.1183/13993003.01881-2021] [Reference Citation Analysis]
569 Gupta A, Madhavan MV, Poterucha TJ, DeFilippis EM, Hennessey JA, Redfors B, Eckhardt C, Bikdeli B, Platt J, Nalbandian A, Elias P, Cummings MJ, Nouri SN, Lawlor M, Ranard LS, Li J, Boyle C, Givens R, Brodie D, Krumholz HM, Stone GW, Sethi SS, Burkhoff D, Uriel N, Schwartz A, Leon MB, Kirtane AJ, Wan EY, Parikh SA. Association between antecedent statin use and decreased mortality in hospitalized patients with COVID-19. Nat Commun 2021;12:1325. [PMID: 33637713 DOI: 10.1038/s41467-021-21553-1] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 30.0] [Reference Citation Analysis]
570 Ebeyer-masotta M, Eichhorn T, Weiss R, Semak V, Lauková L, Fischer MB, Weber V. Heparin-Functionalized Adsorbents Eliminate Central Effectors of Immunothrombosis, including Platelet Factor 4, High-Mobility Group Box 1 Protein and Histones. IJMS 2022;23:1823. [DOI: 10.3390/ijms23031823] [Reference Citation Analysis]
571 Bagate F, Masi P, d'Humières T, Al-Assaad L, Chakra LA, Razazi K, de Prost N, Carteaux G, Derumeaux G, Mekontso Dessap A. Advanced echocardiographic phenotyping of critically ill patients with coronavirus-19 sepsis: a prospective cohort study. J Intensive Care 2021;9:12. [PMID: 33472693 DOI: 10.1186/s40560-020-00516-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
572 Bai C, Chotirmall SH, Rello J, Alba GA, Ginns LC, Krishnan JA, Rogers R, Bendstrup E, Burgel PR, Chalmers JD, Chua A, Crothers KA, Duggal A, Kim YW, Laffey JG, Luna CM, Niederman MS, Raghu G, Ramirez JA, Riera J, Roca O, Tamae-Kakazu M, Torres A, Watkins RR, Barrecheguren M, Belliato M, Chami HA, Chen R, Cortes-Puentes GA, Delacruz C, Hayes MM, Heunks LMA, Holets SR, Hough CL, Jagpal S, Jeon K, Johkoh T, Lee MM, Liebler J, McElvaney GN, Moskowitz A, Oeckler RA, Ojanguren I, O'Regan A, Pletz MW, Rhee CK, Schultz MJ, Storti E, Strange C, Thomson CC, Torriani FJ, Wang X, Wuyts W, Xu T, Yang D, Zhang Z, Wilson KC. Updated guidance on the management of COVID-19: from an American Thoracic Society/European Respiratory Society coordinated International Task Force (29 July 2020). Eur Respir Rev 2020;29:200287. [PMID: 33020069 DOI: 10.1183/16000617.0287-2020] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 16.0] [Reference Citation Analysis]
573 Lunardi F, Fortarezza F, Vedovelli L, Pezzuto F, Boscolo A, Rossato M, Vettor R, Cattelan AM, Del Vecchio C, Crisanti A, Navalesi P, Gregori D, Calabrese F. Lower Gene Expression of Angiotensin Converting Enzyme 2 Receptor in Lung Tissues of Smokers with COVID-19 Pneumonia. Biomolecules 2021;11:796. [PMID: 34073591 DOI: 10.3390/biom11060796] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
574 Patel BV, Arachchillage DJ, Ridge CA, Bianchi P, Doyle JF, Garfield B, Ledot S, Morgan C, Passariello M, Price S, Singh S, Thakuria L, Trenfield S, Trimlett R, Weaver C, Wort SJ, Xu T, Padley SPG, Devaraj A, Desai SR. Pulmonary Angiopathy in Severe COVID-19: Physiologic, Imaging, and Hematologic Observations. Am J Respir Crit Care Med. 2020;202:690-699. [PMID: 32667207 DOI: 10.1164/rccm.202004-1412oc] [Cited by in Crossref: 93] [Cited by in F6Publishing: 60] [Article Influence: 46.5] [Reference Citation Analysis]
575 Farid N, Rola N, Koch EAT, Nakhoul N. Active vitamin D supplementation and COVID-19 infections: review. Ir J Med Sci 2021. [PMID: 33409846 DOI: 10.1007/s11845-020-02452-8] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
576 Rudrabhatla PK, Reghukumar A, Thomas SV. Mucormycosis in COVID-19 patients: predisposing factors, prevention and management. Acta Neurol Belg 2021. [PMID: 34820787 DOI: 10.1007/s13760-021-01840-w] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
577 McFadyen JD, Stevens H, Peter K. The Emerging Threat of (Micro)Thrombosis in COVID-19 and Its Therapeutic Implications. Circ Res. 2020;127:571-587. [PMID: 32586214 DOI: 10.1161/circresaha.120.317447] [Cited by in Crossref: 143] [Cited by in F6Publishing: 103] [Article Influence: 71.5] [Reference Citation Analysis]
578 Milanese M, Anselmo M, Buscaglia S, Garra L, Goretti R, Parodi L, Riccio G, Tassara R, Gnerre P. COVID-19 6 months after hospital discharge: pulmonary function impairment and its heterogeneity. ERJ Open Res 2021;7:00196-2021. [PMID: 34285908 DOI: 10.1183/23120541.00196-2021] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
579 Chan ED, Sharma V. Does Hypoxia Itself Beget Worsening Hypoxemia in COVID-19? Mayo Clin Proc 2021;96:824-5. [PMID: 33673937 DOI: 10.1016/j.mayocp.2021.01.007] [Reference Citation Analysis]
580 Braithwaite SA, Kearns DJ, Douglas E, Hoyles RK, Tapping CR. Delayed Post COVID-19 Bronchial Artery Pseudoaneurysm Treated with Embolisation: Letter to the Editor. Cardiovasc Intervent Radiol 2021. [PMID: 34109458 DOI: 10.1007/s00270-021-02881-7] [Reference Citation Analysis]
581 Lombardi A, Duiella S, Li Piani L, Comelli A, Ceriotti F, Oggioni M, Muscatello A, Bandera A, Gori A, Ferrazzi E. Inflammatory biomarkers in pregnant women with COVID-19: a retrospective cohort study. Sci Rep 2021;11:13350. [PMID: 34172816 DOI: 10.1038/s41598-021-92885-7] [Reference Citation Analysis]
582 Eslami N, Aghbash PS, Shamekh A, Entezari-Maleki T, Nahand JS, Sales AJ, Baghi HB. SARS-CoV-2: Receptor and Co-receptor Tropism Probability. Curr Microbiol 2022;79:133. [PMID: 35292865 DOI: 10.1007/s00284-022-02807-7] [Reference Citation Analysis]
583 Hannemann J, Böger R. Dysregulation of the Nitric Oxide/Dimethylarginine Pathway in Hypoxic Pulmonary Vasoconstriction—Molecular Mechanisms and Clinical Significance. Front Med 2022;9:835481. [DOI: 10.3389/fmed.2022.835481] [Reference Citation Analysis]
584 Vassiliou AG, Kotanidou A, Dimopoulou I, Orfanos SE. Endothelial Damage in Acute Respiratory Distress Syndrome. Int J Mol Sci 2020;21:E8793. [PMID: 33233715 DOI: 10.3390/ijms21228793] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
585 Leth S, Gunst JD, Mathiasen V, Hansen K, Søgaard O, Østergaard L, Jensen-Fangel S, Storgaard M, Agergaard J. Persistent Symptoms in Patients Recovering From COVID-19 in Denmark. Open Forum Infect Dis 2021;8:ofab042. [PMID: 33875970 DOI: 10.1093/ofid/ofab042] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
586 Flikweert AW, Grootenboers MJJH, Yick DCY, du Mée AWF, van der Meer NJM, Rettig TCD, Kant MKM. Late histopathologic characteristics of critically ill COVID-19 patients: Different phenotypes without evidence of invasive aspergillosis, a case series. J Crit Care 2020;59:149-55. [PMID: 32674001 DOI: 10.1016/j.jcrc.2020.07.002] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 19.0] [Reference Citation Analysis]
587 Wiesner O, Busch M, David S. [Treatment of severe COVID-19 courses in intensive care medicine]. Internist (Berl) 2020;61:804-12. [PMID: 32710161 DOI: 10.1007/s00108-020-00850-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
588 Deng H, Tang TX, Chen D, Tang LS, Yang XP, Tang ZH. Endothelial Dysfunction and SARS-CoV-2 Infection: Association and Therapeutic Strategies. Pathogens 2021;10:582. [PMID: 34064553 DOI: 10.3390/pathogens10050582] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
589 Zaidi AK, Dehgani-Mobaraki P. The mechanisms of action of ivermectin against SARS-CoV-2-an extensive review. J Antibiot (Tokyo) 2021. [PMID: 34931048 DOI: 10.1038/s41429-021-00491-6] [Reference Citation Analysis]
590 von der Thüsen JH, Ghariq E, Overbeek MJ, Leyten E, Drijkoningen T, Gietema HA, Prokop M, Quarles van Ufford HME. Spectrum of Vascular Involvement in Coronavirus Disease 2019 Pneumonia-Findings on CT Perfusion. Crit Care Explor 2020;2:e0266. [PMID: 33134952 DOI: 10.1097/CCE.0000000000000266] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
591 Battina HL, Alentado VJ, Srour EF, Moliterno AR, Kacena MA. Interaction of the inflammatory response and megakaryocytes in COVID-19 infection. Exp Hematol 2021:S0301-472X(21)00328-3. [PMID: 34563606 DOI: 10.1016/j.exphem.2021.09.005] [Reference Citation Analysis]
592 Gerotziafas GT, Catalano M, Colgan MP, Pecsvarady Z, Wautrecht JC, Fazeli B, Olinic DM, Farkas K, Elalamy I, Falanga A, Fareed J, Papageorgiou C, Arellano RS, Agathagelou P, Antic D, Auad L, Banfic L, Bartolomew JR, Benczur B, Bernardo MB, Boccardo F, Cifkova R, Cosmi B, De Marchi S, Dimakakos E, Dimopoulos MA, Dimitrov G, Durand-Zaleski I, Edmonds M, El Nazar EA, Erer D, Esponda OL, Gresele P, Gschwandtner M, Gu Y, Heinzmann M, Hamburg NM, Hamadé A, Jatoi NA, Karahan O, Karetova D, Karplus T, Klein-Weigel P, Kolossvary E, Kozak M, Lefkou E, Lessiani G, Liew A, Marcoccia A, Marshang P, Marakomichelakis G, Matuska J, Moraglia L, Pillon S, Poredos P, Prior M, Salvador DRK, Schlager O, Schernthaner G, Sieron A, Spaak J, Spyropoulos A, Sprynger M, Suput D, Stanek A, Stvrtinova V, Szuba A, Tafur A, Vandreden P, Vardas PE, Vasic D, Vikkula M, Wennberg P, Zhai Z; Scientific Reviewer Committee. Guidance for the Management of Patients with Vascular Disease or Cardiovascular Risk Factors and COVID-19: Position Paper from VAS-European Independent Foundation in Angiology/Vascular Medicine. Thromb Haemost 2020;120:1597-628. [PMID: 32920811 DOI: 10.1055/s-0040-1715798] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 21.0] [Reference Citation Analysis]
593 Khandait H, Gandotra G, Sachdeva S, Kramer CA, Nye D, Golamari R, Jain R. COVID-19 and Hematology-What Do We Know So Far? SN Compr Clin Med 2020;:1-6. [PMID: 33134847 DOI: 10.1007/s42399-020-00607-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
594 Pamukçu B. Inflammation and thrombosis in patients with COVID-19: A prothrombotic and inflammatory disease caused by SARS coronavirus-2. Anatol J Cardiol 2020;24:224-34. [PMID: 33001051 DOI: 10.14744/AnatolJCardiol.2020.56727] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
595 Medina-Enríquez MM, Lopez-León S, Carlos-Escalante JA, Aponte-Torres Z, Cuapio A, Wegman-Ostrosky T. ACE2: the molecular doorway to SARS-CoV-2. Cell Biosci 2020;10:148. [PMID: 33380340 DOI: 10.1186/s13578-020-00519-8] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 10.0] [Reference Citation Analysis]
596 Cao Y, Geng C, Li Y, Zhang Y. In situ Pulmonary Artery Thrombosis: A Previously Overlooked Disease. Front Pharmacol 2021;12:671589. [PMID: 34305592 DOI: 10.3389/fphar.2021.671589] [Reference Citation Analysis]
597 Hajjar LA, Costa IBSDS, Rizk SI, Biselli B, Gomes BR, Bittar CS, de Oliveira GQ, de Almeida JP, de Oliveira Bello MV, Garzillo C, Leme AC, Elena M, Val F, de Almeida Lopes M, Lacerda MVG, Ramires JAF, Kalil Filho R, Teboul JL, Landoni G. Intensive care management of patients with COVID-19: a practical approach. Ann Intensive Care 2021;11:36. [PMID: 33604873 DOI: 10.1186/s13613-021-00820-w] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
598 Luan YY, Liu Y, Liu XY, Yu BJ, Chen RL, Peng M, Ren D, Li HL, Huang L, Li JX, Feng YW, Wu M. Coronavirus disease 2019 (COVID-19) associated coagulopathy and its impact on outcomes in Shenzhen, China: A retrospective cohort study. Thromb Res. 2020;195:62-68. [PMID: 32659462 DOI: 10.1016/j.thromres.2020.07.015] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
599 Zhao S, Huang Z, Zeng H, Chen Z, Luo F, Zhang C, Song B. Combining initial chest CT with clinical variables in differentiating coronavirus disease 2019 (COVID-19) pneumonia from influenza pneumonia. Sci Rep 2021;11:6422. [PMID: 33742041 DOI: 10.1038/s41598-021-85779-1] [Reference Citation Analysis]
600 Wang K, Gheblawi M, Nikhanj A, Munan M, MacIntyre E, O'Neil C, Poglitsch M, Colombo D, Del Nonno F, Kassiri Z, Sligl W, Oudit GY. Dysregulation of ACE (Angiotensin-Converting Enzyme)-2 and Renin-Angiotensin Peptides in SARS-CoV-2 Mediated Mortality and End-Organ Injuries. Hypertension 2021;:HYPERTENSIONAHA12118295. [PMID: 34844421 DOI: 10.1161/HYPERTENSIONAHA.121.18295] [Reference Citation Analysis]
601 Uaprasert N, Moonla C, Sosothikul D, Rojnuckarin P, Chiasakul T. Systemic Coagulopathy in Hospitalized Patients With Coronavirus Disease 2019: A Systematic Review and Meta-Analysis. Clin Appl Thromb Hemost 2021;27:1076029620987629. [PMID: 33443456 DOI: 10.1177/1076029620987629] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 9.0] [Reference Citation Analysis]
602 Menezes MCS, Pestana DVS, Gameiro GR, da Silva LFF, Baron Ė, Rouby JJ, Auler JOC Jr. SARS-CoV-2 pneumonia-receptor binding and lung immunopathology: a narrative review. Crit Care 2021;25:53. [PMID: 33557908 DOI: 10.1186/s13054-020-03399-z] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
603 Riera-Mestre A, Jara-Palomares L, Lecumberri R, Trujillo-Santos J, Grau E, Blanco-Molina A, Piera Carbonell A, Jiménez S, Frías Vargas M, Fuset MP, Bellmunt-Montoya S, Monreal M, Jiménez D, On Behalf Of The Covilax Project. PICO Questions and DELPHI Methodology for the Management of Venous Thromboembolism Associated with COVID-19. Viruses 2021;13:2128. [PMID: 34834935 DOI: 10.3390/v13112128] [Reference Citation Analysis]
604 Ai J, Hong W, Wu M, Wei X. Pulmonary vascular system: A vulnerable target for COVID-19. MedComm (2020) 2021. [PMID: 34909758 DOI: 10.1002/mco2.94] [Reference Citation Analysis]
605 Swenson ER, Hopkins SR, Stickland MK. Positive Bubble Study in Severe COVID-19: Bubbles May Be Unrelated to Gas Exchange Impairment. Am J Respir Crit Care Med 2021;203:389-90. [PMID: 33207121 DOI: 10.1164/rccm.202010-3800LE] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
606 Meiler S, Hamer OW, Schaible J, Zeman F, Zorger N, Kleine H, Rennert J, Stroszczynski C, Poschenrieder F. Computed tomography characterization and outcome evaluation of COVID-19 pneumonia complicated by venous thromboembolism. PLoS One 2020;15:e0242475. [PMID: 33211737 DOI: 10.1371/journal.pone.0242475] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
607 Chu R, van Eeden C, Suresh S, Sligl WI, Osman M, Cohen Tervaert JW. Do COVID-19 Infections Result in a Different Form of Secondary Hemophagocytic Lymphohistiocytosis. Int J Mol Sci 2021;22:2967. [PMID: 33803997 DOI: 10.3390/ijms22062967] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
608 Boor P, Eichhorn P, Hartmann A, Lax SF, Märkl B, Menter T, Skok K, Slotta-Huspenina J, von Stillfried S, Tzankov A, Weirich G. [Practical aspects of COVID-19 autopsies]. Pathologe 2021;42:197-207. [PMID: 33625535 DOI: 10.1007/s00292-021-00925-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
609 Flores-Pliego A, Miranda J, Vega-Torreblanca S, Valdespino-Vázquez Y, Helguera-Repetto C, Espejel-Nuñez A, Borboa-Olivares H, Espino Y Sosa S, Mateu-Rogell P, León-Juárez M, Ramírez-Santes V, Cardona-Pérez A, Villegas-Mota I, Torres-Torres J, Juárez-Reyes Á, Rizo-Pica T, González RO, González-Mariscal L, Estrada-Gutierrez G. Molecular Insights into the Thrombotic and Microvascular Injury in Placental Endothelium of Women with Mild or Severe COVID-19. Cells 2021;10:364. [PMID: 33578631 DOI: 10.3390/cells10020364] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
610 Lopez-Castaneda S, García-Larragoiti N, Cano-Mendez A, Blancas-Ayala K, Damian-Vázquez G, Perez-Medina AI, Chora-Hernández LD, Arean-Martínez C, Viveros-Sandoval ME. Inflammatory and Prothrombotic Biomarkers Associated With the Severity of COVID-19 Infection. Clin Appl Thromb Hemost 2021;27:1076029621999099. [PMID: 33835872 DOI: 10.1177/1076029621999099] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
611 Johnson HM, Lewin AS, Ahmed CM. SOCS, Intrinsic Virulence Factors, and Treatment of COVID-19. Front Immunol 2020;11:582102. [PMID: 33193390 DOI: 10.3389/fimmu.2020.582102] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
612 Canoglu K, Saylan B. Therapeutic dosing of low-molecular-weight heparin may decrease mortality in patients with severe COVID-19 infection. Ann Saudi Med 2020;40:462-8. [PMID: 33307734 DOI: 10.5144/0256-4947.2020.462] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
613 Huang S, Vignon P, Mekontso-Dessap A, Tran S, Prat G, Chew M, Balik M, Sanfilippo F, Banauch G, Clau-Terre F, Morelli A, De Backer D, Cholley B, Slama M, Charron C, Goudelin M, Bagate F, Bailly P, Blixt PJ, Masi P, Evrard B, Orde S, Mayo P, McLean AS, Vieillard-Baron A; ECHO-COVID research group. Echocardiography findings in COVID-19 patients admitted to intensive care units: a multi-national observational study (the ECHO-COVID study). Intensive Care Med 2022. [PMID: 35445822 DOI: 10.1007/s00134-022-06685-2] [Reference Citation Analysis]
614 Yamaya T, Hagiwara E, Baba T, Kitayama T, Murohashi K, Higa K, Sato Y, Otoshi R, Tabata E, Shintani R, Okabayashi H, Ikeda S, Niwa T, Nakazawa A, Oda T, Okuda R, Sekine A, Kitamura H, Komatsu S, Ogura T. Serum Krebs von den Lungen-6 levels are associated with mortality and severity in patients with coronavirus disease 2019. Respir Investig 2021;59:596-601. [PMID: 33965361 DOI: 10.1016/j.resinv.2021.04.002] [Reference Citation Analysis]
615 Jeong JH, Ojha U, Lee YM. Pathological angiogenesis and inflammation in tissues. Arch Pharm Res 2021;44:1-15. [PMID: 33230600 DOI: 10.1007/s12272-020-01287-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
616 Ibrahim S, Lowe JR, Bramante CT, Shah S, Klatt NR, Sherwood N, Aronne L, Puskarich M, Tamariz L, Palacio A, Bomberg E, Usher M, King S, Benson B, Vojta D, Tignanelli C, Ingraham N. Metformin and Covid-19: Focused Review of Mechanisms and Current Literature Suggesting Benefit. Front Endocrinol (Lausanne) 2021;12:587801. [PMID: 34367059 DOI: 10.3389/fendo.2021.587801] [Reference Citation Analysis]
617 Youdhestar, Mahar FK, Das G, Tajammul A, Ahmed F, Khatri M, Khan S, Khatri Z. Fabrication of Ceftriaxone-Loaded Cellulose Acetate and Polyvinyl Alcohol Nanofibers and Their Antibacterial Evaluation. Antibiotics 2022;11:352. [DOI: 10.3390/antibiotics11030352] [Reference Citation Analysis]
618 Wong DWL, Klinkhammer BM, Djudjaj S, Villwock S, Timm MC, Buhl EM, Wucherpfennig S, Cacchi C, Braunschweig T, Knüchel-Clarke R, Jonigk D, Werlein C, Bülow RD, Dahl E, von Stillfried S, Boor P. Multisystemic Cellular Tropism of SARS-CoV-2 in Autopsies of COVID-19 Patients. Cells 2021;10:1900. [PMID: 34440669 DOI: 10.3390/cells10081900] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
619 Rossi ÁD, de Araújo JLF, de Almeida TB, Ribeiro-Alves M, de Almeida Velozo C, Almeida JM, de Carvalho Leitão I, Ferreira SN, da Silva Oliveira J, Alves HJ, Scheid HT, Faffe DS, Galliez RM, de Ávila RE, Resende GG, Teixeira MM, da Costa Ferreira Júnior O, Castiñeiras TMPP, Souza RP, Tanuri A, Aguiar RS, Barroso SPC, Cardoso CC; COVID-19 UFRJ Workgroup. Association between ACE2 and TMPRSS2 nasopharyngeal expression and COVID-19 respiratory distress. Sci Rep 2021;11:9658. [PMID: 33958627 DOI: 10.1038/s41598-021-88944-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
620 Barilli A, Visigalli R, Ferrari F, Bianchi MG, Dall’asta V, Rotoli BM. Immune-Mediated Inflammatory Responses of Alveolar Epithelial Cells: Implications for COVID-19 Lung Pathology. Biomedicines 2022;10:618. [DOI: 10.3390/biomedicines10030618] [Reference Citation Analysis]
621 Yamaoka-Tojo M. Vascular Endothelial Glycocalyx Damage in COVID-19. Int J Mol Sci 2020;21:E9712. [PMID: 33352699 DOI: 10.3390/ijms21249712] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
622 Tamura Y, Takeyasu R, Furukawa A, Takada H, Takechi M, Taniguchi H, Kawamura A. How COVID-19 Affected the Introduction of Telemedicine and Patient Reported Outcomes Among Patients With Pulmonary Hypertension - A Report From a Referral Center in Japan. Circ Rep 2020;2:526-30. [PMID: 33693278 DOI: 10.1253/circrep.CR-20-0088] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
623 Lopes RD, de Barros E Silva PGM, Furtado RHM, Macedo AVS, Bronhara B, Damiani LP, Barbosa LM, de Aveiro Morata J, Ramacciotti E, de Aquino Martins P, de Oliveira AL, Nunes VS, Ritt LEF, Rocha AT, Tramujas L, Santos SV, Diaz DRA, Viana LS, Melro LMG, de Alcântara Chaud MS, Figueiredo EL, Neuenschwander FC, Dracoulakis MDA, Lima RGSD, de Souza Dantas VC, Fernandes ACS, Gebara OCE, Hernandes ME, Queiroz DAR, Veiga VC, Canesin MF, de Faria LM, Feitosa-Filho GS, Gazzana MB, Liporace IL, de Oliveira Twardowsky A, Maia LN, Machado FR, de Matos Soeiro A, Conceição-Souza GE, Armaganijan L, Guimarães PO, Rosa RG, Azevedo LCP, Alexander JH, Avezum A, Cavalcanti AB, Berwanger O; ACTION Coalition COVID-19 Brazil IV Investigators. Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial. Lancet 2021;397:2253-63. [PMID: 34097856 DOI: 10.1016/S0140-6736(21)01203-4] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 17.0] [Reference Citation Analysis]
624 Kutsogiannis DJ, Alharthy A, Balhamar A, Faqihi F, Papanikolaou J, Alqahtani SA, Memish ZA, Brindley PG, Brochard L, Karakitsos D. Mortality and Pulmonary Embolism in Acute Respiratory Distress Syndrome From COVID-19 vs. Non-COVID-19. Front Med 2022;9:800241. [DOI: 10.3389/fmed.2022.800241] [Reference Citation Analysis]
625 Holcomb D, Alexaki A, Hernandez N, Laurie K, Kames J, Hamasaki-Katagiri N, Komar AA, DiCuccio M, Kimchi-Sarfaty C. Potential impact on coagulopathy of gene variants of coagulation related proteins that interact with SARS-CoV-2. bioRxiv 2020:2020. [PMID: 32935103 DOI: 10.1101/2020.09.08.272328] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
626 Ieni A, Tuccari G. The COVID-19 pandemic: Pathologists support the clinical infectious diseases team. Int J Infect Dis 2021;104:479-81. [PMID: 33383219 DOI: 10.1016/j.ijid.2020.12.069] [Reference Citation Analysis]
627 Fraiman P, Godeiro Junior C, Moro E, Cavallieri F, Zedde M. COVID-19 and Cerebrovascular Diseases: A Systematic Review and Perspectives for Stroke Management. Front Neurol 2020;11:574694. [PMID: 33250845 DOI: 10.3389/fneur.2020.574694] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 7.5] [Reference Citation Analysis]
628 Amraei R, Rahimi N. COVID-19, Renin-Angiotensin System and Endothelial Dysfunction. Cells. 2020;9. [PMID: 32660065 DOI: 10.3390/cells9071652] [Cited by in Crossref: 68] [Cited by in F6Publishing: 63] [Article Influence: 34.0] [Reference Citation Analysis]
629 Ionescu MD, Balgradean M, Cirstoveanu CG, Balgradean I, Popa LI, Pavelescu C, Capitanescu A, Berghea EC, Filip C. Myopericarditis Associated with COVID-19 in a Pediatric Patient with Kidney Failure Receiving Hemodialysis. Pathogens 2021;10:486. [PMID: 33920512 DOI: 10.3390/pathogens10040486] [Reference Citation Analysis]
630 Kerget B, Kerget F, Koçak AO, Kızıltunç A, Araz Ö, Uçar EY, Akgün M. Are Serum Interleukin 6 and Surfactant Protein D Levels Associated with the Clinical Course of COVID-19? Lung 2020;198:777-84. [PMID: 32918573 DOI: 10.1007/s00408-020-00393-8] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 9.0] [Reference Citation Analysis]
631 Gillich A, Zhang F, Farmer CG, Travaglini KJ, Tan SY, Gu M, Zhou B, Feinstein JA, Krasnow MA, Metzger RJ. Capillary cell-type specialization in the alveolus. Nature 2020;586:785-9. [PMID: 33057196 DOI: 10.1038/s41586-020-2822-7] [Cited by in Crossref: 39] [Cited by in F6Publishing: 23] [Article Influence: 19.5] [Reference Citation Analysis]
632 Rapkiewicz AV, Mai X, Carsons SE, Pittaluga S, Kleiner DE, Berger JS, Thomas S, Adler NM, Charytan DM, Gasmi B, Hochman JS, Reynolds HR. Megakaryocytes and platelet-fibrin thrombi characterize multi-organ thrombosis at autopsy in COVID-19: A case series. EClinicalMedicine 2020;24:100434. [PMID: 32766543 DOI: 10.1016/j.eclinm.2020.100434] [Cited by in Crossref: 180] [Cited by in F6Publishing: 172] [Article Influence: 90.0] [Reference Citation Analysis]
633 Rouzé A, Nseir S. Hospital-Acquired Pneumonia/Ventilator-Associated Pneumonia and Ventilator-Associated Tracheobronchitis in COVID-19. Semin Respir Crit Care Med 2022. [PMID: 35042264 DOI: 10.1055/s-0041-1740334] [Reference Citation Analysis]
634 Sin DD. COVID-19 in COPD: A growing concern. EClinicalMedicine 2020;26:100546. [PMID: 32984790 DOI: 10.1016/j.eclinm.2020.100546] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
635 Halaby R, Cuker A, Yui J, Matthews A, Ishaaya E, Traxler E, Domenico C, Cooper T, Tierney A, Niami P, van der Rijst N, Adusumalli S, Gutsche J, Giri J, Pugliese S, Hecht TEH, Pishko AM. Bleeding risk by intensity of anticoagulation in critically ill patients with COVID-19: A retrospective cohort study. J Thromb Haemost 2021;19:1533-45. [PMID: 33774903 DOI: 10.1111/jth.15310] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
636 Lapinsky SE, Al Mandhari M. COVID-19 critical illness in pregnancy. Obstet Med. [DOI: 10.1177/1753495x211051246] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
637 Westhoff M, Geiseler J, Schönhofer B, Pfeifer M, Dellweg D, Bachmann M, Randerath W. [Weaning in a Pandemic Situation - A Position Paper]. Pneumologie 2021;75:113-21. [PMID: 33352589 DOI: 10.1055/a-1337-9848] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
638 Bertini M, Ferrari R, Rapezzi C. What Happened to Electrocardiogram as a Screening Test to Recognize Cardiovascular Complications in COVID-19 Patients? J Am Coll Cardiol 2020;76:2799-800. [PMID: 33272378 DOI: 10.1016/j.jacc.2020.09.611] [Reference Citation Analysis]
639 Scimeca M, Urbano N, Bonfiglio R, Montanaro M, Bonanno E, Schillaci O, Mauriello A. Imaging Diagnostics and Pathology in SARS-CoV-2-Related Diseases. Int J Mol Sci 2020;21:E6960. [PMID: 32971906 DOI: 10.3390/ijms21186960] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
640 Thakur V, Ratho RK, Kumar P, Bhatia SK, Bora I, Mohi GK, Saxena SK, Devi M, Yadav D, Mehariya S. Multi-Organ Involvement in COVID-19: Beyond Pulmonary Manifestations. J Clin Med 2021;10:446. [PMID: 33498861 DOI: 10.3390/jcm10030446] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 14.0] [Reference Citation Analysis]
641 Samidurai A, Das A. Cardiovascular Complications Associated with COVID-19 and Potential Therapeutic~Strategies. Int J Mol Sci. 2020;21. [PMID: 32947927 DOI: 10.3390/ijms21186790] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
642 Scappaticcio L, Pitoia F, Esposito K, Piccardo A, Trimboli P. Impact of COVID-19 on the thyroid gland: an update. Rev Endocr Metab Disord 2020. [PMID: 33241508 DOI: 10.1007/s11154-020-09615-z] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 11.5] [Reference Citation Analysis]
643 Napoli C, Tritto I, Benincasa G, Mansueto G, Ambrosio G. Cardiovascular involvement during COVID-19 and clinical implications in elderly patients. A review. Ann Med Surg (Lond) 2020;57:236-43. [PMID: 32802325 DOI: 10.1016/j.amsu.2020.07.054] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 8.5] [Reference Citation Analysis]
644 Odilov A, Volkov A, Abdullaev A, Gasanova T, Lipina T, Babichenko I. COVID-19: Multiorgan Dissemination of SARS-CoV-2 Is Driven by Pulmonary Factors. Viruses 2021;14:39. [PMID: 35062243 DOI: 10.3390/v14010039] [Reference Citation Analysis]
645 Martin-Cardona A, Lloreta Trull J, Albero-González R, Paraira Beser M, Andújar X, Ruiz-Ramirez P, Tur-Martínez J, Ferrer C, De Marcos Izquierdo JA, Pérez-Madrigal A, Goiburú González L, Espinós Perez J, Esteve M. SARS-CoV-2 identified by transmission electron microscopy in lymphoproliferative and ischaemic intestinal lesions of COVID-19 patients with acute abdominal pain: two case reports. BMC Gastroenterol 2021;21:334. [PMID: 34445965 DOI: 10.1186/s12876-021-01905-3] [Reference Citation Analysis]
646 Marchandot B, Trimaille A, Curtiaud A, Matsushita K, Jesel L, Morel O. Thromboprophylaxis: balancing evidence and experience during the COVID-19 pandemic. J Thromb Thrombolysis 2020;50:799-808. [PMID: 32696172 DOI: 10.1007/s11239-020-02231-3] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
647 Song J, Liu X. The Application of Autopsy and Explanted Heart Samples in Scientific Research. Cardiovascular Pathology 2022. [DOI: 10.1016/j.carpath.2022.107424] [Reference Citation Analysis]
648 Gregoriano C, Molitor A, Haag E, Kutz A, Koch D, Haubitz S, Conen A, Bernasconi L, Hammerer-Lercher A, Fux CA, Mueller B, Schuetz P. Activation of Vasopressin System During COVID-19 is Associated With Adverse Clinical Outcomes: An Observational Study. J Endocr Soc 2021;5:bvab045. [PMID: 34056499 DOI: 10.1210/jendso/bvab045] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
649 Wu Z, Zhang Q, Ye G, Zhang H, Heng BC, Fei Y, Zhao B, Zhou J. Structural and physiological changes of the human body upon SARS-CoV-2 infection. J Zhejiang Univ Sci B 2021;22:310-7. [PMID: 33835765 DOI: 10.1631/jzus.B2000523] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
650 Miller J, Bruen C, Schnaus M, Zhang J, Ali S, Lind A, Stoecker Z, Stauderman K, Hebbar S. Auxora versus standard of care for the treatment of severe or critical COVID-19 pneumonia: results from a randomized controlled trial. Crit Care 2020;24:502. [PMID: 32795330 DOI: 10.1186/s13054-020-03220-x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 9.5] [Reference Citation Analysis]
651 Sobh E, Reihan MS, Hifnawy TMS, Abdelsalam KG, Awad SS, Mahmoud NMH, Sindi NA, Alhadrami HA. Cardiovascular system and coronavirus disease-2019 (COVID-19): mutual injuries and unexpected outcomes. Egypt Heart J 2021;73:77. [PMID: 34478001 DOI: 10.1186/s43044-021-00202-4] [Reference Citation Analysis]
652 Sessa F, Bertozzi G, Cipolloni L, Baldari B, Cantatore S, D'Errico S, Di Mizio G, Asmundo A, Castorina S, Salerno M, Pomara C. Clinical-Forensic Autopsy Findings to Defeat COVID-19 Disease: A Literature Review. J Clin Med 2020;9:E2026. [PMID: 32605192 DOI: 10.3390/jcm9072026] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 10.5] [Reference Citation Analysis]
653 Iturriaga-Goyon E, Buentello-Volante B, Magaña-Guerrero FS, Garfias Y. Future Perspectives of Therapeutic, Diagnostic and Prognostic Aptamers in Eye Pathological Angiogenesis. Cells 2021;10:1455. [PMID: 34200613 DOI: 10.3390/cells10061455] [Reference Citation Analysis]
654 Hirschbühl K, Schaller T, Märkl B, Claus R, Sipos E, Rentschler L, Maccagno A, Grosser B, Kling E, Neidig M, Kröncke T, Spring O, Braun G, Bösmüller H, Seidl M, Esposito I, Pablik J, Hilsenbeck J, Boor P, Beer M, Dintner S, Wylezich C. High viral loads: what drives fatal cases of COVID-19 in vaccinees? - an autopsy study. Mod Pathol 2022. [PMID: 35365771 DOI: 10.1038/s41379-022-01069-9] [Reference Citation Analysis]
655 Bryce C, Grimes Z, Pujadas E, Ahuja S, Beasley MB, Albrecht R, Hernandez T, Stock A, Zhao Z, AlRasheed MR, Chen J, Li L, Wang D, Corben A, Haines GK 3rd, Westra WH, Umphlett M, Gordon RE, Reidy J, Petersen B, Salem F, Fiel MI, El Jamal SM, Tsankova NM, Houldsworth J, Mussa Z, Veremis B, Sordillo E, Gitman MR, Nowak M, Brody R, Harpaz N, Merad M, Gnjatic S, Liu WC, Schotsaert M, Miorin L, Aydillo Gomez TA, Ramos-Lopez I, Garcia-Sastre A, Donnelly R, Seigler P, Keys C, Cameron J, Moultrie I, Washington KL, Treatman J, Sebra R, Jhang J, Firpo A, Lednicky J, Paniz-Mondolfi A, Cordon-Cardo C, Fowkes ME. Pathophysiology of SARS-CoV-2: the Mount Sinai COVID-19 autopsy experience. Mod Pathol 2021;34:1456-67. [PMID: 33795830 DOI: 10.1038/s41379-021-00793-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 13.0] [Reference Citation Analysis]
656 Han K, Blair RV, Iwanaga N, Liu F, Russell-Lodrigue KE, Qin Z, Midkiff CC, Golden NA, Doyle-Meyers LA, Kabir ME, Chandler KE, Cutrera KL, Ren M, Monjure CJ, Lehmicke G, Fischer T, Beddingfield B, Wanek AG, Birnbaum A, Maness NJ, Roy CJ, Datta PK, Rappaport J, Kolls JK, Qin X. Lung Expression of Human Angiotensin-Converting Enzyme 2 Sensitizes the Mouse to SARS-CoV-2 Infection. Am J Respir Cell Mol Biol. 2021;64:79-88. [PMID: 32991819 DOI: 10.1165/rcmb.2020-0354oc] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 15.0] [Reference Citation Analysis]
657 Chow JH, Yin Y, Yamane DP, Davison D, Keneally RJ, Hawkins K, Parr KG, Al-Mashat M, Berger JS, Bushardt RL, Mazzeffi MA, Nelson SJ. Association of prehospital antiplatelet therapy with survival in patients hospitalized with COVID-19: A propensity score-matched analysis. J Thromb Haemost 2021;19:2814-24. [PMID: 34455688 DOI: 10.1111/jth.15517] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
658 Valencia M, Becerra JE, Reyes JC, Castro KG. Assessment of early mitigation measures against COVID-19 in Puerto Rico: March 15-May 15, 2020. PLoS One 2020;15:e0240013. [PMID: 33052958 DOI: 10.1371/journal.pone.0240013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
659 Barros CMSS, Freire RS, Frota E, Rezende Santos AG, Farias MEL, Rodrigues MGA, Silva BM, Prado Jeronimo CM, Netto RLA, Silva Borba MG, Baía-da-Silva D, Brito-Sousa JD, Xavier MS, Araújo-Alexandre MA, Sampaio VS, Melo GC, Arêas GT, Hajjar LA, Monteiro WM, Gomes Naveca F, Costa FTM, Val FFA, Lacerda MVG; Metcovid team. Short-Course of Methylprednisolone Improves Respiratory Functional Parameters After 120 Days in Hospitalized COVID-19 Patients (Metcovid Trial): A Randomized Clinical Trial. Front Med (Lausanne) 2021;8:758405. [PMID: 34917633 DOI: 10.3389/fmed.2021.758405] [Reference Citation Analysis]
660 Hingmire S, Wategaonkar R, Hegde S, Mekha M, Kulkarni R, Rajbhoj A, Deshmukh C, Kulkarni P, Patil T, Kanitkar G, Wanjarkhedkar P, Mane A, Bokil K, Parasnis A, Gawande J, Bhatia J, Khaladkar B, Sirsath N, Melinkeri S, Kashyapi B, Agrawal RK, Prabhakaran A, Desai I, Kelkar D. Outcome of COVID-19 Infection in Cancer Patients in Pune. South Asian J Cancer 2021;10:23-7. [PMID: 34430515 DOI: 10.1055/s-0041-1731910] [Reference Citation Analysis]
661 Ansarin K, Tolouian R, Ardalan M, Taghizadieh A, Varshochi M, Teimouri S, Vaezi T, Valizadeh H, Saleh P, Safiri S, Chapman KR. Effect of bromhexine on clinical outcomes and mortality in COVID-19 patients: A randomized clinical trial. Bioimpacts 2020;10:209-15. [PMID: 32983936 DOI: 10.34172/bi.2020.27] [Cited by in Crossref: 36] [Cited by in F6Publishing: 27] [Article Influence: 18.0] [Reference Citation Analysis]
662 Camilli C, Hoeh AE, De Rossi G, Moss SE, Greenwood J. LRG1: an emerging player in disease pathogenesis. J Biomed Sci 2022;29. [DOI: 10.1186/s12929-022-00790-6] [Reference Citation Analysis]
663 Brandner JM, Boor P, Borcherding L, Edler C, Gerber S, Heinemann A, Hilsenbeck J, Kasajima A, Lohner L, Märkl B, Pablik J, Schröder AS, Slotta-Huspenina J, Sommer L, Sperhake JP, von Stillfried S, Dintner S. Contamination of personal protective equipment during COVID-19 autopsies. Virchows Arch 2022. [PMID: 34993593 DOI: 10.1007/s00428-021-03263-7] [Reference Citation Analysis]
664 Elyaspour Z, Zibaeenezhad MJ, Razmkhah M, Razeghian-Jahromi I. Is It All About Endothelial Dysfunction and Thrombosis Formation? The Secret of COVID-19. Clin Appl Thromb Hemost 2021;27:10760296211042940. [PMID: 34693754 DOI: 10.1177/10760296211042940] [Reference Citation Analysis]
665 Flinspach AN, Zacharowski K, Ioanna D, Adam EH. Volatile Isoflurane in Critically Ill Coronavirus Disease 2019 Patients-A Case Series and Systematic Review. Crit Care Explor 2020;2:e0256. [PMID: 33134946 DOI: 10.1097/CCE.0000000000000256] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
666 Jandial A, Gupta A, Malviya A, Agastam S, Kumar D. Coagulation abnormalities & thromboprophylaxis in COVID-19. Indian J Med Res 2021;153:606-18. [PMID: 34643567 DOI: 10.4103/ijmr.IJMR_3841_20] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
667 Han T, Yuan H, Ye L, Jiang X, Bai L, Wang C. [Impact of cardiovascular metabolic diseases on COVID-19: review of recent progress]. Nan Fang Yi Ke Da Xue Xue Bao 2021;41:628-32. [PMID: 33963726 DOI: 10.12122/j.issn.1673-4254.2021.04.22] [Reference Citation Analysis]
668 Lai A, Chang ML, O'Donnell RP, Zhou C, Sumner JA, Hsiai TK. Association of COVID-19 transmission with high levels of ambient pollutants: Initiation and impact of the inflammatory response on cardiopulmonary disease. Sci Total Environ 2021;779:146464. [PMID: 33961545 DOI: 10.1016/j.scitotenv.2021.146464] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
669 Fodor A, Tiperciuc B, Login C, Orasan OH, Lazar AL, Buchman C, Hanghicel P, Sitar-Taut A, Suharoschi R, Vulturar R, Cozma A. Endothelial Dysfunction, Inflammation, and Oxidative Stress in COVID-19-Mechanisms and Therapeutic Targets. Oxid Med Cell Longev 2021;2021:8671713. [PMID: 34457119 DOI: 10.1155/2021/8671713] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
670 Robert J, Osto E, von Eckardstein A. The Endothelium Is Both a Target and a Barrier of HDL's Protective Functions. Cells 2021;10:1041. [PMID: 33924941 DOI: 10.3390/cells10051041] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
671 Ylescupidez A, Rips A, Bahnson HT, Speake C, Verma P, Hocking AM, Buckner JH, Malhotra U. Early Prognostic Indicators of Subsequent Hospitalization in Patients with Mild COVID-19. J Clin Med 2021;10:1562. [PMID: 33917702 DOI: 10.3390/jcm10081562] [Reference Citation Analysis]
672 Abourida Y, Rebahi H, Chichou H, Fenane H, Msougar Y, Fakhri A, Hazmiri FE, Ismail A, Rais H, Soraa N, Samkaoui MA. What Open-Lung Biopsy Teaches Us about ARDS in COVID-19 Patients: Mechanisms, Pathology, and Therapeutic Implications. Biomed Res Int 2020;2020:2909673. [PMID: 33376717 DOI: 10.1155/2020/2909673] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
673 Afzali B, Noris M, Lambrecht BN, Kemper C. The state of complement in COVID-19. Nat Rev Immunol 2021. [PMID: 34912108 DOI: 10.1038/s41577-021-00665-1] [Reference Citation Analysis]
674 . Flavia Carriero, Laura Cortese, Valentina Rubino, Anna Teresa Palatucci, Angela Giovazzino, Giuseppina Ruggiero, Diego Piantedosi, Nadia Musco, Pietro Lombardi and Giuseppe Terrazzano: An Open Question in the COVID-19 Pandemic: Can Humans Transmit the Disease to Pets and Vice Versa? J Comp Pathol 2021:S0021-9975(21)00079-7. [PMID: 34304901 DOI: 10.1016/j.jcpa.2021.05.008] [Reference Citation Analysis]
675 Masterson CH, Ceccato A, Artigas A, Dos Santos C, Rocco PR, Rolandsson Enes S, Weiss DJ, McAuley D, Matthay MA, English K, Curley GF, Laffey JG. Mesenchymal stem/stromal cell-based therapies for severe viral pneumonia: therapeutic potential and challenges. Intensive Care Med Exp 2021;9:61. [PMID: 34970706 DOI: 10.1186/s40635-021-00424-5] [Reference Citation Analysis]
676 Larenas-Linnemann D, Rodríguez-Pérez N, Arias-Cruz A, Blandón-Vijil MV, Del Río-Navarro BE, Estrada-Cardona A, Gereda JE, Luna-Pech JA, Navarrete-Rodríguez EM, Onuma-Takane E, Pozo-Beltrán CF, Rojo-Gutiérrez MI. Enhancing innate immunity against virus in times of COVID-19: Trying to untangle facts from fictions. World Allergy Organ J 2020;13:100476. [PMID: 33072240 DOI: 10.1016/j.waojou.2020.100476] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 4.5] [Reference Citation Analysis]
677 Jorda A, Siller-Matula JM, Zeitlinger M, Jilma B, Gelbenegger G. Anticoagulant Treatment Regimens in Patients with Covid-19: A Meta-Analysis. Clin Pharmacol Ther 2021. [PMID: 34862791 DOI: 10.1002/cpt.2504] [Reference Citation Analysis]
678 Logette E, Lorin C, Favreau C, Oshurko E, Coggan JS, Casalegno F, Sy MF, Monney C, Bertschy M, Delattre E, Fonta PA, Krepl J, Schmidt S, Keller D, Kerrien S, Scantamburlo E, Kaufmann AK, Markram H. A Machine-Generated View of the Role of Blood Glucose Levels in the Severity of COVID-19. Front Public Health 2021;9:695139. [PMID: 34395368 DOI: 10.3389/fpubh.2021.695139] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
679 Zheng W, Wang T, Wu P, Yan Q, Liu C, Wu H, Zhan S, Liu X, Jiang Y, Zhuang H. Host Factor Interaction Networks Identified by Integrative Bioinformatics Analysis Reveals Therapeutic Implications in COPD Patients With COVID-19. Front Pharmacol 2021;12:718874. [PMID: 35002688 DOI: 10.3389/fphar.2021.718874] [Reference Citation Analysis]
680 Polito MV, Silverio A, Bellino M, Iuliano G, Di Maio M, Alfano C, Iannece P, Esposito N, Galasso G. Cardiovascular Involvement in COVID-19: What Sequelae Should We Expect? Cardiol Ther 2021. [PMID: 34191268 DOI: 10.1007/s40119-021-00232-8] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
681 Mann R, Perisetti A, Gajendran M, Gandhi Z, Umapathy C, Goyal H. Clinical Characteristics, Diagnosis, and Treatment of Major Coronavirus Outbreaks. Front Med (Lausanne). 2020;7:581521. [PMID: 33282890 DOI: 10.3389/fmed.2020.581521] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
682 Fabbri VP, Foschini MP, Lazzarotto T, Gabrielli L, Cenacchi G, Gallo C, Aspide R, Frascaroli G, Cortelli P, Riefolo M, Giannini C, D'Errico A. Brain ischemic injury in COVID-19-infected patients: a series of 10 post-mortem cases. Brain Pathol 2021;31:205-10. [PMID: 33002281 DOI: 10.1111/bpa.12901] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
683 Flerlage T, Boyd DF, Meliopoulos V, Thomas PG, Schultz-Cherry S. Influenza virus and SARS-CoV-2: pathogenesis and host responses in the respiratory tract. Nat Rev Microbiol 2021;19:425-41. [PMID: 33824495 DOI: 10.1038/s41579-021-00542-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
684 Michalski JE, Kurche JS, Schwartz DA. From ARDS to pulmonary fibrosis: the next phase of the COVID-19 pandemic? Transl Res 2021:S1931-5244(21)00243-7. [PMID: 34547499 DOI: 10.1016/j.trsl.2021.09.001] [Reference Citation Analysis]
685 Janssen R, Walk J. Vitamin K epoxide reductase complex subunit 1 (VKORC1) gene polymorphism as determinant of differences in Covid-19-related disease severity. Med Hypotheses 2020;144:110218. [PMID: 33254525 DOI: 10.1016/j.mehy.2020.110218] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
686 İnanç İ, Erdemli E. Histopathological features of SARS-CoV-2 infection and relationships with organoid technology. J Int Med Res 2021;49:3000605211044382. [PMID: 34521239 DOI: 10.1177/03000605211044382] [Reference Citation Analysis]
687 Legrand M, Bell S, Forni L, Joannidis M, Koyner JL, Liu K, Cantaluppi V. Pathophysiology of COVID-19-associated acute kidney injury. Nat Rev Nephrol 2021. [PMID: 34226718 DOI: 10.1038/s41581-021-00452-0] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
688 Ackermann M, Anders HJ, Bilyy R, Bowlin GL, Daniel C, De Lorenzo R, Egeblad M, Henneck T, Hidalgo A, Hoffmann M, Hohberger B, Kanthi Y, Kaplan MJ, Knight JS, Knopf J, Kolaczkowska E, Kubes P, Leppkes M, Mahajan A, Manfredi AA, Maueröder C, Maugeri N, Mitroulis I, Muñoz LE, Narasaraju T, Naschberger E, Neeli I, Ng LG, Radic MZ, Ritis K, Rovere-Querini P, Schapher M, Schauer C, Simon HU, Singh J, Skendros P, Stark K, Stürzl M, van der Vlag J, Vandenabeele P, Vitkov L, von Köckritz-Blickwede M, Yanginlar C, Yousefi S, Zarbock A, Schett G, Herrmann M. Patients with COVID-19: in the dark-NETs of neutrophils. Cell Death Differ 2021. [PMID: 34031543 DOI: 10.1038/s41418-021-00805-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
689 Cullivan S, Sholzberg M, Áinle F, Kevane B. Anticoagulation as a therapeutic strategy for hospitalised patients with COVID-19. Thrombosis Update 2022;6:100097. [DOI: 10.1016/j.tru.2022.100097] [Reference Citation Analysis]
690 Gambardella J, Khondkar W, Morelli MB, Wang X, Santulli G, Trimarco V. Arginine and Endothelial Function. Biomedicines 2020;8:E277. [PMID: 32781796 DOI: 10.3390/biomedicines8080277] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
691 Ngu S, Smith JK, Goldin M. Use of Anticoagulants in COVID-19: A Review. Am J Ther 2022. [PMID: 35476050 DOI: 10.1097/MJT.0000000000001515] [Reference Citation Analysis]
692 Yao S, Luo N, Liu J, Zha H, Ai Y, Luo J, Shi S, Wu K. Elevated Serum Levels of Progranulin and Soluble Vascular Cell Adhesion Molecule-1 in Patients with COVID-19. J Inflamm Res 2021;14:4785-94. [PMID: 34584437 DOI: 10.2147/JIR.S330356] [Reference Citation Analysis]
693 Moore KM, Suthar MS. Comprehensive analysis of COVID-19 during pregnancy. Biochem Biophys Res Commun 2021;538:180-6. [PMID: 33384142 DOI: 10.1016/j.bbrc.2020.12.064] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
694 García-escobar A, Vera-vera S, Jurado-román A, Jiménez-valero S, Galeote G, Moreno R. Calcium Signaling Pathway Is Involved in the Shedding of ACE2 Catalytic Ectodomain: New Insights for Clinical and Therapeutic Applications of ACE2 for COVID-19. Biomolecules 2022;12:76. [DOI: 10.3390/biom12010076] [Reference Citation Analysis]
695 Violi F, Cammisotto V, Pignatelli P. Thrombosis in Covid-19 and non-Covid-19 pneumonia: role of platelets. Platelets 2021;:1-9. [PMID: 34097572 DOI: 10.1080/09537104.2021.1936478] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
696 Villard O, Morquin D, Molinari N, Raingeard I, Nagot N, Cristol JP, Jung B, Roubille C, Foulongne V, Fesler P, Lamure S, Taourel P, Konate A, Maria ATJ, Makinson A, Bertchansky I, Larcher R, Klouche K, Le Moing V, Renard E, Guilpain P. The Plasmatic Aldosterone and C-Reactive Protein Levels, and the Severity of Covid-19: The Dyhor-19 Study. J Clin Med 2020;9:E2315. [PMID: 32708205 DOI: 10.3390/jcm9072315] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
697 Amraei R, Yin W, Napoleon MA, Suder EL, Berrigan J, Zhao Q, Olejnik J, Chandler KB, Xia C, Feldman J, Hauser BM, Caradonna TM, Schmidt AG, Gummuluru S, Mühlberger E, Chitalia V, Costello CE, Rahimi N. CD209L/L-SIGN and CD209/DC-SIGN Act as Receptors for SARS-CoV-2. ACS Cent Sci 2021;7:1156-65. [PMID: 34341769 DOI: 10.1021/acscentsci.0c01537] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
698 Itoh M, Herai Y, Nakamura H, Aoshiba K. Multiple pulmonary cyst formation after COVID-19 pneumonia. IDCases 2022;27:e01389. [PMID: 35018282 DOI: 10.1016/j.idcr.2022.e01389] [Reference Citation Analysis]
699 Nopp S, Moik F, Jilma B, Pabinger I, Ay C. Risk of venous thromboembolism in patients with COVID-19: A systematic review and meta-analysis. Res Pract Thromb Haemost 2020. [PMID: 33043231 DOI: 10.1002/rth2.12439] [Cited by in Crossref: 83] [Cited by in F6Publishing: 73] [Article Influence: 41.5] [Reference Citation Analysis]
700 Nascimento DDC, Rolnick N, Neto IVDS, Severin R, Beal FLR. A Useful Blood Flow Restriction Training Risk Stratification for Exercise and Rehabilitation. Front Physiol 2022;13:808622. [DOI: 10.3389/fphys.2022.808622] [Reference Citation Analysis]
701 Rodríguez C, Luque N, Blanco I, Sebastian L, Barberà JA, Peinado VI, Tura-Ceide O. Pulmonary Endothelial Dysfunction and Thrombotic Complications in Patients with COVID-19. Am J Respir Cell Mol Biol 2021;64:407-15. [PMID: 33180562 DOI: 10.1165/rcmb.2020-0359PS] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
702 Matthay MA, Arabi YM, Siegel ER, Ware LB, Bos LDJ, Sinha P, Beitler JR, Wick KD, Curley MAQ, Constantin JM, Levitt JE, Calfee CS. Phenotypes and personalized medicine in the acute respiratory distress syndrome. Intensive Care Med 2020;46:2136-52. [PMID: 33206201 DOI: 10.1007/s00134-020-06296-9] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
703 Rosa BA, Ahmed M, Singh DK, Choreño-Parra JA, Cole J, Jiménez-Álvarez LA, Rodríguez-Reyna TS, Singh B, Gonzalez O, Carrion R Jr, Schlesinger LS, Martin J, Zúñiga J, Mitreva M, Khader SA, Kaushal D. IFN signaling and neutrophil degranulation transcriptional signatures are induced during SARS-CoV-2 infection. bioRxiv 2020:2020. [PMID: 32793903 DOI: 10.1101/2020.08.06.239798] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
704 Yeates EO, Grigorian A, Schellenberg M, Owattanapanich N, Barmparas G, Margulies D, Juillard C, Garber K, Cryer H, Tillou A, Burruss S, Figueras RA, Mladenov G, Brenner M, Firek C, Costantini T, Santorelli J, Curry T, Wintz D, Biffl WL, Schaffer KB, Duncan TK, Barbaro C, Diaz G, Johnson A, Chinn J, Naaseh A, Leung A, Grabar C, Nahmias J. COVID-19 in trauma: a propensity-matched analysis of COVID and non-COVID trauma patients. Eur J Trauma Emerg Surg 2021. [PMID: 34031703 DOI: 10.1007/s00068-021-01699-9] [Reference Citation Analysis]
705 Yang Y, Xiao Z, Ye K, He X, Sun B, Qin Z, Yu J, Yao J, Wu Q, Bao Z, Zhao W. SARS-CoV-2: characteristics and current advances in research. Virol J 2020;17:117. [PMID: 32727485 DOI: 10.1186/s12985-020-01369-z] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 14.0] [Reference Citation Analysis]
706 Palazzuoli A, Giustozzi M, Ruocco G, Tramonte F, Gronda E, Agnelli G. Thromboembolic Complications in Covid-19: From Clinical Scenario to Laboratory Evidence. Life (Basel) 2021;11:395. [PMID: 33925334 DOI: 10.3390/life11050395] [Reference Citation Analysis]
707 Fuehner T, Renger I, Welte T, Freundt T, Gottlieb J. Silent Hypoxia in COVID-19: A Case Series. Respiration 2021;:1-5. [PMID: 34839295 DOI: 10.1159/000520083] [Reference Citation Analysis]
708 Caro-Codón J, Rey JR, Buño A, Iniesta AM, Rosillo SO, Castrejon-Castrejon S, Merino C, Marco I, Martinez LA, Garcia-Veas JM, Martin-Polo L, Rodriguez-Sotelo L, Martinez-Cossiani M, Gonzalez-Valle L, Herrero A, López-de-Sá E, Merino JL; CARD-COVID Investigators. Characterization of myocardial injury in a cohort of patients with SARS-CoV-2 infection. Med Clin (Barc) 2021:S0025-7753(21)00092-0. [PMID: 33846001 DOI: 10.1016/j.medcli.2021.02.001] [Reference Citation Analysis]
709 Stals M, Grootenboers M, van Guldener C, Kaptein F, Braken S, Chen Q, Chu G, van Driel EM, Iglesias Del Sol A, de Jonge E, Kant KM, Pals F, Toorop M, Cannegieter SC, Klok FA, Huisman MV; Dutch COVID, Thrombosis Coalition (DCTC). Risk of thrombotic complications in influenza versus COVID-19 hospitalized patients. Res Pract Thromb Haemost 2021. [PMID: 33821230 DOI: 10.1002/rth2.12496] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
710 Gelzo M, Cacciapuoti S, Pinchera B, De Rosa A, Cernera G, Scialò F, Comegna M, Mormile M, Fabbrocini G, Parrella R, Corso G, Gentile I, Castaldo G. Further Findings Concerning Endothelial Damage in COVID-19 Patients. Biomolecules 2021;11:1368. [PMID: 34572581 DOI: 10.3390/biom11091368] [Reference Citation Analysis]
711 Krishnamachary B, Cook C, Kumar A, Spikes L, Chalise P, Dhillon NK. Extracellular vesicle-mediated endothelial apoptosis and EV-associated proteins correlate with COVID-19 disease severity. J Extracell Vesicles 2021;10:e12117. [PMID: 34262673 DOI: 10.1002/jev2.12117] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
712 Peng XL, Cheng JS, Gong HL, Yuan MD, Zhao XH, Li Z, Wei DX. Advances in the design and development of SARS-CoV-2 vaccines. Mil Med Res 2021;8:67. [PMID: 34911569 DOI: 10.1186/s40779-021-00360-1] [Reference Citation Analysis]
713 Stakišaitis D, Kapočius L, Valančiūtė A, Balnytė I, Tamošuitis T, Vaitkevičius A, Sužiedėlis K, Urbonienė D, Tatarūnas V, Kilimaitė E, Gečys D, Lesauskaitė V. SARS-CoV-2 Infection, Sex-Related Differences, and a Possible Personalized Treatment Approach with Valproic Acid: A Review. Biomedicines 2022;10:962. [DOI: 10.3390/biomedicines10050962] [Reference Citation Analysis]
714 Singh H, Chauhan P, Singh J, Saurabh, Gautam CS, Kakkar AK. Concomitant use of dexamethasone and tetracyclines: a potential therapeutic option for the management of severe COVID-19 infection? Expert Rev Clin Pharmacol 2021;14:315-22. [PMID: 33586566 DOI: 10.1080/17512433.2021.1888714] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
715 Salva O, Alasino R, Giller C, Borello J, Doresky A, Karayan G, Beltramo D. Nebulization with alkaline hipertonic ibuprofen induces a rapid increase in platelets circulating in COVID-19 patients but not in healthy subjects. Platelets 2021;:1-8. [PMID: 34423724 DOI: 10.1080/09537104.2021.1967918] [Reference Citation Analysis]
716 Perazzolo S, Zhu L, Lin W, Nguyen A, Ho RJY. Systems and Clinical Pharmacology of COVID-19 Therapeutic Candidates: A Clinical and Translational Medicine Perspective. J Pharm Sci 2021;110:1002-17. [PMID: 33248057 DOI: 10.1016/j.xphs.2020.11.019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
717 Simeone PG, Crosta F, Stanziani D, Colameco F, Sanrocco C, Desideri G, Santilli F, Savini V, Scurti R, Parruti G. Could ischemic colitis be the first manifestation of COVID-19? A case report. JGG 2020;68:231-4. [DOI: 10.36150/2499-6564-258] [Reference Citation Analysis]
718 Yaykasli KO, Schauer C, Muñoz LE, Mahajan A, Knopf J, Schett G, Herrmann M. Neutrophil Extracellular Trap-Driven Occlusive Diseases. Cells 2021;10:2208. [PMID: 34571857 DOI: 10.3390/cells10092208] [Reference Citation Analysis]
719 Karimi-Galougahi M, Yousefi-Koma A, Raygani N, Bakhshayeshkaram M, Haseli S. 18FDG-PET/CT Assessment of COVID-19-Induced Bell's Palsy. Acad Radiol 2021;28:144-5. [PMID: 33189551 DOI: 10.1016/j.acra.2020.11.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
720 Chen R, Lan Z, Ye J, Pang L, Liu Y, Wu W, Qin X, Guo Y, Zhang P. Cytokine Storm: The Primary Determinant for the Pathophysiological Evolution of COVID-19 Deterioration. Front Immunol 2021;12:589095. [PMID: 33995341 DOI: 10.3389/fimmu.2021.589095] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
721 Eisenhut M, Shin JI. Pathways in the Pathophysiology of Coronavirus 19 Lung Disease Accessible to Prevention and Treatment. Front Physiol 2020;11:872. [PMID: 32922301 DOI: 10.3389/fphys.2020.00872] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
722 Paley EL. Towards Understanding COVID-19: Molecular Insights, Co-infections, Associated Disorders, and Aging. J Alzheimers Dis Rep 2021;5:571-600. [PMID: 34514341 DOI: 10.3233/ADR-210010] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
723 Apostolidis SA, Sarkar A, Giannini HM, Goel RR, Mathew D, Suzuki A, Baxter AE, Greenplate AR, Alanio C, Abdel-Hakeem M, Oldridge DA, Giles J, Wu JE, Chen Z, Huang YJ, Pattekar A, Manne S, Kuthuru O, Dougherty J, Weiderhold B, Weisman AR, Ittner CAG, Gouma S, Dunbar D, Frank I, Huang AC, Vella LA, Reilly JP, Hensley SE, Rauova L, Zhao L, Meyer NJ, Poncz M, Abrams CS, Wherry EJ; UPenn COVID Processing Unit. Signaling through FcγRIIA and the C5a-C5aR pathway mediates platelet hyperactivation in COVID-19. bioRxiv 2021:2021. [PMID: 33972943 DOI: 10.1101/2021.05.01.442279] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
724 Soares CD, Carvalho RA, Carvalho KA, Carvalho MG, Almeida OP. Letter to Editor: Oral lesions in a patient with Covid-19. Med Oral Patol Oral Cir Bucal 2020;25:e563-4. [PMID: 32520921 DOI: 10.4317/medoral.24044] [Cited by in Crossref: 11] [Cited by in F6Publishing: 21] [Article Influence: 5.5] [Reference Citation Analysis]
725 Gavriatopoulou M, Ntanasis-Stathopoulos I, Korompoki E, Fotiou D, Migkou M, Tzanninis IG, Psaltopoulou T, Kastritis E, Terpos E, Dimopoulos MA. Emerging treatment strategies for COVID-19 infection. Clin Exp Med 2021;21:167-79. [PMID: 33128197 DOI: 10.1007/s10238-020-00671-y] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 11.0] [Reference Citation Analysis]
726 Gu SX, Tyagi T, Jain K, Gu VW, Lee SH, Hwa JM, Kwan JM, Krause DS, Lee AI, Halene S, Martin KA, Chun HJ, Hwa J. Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation. Nat Rev Cardiol 2021;18:194-209. [PMID: 33214651 DOI: 10.1038/s41569-020-00469-1] [Cited by in Crossref: 49] [Cited by in F6Publishing: 51] [Article Influence: 24.5] [Reference Citation Analysis]
727 George PM, Desai SR. COVID-19 pneumonia and the pulmonary vasculature - a marriage made in hell. Eur Respir J 2021:2100811. [PMID: 33863736 DOI: 10.1183/13993003.00811-2021] [Reference Citation Analysis]
728 Altmayer V, Ziveri J, Frère C, Salem JE, Weiss N, Cao A, Marois C, Rohaut B, Demeret S, Bourdoulous S, Le Guennec L. Endothelial cell biomarkers in critically ill COVID-19 patients with encephalitis. J Neurochem 2021. [PMID: 34822163 DOI: 10.1111/jnc.15545] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
729 Bertoletti L, Huisman MV. How can we better predict pulmonary blood clots in patients hospitalised for COVID-19? Eur Respir J 2020;56:2003092. [PMID: 32907888 DOI: 10.1183/13993003.03092-2020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
730 Jacob MHF, Leal TCAT, Soares PR, Soeiro AM. Mechanical Aortic Prosthetic Thrombosis in a 65-Year-Old Woman with SARS-CoV-2 Infection. Arq Bras Cardiol 2020;115:1180-3. [PMID: 33470321 DOI: 10.36660/abc.20200754] [Reference Citation Analysis]
731 Pannone G, Caponio VCA, De Stefano IS, Ramunno MA, Meccariello M, Agostinone A, Pedicillo MC, Troiano G, Zhurakivska K, Cassano T, Bizzoca ME, Papagerakis S, Buonaguro FM, Advani S, Muzio LL. Lung histopathological findings in COVID-19 disease - a systematic review. Infect Agent Cancer 2021;16:34. [PMID: 34001199 DOI: 10.1186/s13027-021-00369-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
732 Feng Y, Tang K, Lai Q, Liang J, Feng M, Zhou Z, Cui H, Du X, Zhang H, Sun L. The Landscape of Aminoacyl-tRNA Synthetases Involved in Severe Acute Respiratory Syndrome Coronavirus 2 Infection. Front Physiol 2022;12:818297. [DOI: 10.3389/fphys.2021.818297] [Reference Citation Analysis]
733 Miedema J, Schreurs M, van der Sar-van der Brugge S, Paats M, Baart S, Bakker M, Hoek R, Dik WA, Endeman H, Van Der Velden V, van Gammeren A, Ermens A, Aerts JG, Thüsen JV. Antibodies Against Angiotensin II Receptor Type 1 and Endothelin A Receptor Are Associated With an Unfavorable COVID19 Disease Course. Front Immunol 2021;12:684142. [PMID: 34054876 DOI: 10.3389/fimmu.2021.684142] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
734 Malguria N, Yen LH, Lin T, Hussein A, Fishman EK. Role of Chest CT in COVID-19. J Clin Imaging Sci 2021;11:30. [PMID: 34221639 DOI: 10.25259/JCIS_138_2020] [Reference Citation Analysis]
735 Rodeghiero F, Cantoni S, Carli G, Carpenedo M, Carrai V, Chiurazzi F, De Stefano V, Santoro C, Siragusa S, Zaja F, Vianelli N. Practical Recommendations for the Management of Patients with ITP During the COVID-19 Pandemic. Mediterr J Hematol Infect Dis 2021;13:e2021032. [PMID: 34007420 DOI: 10.4084/MJHID.2021.032] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
736 García-carnero LC, Mora-montes HM. Mucormycosis and COVID-19-Associated Mucormycosis: Insights of a Deadly but Neglected Mycosis. JoF 2022;8:445. [DOI: 10.3390/jof8050445] [Reference Citation Analysis]
737 Zergane M, Kuebler WM, Michalick L. Heteromeric TRP Channels in Lung Inflammation. Cells 2021;10:1654. [PMID: 34359824 DOI: 10.3390/cells10071654] [Reference Citation Analysis]
738 Rysz S, Al-Saadi J, Sjöström A, Farm M, Campoccia Jalde F, Plattén M, Eriksson H, Klein M, Vargas-Paris R, Nyrén S, Abdula G, Ouellette R, Granberg T, Jonsson Fagerlund M, Lundberg J. COVID-19 pathophysiology may be driven by an imbalance in the renin-angiotensin-aldosterone system. Nat Commun 2021;12:2417. [PMID: 33893295 DOI: 10.1038/s41467-021-22713-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
739 D'Errico S, Zanon M, Montanaro M, Radaelli D, Sessa F, Di Mizio G, Montana A, Corrao S, Salerno M, Pomara C. More than Pneumonia: Distinctive Features of SARS-Cov-2 Infection. From Autopsy Findings to Clinical Implications: A Systematic Review. Microorganisms 2020;8:E1642. [PMID: 33114061 DOI: 10.3390/microorganisms8111642] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
740 Lampert J, Miller M, Halperin JL, Oates C, Giustino G, Nelson K, Feinman J, Kocovic N, Pulaski M, Musikantow D, Turagam MK, Sofi A, Choudry S, Langan MN, Koruth JS, Whang W, Miller MA, Dukkipati SR, Bassily-Marcus A, Kohli-Seth R, Goldman ME, Reddy VY. Prognostic Value of Electrocardiographic QRS Diminution in Patients Hospitalized With COVID-19 or Influenza. Am J Cardiol 2021;159:129-37. [PMID: 34579830 DOI: 10.1016/j.amjcard.2021.07.048] [Reference Citation Analysis]
741 Jahanafrooz Z, Chen Z, Bao J, Li H, Lipworth L, Guo X. An overview of human proteins and genes involved in SARS-CoV-2 infection. Gene 2022;808:145963. [PMID: 34530086 DOI: 10.1016/j.gene.2021.145963] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
742 Canovi S, Besutti G, Bonelli E, Iotti V, Ottone M, Albertazzi L, Zerbini A, Pattacini P, Giorgi Rossi P, Colla R, Fasano T; Reggio Emilia COVID-19 Working Group;. The association between clinical laboratory data and chest CT findings explains disease severity in a large Italian cohort of COVID-19 patients. BMC Infect Dis 2021;21:157. [PMID: 33557778 DOI: 10.1186/s12879-021-05855-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
743 Mylvaganam RJ, Bailey JI, Sznajder JI, Sala MA; Northwestern Comprehensive COVID Center Consortium. Recovering from a pandemic: pulmonary fibrosis after SARS-CoV-2 infection. Eur Respir Rev 2021;30:210194. [PMID: 34911696 DOI: 10.1183/16000617.0194-2021] [Reference Citation Analysis]
744 Nouailles G, Wyler E, Pennitz P, Postmus D, Vladimirova D, Kazmierski J, Pott F, Dietert K, Muelleder M, Farztdinov V, Obermayer B, Wienhold SM, Andreotti S, Hoefler T, Sawitzki B, Drosten C, Sander LE, Suttorp N, Ralser M, Beule D, Gruber AD, Goffinet C, Landthaler M, Trimpert J, Witzenrath M. Temporal omics analysis in Syrian hamsters unravel cellular effector responses to moderate COVID-19. Nat Commun 2021;12:4869. [PMID: 34381043 DOI: 10.1038/s41467-021-25030-7] [Reference Citation Analysis]
745 Becher T, Frerichs I. Mortality in COVID-19 is not merely a question of resource availability. Lancet Respir Med 2020;8:832-3. [PMID: 32735840 DOI: 10.1016/S2213-2600(20)30312-X] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
746 Li Y, Schneider AM, Mehta A, Sade-Feldman M, Kays KR, Gentili M, Charland NC, Gonye AL, Gushterova I, Khanna HK, LaSalle TJ, Lavin-Parsons KM, Lilley BM, Lodenstein CL, Manakongtreecheep K, Margolin JD, McKaig BN, Parry BA, Rojas-Lopez M, Russo BC, Sharma N, Tantivit J, Thomas MF, Regan J, Flynn JP, Villani AC, Hacohen N, Goldberg MB, Filbin MR, Li JZ. SARS-CoV-2 viremia is associated with distinct proteomic pathways and predicts COVID-19 outcomes. J Clin Invest 2021;131:148635. [PMID: 34196300 DOI: 10.1172/JCI148635] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
747 Mitchell EP. COVID-19 Innovations: Addressing Rapidly Changing Clinical Needs. J Natl Med Assoc 2020;112:237-8. [PMID: 32709271 DOI: 10.1016/j.jnma.2020.06.004] [Reference Citation Analysis]
748 Wagner WL, Hellbach K, Fiedler MO, Salg GA, Wehrse E, Ziener CH, Merle U, Eckert C, Weber TF, Stiller W, Wielpütz MO, Dullin C, Kenngott HG, Schlemmer HP, Weigand MA, Schirmacher P, Longerich T, Kauczor HU, Kommoss FK, Schwab C. [Microvascular changes in COVID-19]. Radiologe 2020;60:934-42. [PMID: 32857175 DOI: 10.1007/s00117-020-00743-w] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
749 Vianello A, Guarnieri G, Braccioni F, Molena B, Lococo S, Achille A, Lionello F, Salviati L, Caminati M, Senna G. Correlation between α1-Antitrypsin Deficiency and SARS-CoV-2 Infection: Epidemiological Data and Pathogenetic Hypotheses. J Clin Med 2021;10:4493. [PMID: 34640510 DOI: 10.3390/jcm10194493] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
750 Kang S, Tanaka T, Inoue H, Ono C, Hashimoto S, Kioi Y, Matsumoto H, Matsuura H, Matsubara T, Shimizu K, Ogura H, Matsuura Y, Kishimoto T. Reply to Cheng et al.: COVID-19 induces lower extent of cytokines, but damages vascular endothelium by IL-6 signaling. Proc Natl Acad Sci U S A 2021;118:e2105040118. [PMID: 33972413 DOI: 10.1073/pnas.2105040118] [Reference Citation Analysis]
751 Seeliger B, Wendel-Garcia PD, Stahl K, Bode C, David S. It takes two to bleed: anticoagulation intensity and the host's vascular susceptibility. Intensive Care Med 2022. [PMID: 35142897 DOI: 10.1007/s00134-022-06643-y] [Reference Citation Analysis]
752 Cabbab ILN, Manalo RVM. Anti-inflammatory drugs and the renin-angiotensin-aldosterone system: Current knowledge and potential effects on early SARS-CoV-2 infection. Virus Res 2021;291:198190. [PMID: 33039544 DOI: 10.1016/j.virusres.2020.198190] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
753 Palumbo P, Palumbo MM, Bruno F, Picchi G, Iacopino A, Acanfora C, Sgalambro F, Arrigoni F, Ciccullo A, Cosimini B, Splendiani A, Barile A, Masedu F, Grimaldi A, Di Cesare E, Masciocchi C. Automated Quantitative Lung CT Improves Prognostication in Non-ICU COVID-19 Patients beyond Conventional Biomarkers of Disease. Diagnostics (Basel) 2021;11:2125. [PMID: 34829472 DOI: 10.3390/diagnostics11112125] [Reference Citation Analysis]
754 Java A, Apicelli AJ, Liszewski MK, Coler-Reilly A, Atkinson JP, Kim AH, Kulkarni HS. The complement system in COVID-19: friend and foe? JCI Insight 2020;5:140711. [PMID: 32554923 DOI: 10.1172/jci.insight.140711] [Cited by in Crossref: 100] [Cited by in F6Publishing: 87] [Article Influence: 50.0] [Reference Citation Analysis]
755 Cicco S, Cicco G, Racanelli V, Vacca A. Neutrophil Extracellular Traps (NETs) and Damage-Associated Molecular Patterns (DAMPs): Two Potential Targets for COVID-19 Treatment. Mediators Inflamm 2020;2020:7527953. [PMID: 32724296 DOI: 10.1155/2020/7527953] [Cited by in Crossref: 44] [Cited by in F6Publishing: 50] [Article Influence: 22.0] [Reference Citation Analysis]
756 Abers MS, Delmonte OM, Ricotta EE, Fintzi J, Fink DL, de Jesus AAA, Zarember KA, Alehashemi S, Oikonomou V, Desai JV, Canna SW, Shakoory B, Dobbs K, Imberti L, Sottini A, Quiros-Roldan E, Castelli F, Rossi C, Brugnoni D, Biondi A, Bettini LR, D'Angio' M, Bonfanti P, Castagnoli R, Montagna D, Licari A, Marseglia GL, Gliniewicz EF, Shaw E, Kahle DE, Rastegar AT, Stack M, Myint-Hpu K, Levinson SL, DiNubile MJ, Chertow DW, Burbelo PD, Cohen JI, Calvo KR, Tsang JS, Su HC, Gallin JI, Kuhns DB, Goldbach-Mansky R, Lionakis MS, Notarangelo LD; NIAID COVID-19 Consortium. An immune-based biomarker signature is associated with mortality in COVID-19 patients. JCI Insight 2021;6:144455. [PMID: 33232303 DOI: 10.1172/jci.insight.144455] [Cited by in Crossref: 53] [Cited by in F6Publishing: 52] [Article Influence: 53.0] [Reference Citation Analysis]
757 Humayun L, Smith C, Li W, Zhang YS, Park C, Feng W, Yao J. SARS-CoV-2-related vascular injury: mechanisms, imaging and models. Microphysiol Syst 2021;5:1. [PMID: 33981988 DOI: 10.21037/mps-20-6] [Reference Citation Analysis]
758 Sanino G, Bosco M, Terrazzano G. Physiology of Midkine and Its Potential Pathophysiological Role in COVID-19. Front Physiol 2020;11:616552. [PMID: 33414726 DOI: 10.3389/fphys.2020.616552] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
759 Short SAP, Gupta S, Brenner SK, Hayek SS, Srivastava A, Shaefi S, Singh H, Wu B, Bagchi A, Al-Samkari H, Dy R, Wilkinson K, Zakai NA, Leaf DE; STOP-COVID Investigators. d-dimer and Death in Critically Ill Patients With Coronavirus Disease 2019. Crit Care Med 2021;49:e500-11. [PMID: 33591017 DOI: 10.1097/CCM.0000000000004917] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
760 Cenko E, Badimon L, Bugiardini R, Claeys MJ, De Luca G, de Wit C, Derumeaux G, Dorobantu M, Duncker DJ, Eringa EC, Gorog DA, Hassager C, Heinzel FR, Huber K, Manfrini O, Milicic D, Oikonomou E, Padro T, Trifunovic-Zamaklar D, Vasiljevic-Pokrajcic Z, Vavlukis M, Vilahur G, Tousoulis D. Cardiovascular disease and COVID-19: a consensus paper from the ESC Working Group on Coronary Pathophysiology & Microcirculation, ESC Working Group on Thrombosis and the Association for Acute CardioVascular Care (ACVC), in collaboration with the European Heart Rhythm Association (EHRA). Cardiovasc Res 2021:cvab298. [PMID: 34528075 DOI: 10.1093/cvr/cvab298] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
761 Braxton AM, Creisher PS, Ruiz-Bedoya CA, Mulka KR, Dhakal S, Ordonez AA, Beck SE, Jain SK, Villano JS. Hamsters as a Model of Severe Acute Respiratory Syndrome Coronavirus-2. Comp Med 2021;71:398-410. [PMID: 34588095 DOI: 10.30802/AALAS-CM-21-000036] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
762 Naruse K. Does glycemic control rescue type 2 diabetes patients from COVID-19-related deaths? J Diabetes Investig 2020;11:792-4. [PMID: 32521120 DOI: 10.1111/jdi.13320] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
763 Bruter AV, Korshunova DS, Kubekina MV, Sergiev PV, Kalinina AA, Ilchuk LA, Silaeva YY, Korshunov EN, Soldatov VO, Deykin AV. Novel transgenic mice with Cre-dependent co-expression of GFP and human ACE2: a safe tool for study of COVID-19 pathogenesis. Transgenic Res 2021. [PMID: 33855640 DOI: